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Abstract 
 
 In vitro erythropoiesis of cord blood haematopoietic stem cells (HSCs) to produce 
fully enucleated red blood cells could provide an alternate resource for the erythrocyte. 
However, haematopoietic processes are highly complex and dynamic; defining process 
requirements to produce reproducible cells of high purity and yield is not an easy task. One 
major obstacle is the lack of knowledge in process characteristics. Design of experiments 
(DOE) is proposed as a tool to unveil process complexities that exists in HSC cultures. 
Characterisation and optimisation of in vitro erythropoiesis as a single-step culture is first 
performed via a simple DOE experimental strategy. The optimised DOE culture produced 
significantly better results (higher growth and faster maturation) than other single-step 
cultures. Subsequently, use of DOE to reveal in vitro process dynamics was attempted. This 
study was much more challenging and the repeatability of DOE process models was 
compromised in some cases. Process control of HSC culture bioprocesses is required for the 
delivery of reliable cell culture products suited for clinical applications. The availability of a 
convenient and economical online real-time process monitoring system can provide the 
means to translate stem cell culture bioprocesses from the bench-side into manufacturing 
production. The design and integration of such a system capable of simultaneous process 
monitoring of multiple analytes (ammonia, pH and oxygen) is presented. Operational and 
functional stability of this unique online real-time in situ monitoring platform was achieved. 
Stability of oxygen and ammonia sensors was achieved for up to three and six days 
respectively but biocompatibilities of both sensors require some improvements. Sensors of 
pH were biocompatible but their stability in cell culture is required. 
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CHAPTER 1 
Introduction 
 
 
 
Haematopoiesis is the process of blood formation. Each day, the human body 
produces and replenishes about 5x1011 blood cells for the average adult1. When the process of 
haematopoiesis malfunctions, various types of blood-related malignancies and disorders, 
such as leukaemia and anaemia result. One of the potential cures that have been tested 
clinically is haematopoietic stem cell (HSC) transplantation2,3, which involves the 
transplantation of HSCs derived from, primarily, the bone marrow and, to a lesser extent, 
peripheral blood or umbilical cord blood. Though the procedure is still considered somewhat 
high risk due to the many possible complications, such as graft-versus-host disease 
(GVHD)4,5, HSC transplantation offers the only potential cure or long-term remission for 
many different types of haematological conditions. Human umbilical cord blood stem cells 
have recently gained in popularity due to their reduced risk in immune rejection and GVHD 
occurrences but also due to their ease of collection and wider availability of usage for 
 24 
 
minorities. However, cord blood stem cells are limited by the volume and number of cells 
available in a single cord blood unit. In vitro expansion and differentiation of cord blood stem 
cells have, therefore, been investigated in order to increase the cell number available, thus 
increasing the chances for a successful transplantation. Use of expanded HSCs for treatment 
of blood types diseases, for transfusion or for post-chemotherapy patients has been successful 
in various cases6-8. However, mechanisms controlling HSC fates in vitro are still poorly 
understood and not well defined; operation of a bioprocess that ensures quality and 
consistency of in vitro manipulated HSC products for clinical applications is therefore still 
difficult to achieve. Research efforts continue to further the characterisation of these complex 
bioprocesses in order to improve yield and quality of the cellular product that will meet high 
clinical standards.  
The manufacture of stem cell engineered products suited for clinical applications also 
requires reliability, productivity, and reproducibility of the bioprocess operation. This not 
only demands a thorough understanding and definition of the bioprocess of interest, it also 
requires the necessary tools to perform tight process control9. However, current stem cell 
culture practises still lack the technology that can perform process monitoring in real-time to 
provide the necessary information for achieving tight process control9. This thesis will give 
an overview of some of the problems currently faced in HSC bioprocessing and aims to 
provide potential solutions that will bring about significant contributions for the future of 
stem cell research and bioprocess operation. 
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1.1  THESIS OUTLINE 
Chapter 2 begins with a background of the biology of HSCs, the importance and use 
of umbilical cord blood stem cells, and the expansion and differentiation of HSCs in vitro. 
This is followed by an introduction to design of experiments (DOE) which includes a 
background of basic DOE designs, process characterisation, and optimisation methods. The 
chapter ends with a brief review of a selection of currently available measuring and 
monitoring technology for cell culture studies to underscore the lack and need for a real-time 
monitoring system. To sum up the overarching needs in stem cell bioprocessing, the overall 
goal and objectives of this thesis are presented in Chapter 3. Chapter 4 encompasses all the 
experimental methods and materials used for cord blood stem cell cultures, DOE strategies 
used for characterisation and optimisation studies, DOE strategy for spatial profiling of 
analytes, and the real-time monitoring platform designed for stem cell bioprocessing.  
Chapters 5 through 8 embody the scientific research behind this thesis. The specific 
objectives for each chapter are summarised in Table 1.1. Chapters 5 and 6 focus on 
characterisation and optimisation studies for in vitro erythropoiesis of cord blood stem cells 
using DOE methods. Specifically, chapter 5 demonstrates the use of DOE in process 
screening, characterisation, and optimisation for a single step culture process. The main 
objective in this chapter is to demonstrate a systematic DOE strategy that can effectively and 
efficiently identify and quantify culture parameters in a complex bioprocess. Chapter 6 aims 
to further process characterisation and optimisation by looking at the effects of time on the 
cell expansion and differentiation, using again a DOE approach, to determine in vitro cell 
culture process dynamics. Optimisation of in vitro erythropoiesis as a multi-step is pursued 
here. DOE methods can also be used to study spatial variations within a process space, and 
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this work is demonstrated in Chapter 7, wherein temperature sensors were used to 
demonstrate the feasibility and robustness of this approach. In Chapter 8, results from the 
novel multi-channel multi-analyte real-time online monitoring system are presented. This 
includes biocompatibility/toxicity studies and real-time monitoring data obtained for 
ammonia, pH, and oxygen sensors. Final thoughts regarding the findings from this thesis and 
recommended future directions are summarised and concluded in Chapter 9. 
 
Table 1.1 Scientific objectives for chapters 5, 6, 7 and 8. 
Chapter Scientific objectives 
Chapter 5 DOE process characterisation and optimisation (single-step optimisation) 
Chapter 6 Elucidation of process dynamics using DOE (multi-step optimisation) 
Chapter 7 Spatial profiling using DOE 
Chapter 8 Real-time monitoring using in situ biosensors 
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CHAPTER 2 
Background 
 
 
 
2.1  HAEMATOPOIESIS 
Blood is one of the most essential components that sustain the human body. As blood 
circulates in the body, it helps maintain body temperature, fights infections, and nourishes the 
survival of all organs via the transport of oxygen and nutrients as well as the removal of 
harmful metabolites. Blood cells in circulation have a short lifespan varying from a few days 
to several months. As blood cells die, the human body responds through an elegant feedback 
system, to ensure that blood is continually replenished. This process is called haematopoiesis 
and it takes place in the bone marrow of healthy adults10. The primary function of 
haematopoiesis is to maintain the homeostasis of haematopoiesis by producing the various 
cell progenitors, which then terminally differentiate to generate all mature blood cells. This 
complex and highly regulated process comprises of the processes of self-renewal, 
proliferation, commitment, differentiation, and cell death.  
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The site of haematopoiesis, the bone marrow and its haematopoietic inductive 
microenvironment (HIM), is a complex sinus network consisting of stromal cells, bone cells, 
growth factors, extracellular matrix (ECM) and the residing haematopoietic cells11. The bone 
marrow stroma, consisting of stromal cells, macrophages, endothelial cells, and adipocytes, 
provides structure to the HIM and secretes growth factors that are the key initiators of most 
haematopoietic cell functions, such as homing, cell adhesion, proliferation and 
differentiation11. ECM macromolecules, secreted by the stromal cells, include proteoglycans, 
collagen and adhesive proteins such as laminin and fibronectin, which help to localise growth 
factors and the haematopoietic cells to their specific functional three-dimensional (3D) 
micro-environmental niches11. At these sites, a well-balanced physical, chemical and cellular 
microenvironment enables regulated processes to occur through a series of cell-to-cell and 
cell-to-matrix interactions as well as the micro-concentration gradients of the soluble factors. 
 
2.1.1 Haematopoietic cells 
All mature blood cells originate from a common stem cell called the haematopoietic 
stem cell (HSC), which in adults, resides in the stem cell niches of the bone marrow10. HSCs 
are distinguished by their unique properties of self-renewal - they are able to produce a 
lifetime supply of mature blood cells for the host12 -  and multipotency - their ability to 
differentiate into different types of blood cells, each with a specific and often distinct 
function13 (Figure 2.1). Blood cells can be categorised in three main types: erythrocytes, 
leukocytes and thrombocytes. Erythrocytes, the red blood cells, are biconcave circular 
enucleated cells with a distinct affinity to oxygen due to the presence of haemoglobin. Their 
main function is to carry oxygen from the lungs to the tissues and transport carbon dioxide 
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from the tissues back to the lungs. Leukocytes, consisting largely of granulocytes, 
monocytes, and lymphocytes, vary in the shape of their nucleus and the presence of granules 
in their cytoplasm. Granulocytes, such as neutrophils, have irregular shaped/segmented 
nucleus while basophils and eosinophils are distinguished by the unique features of their 
cytoplasmic granules. Lymphocytes usually have a circular/oval nucleus with little/no 
presence of cytoplasmic granules and can vary significantly in sizes, ranging from 10 to 20 
µm13. Monocytes are the largest blood cells and measure around 15-22 µm13. The nucleus of 
a monocyte can be round, kidney-shaped or indented and generally stain lighter than other 
leukocytes. Leukocytes are cells of the immune system. Cells, such as neutrophils, fight 
bacterial infections, while basophils and eosinophils participate in various inflammatory 
reactions. B- and T-lymphocytes produce antibodies and cytokines to neutralise bacteria and 
viruses, while monocytes/macrophages usually engage in phagocytosis, engulfing dead cells 
and foreign materials as they protect the body against infection. Thrombocytes (platelets) are 
small cell fragments deriving from megakaryocytes and participate mainly in the blood 
clotting process.  
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Figure 2.1 The process of haematopoiesis. (Adapted from Kaufman and Anderson 2003) 
Lineages: B/CFU = burst/colony forming unit, GEMM = granulocyte-erythrocyte 
macrophage and monocytes, Ba = basophil, Eo = eosinophil, Meg = megakaryocyte, E = 
erythrocyte, NK = natural killer cell. 
 
 
Haematopoietic pathways are highly regulated by cytokines/haematopoietic growth 
factors – a family of glycoproteins that regulate cellular processes by recognising and 
interacting with specific cell-surface receptors. These cytokines control the proliferation, 
differentiation, and inhibition of haematopoietic processes, influencing the production of 
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blood in the body or in ex vivo cell culture systems. Figure 2.1 indentifies some of the key 
growth factors that are involved in the various differentiation pathways of the blood14. 
Progressive differentiation of blood cells to the different lineages often requires the 
interaction of several growth factors, some of which may be lineage-specific, such as 
erythropoietin (EPO) which stimulates erythrocyte production and interleukin (IL)-2 which 
stimulates T-cell production, whilst others such as stem cell factor (SCF), IL-3 and FLT-3 
ligand (FL) work across lineage boundaries12. Non-lineage specific growth factors often do 
not act independently, but rather in conjunction with other growth factors to perform the 
required cellular function. Of these, SCF, IL-3, and FL stimulate the survival and 
proliferation of early progenitor cells, including HSCs15. Others, like the granulocyte-
macrophage colony stimulating factor (GM-CSF) and granulocyte colony stimulating factor 
(G-CSF), help in the differentiation of the myeloid lineages12,15. 
 
2.1.2 Haematopoietic stem cell markers 
 HSCs are identified by a number of haematopoietic markers, the most common one 
being CD34, a 90-120 kDa surface molecule from the sialomucin family (ando). The 
determination of haematopoietic markers that signifies the true HSC has been controversial 
as the assessment for long-term self-renewal ability using a reliable assay has not yet been 
established. Many studies have used the multi-lineage repopulating ability of HSCs in non-
obese diabetic/severe combined immunodeficient (NOD/SCID) recipients as a benchmark for 
identifying the HSC, and have determined that the CD45+CD34+CD38- phenotype as a 
reliable source16,17. However, other researchers have also found that CD34- haematopoietic 
cells are also capable of SCID repopulating cell activity18. Recent studies have indicated that 
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a haematopoietic phenotype of CD45-CD34-CD38-Lin- cells are capable of long-term culture 
initiating cell activity and may represent the most immature phenotype identified so far in the 
haematopoietic lineage19. 
 
2.1.3 Cord blood stem cells and their therapeutic applications 
HSCs are commonly used in transplantation for the treatment of malignant and non-
malignant diseases. These include leukaemia, lymphoma, inherited blood, immune, and 
metabolic disorders, such as Hurler’s syndrome, sickle cell disease, and osteoporosis20. 
Sources of stem cells for transplantation include the bone marrow, peripheral blood and cord 
blood. Each HSC source presents its advantages and limitations21. Use of cord blood stem 
cells has gained in popularity due to the ease of collection, rapid availability, worldwide 
acceptance, reduced risks of chronic and acute graft-versus-host diseases (GVHD), and 
greater human leukocyte antigen (HLA) mismatch tolerance6,22-24. To date, over 175,000 cord 
blood units have been banked and are publicly available for transplantation worldwide24. 
Procedures for collecting, banking, and storing cord blood donations are determined by 
several organisations such as the American Association of Blood Banks, the American Red 
Cross, Eurocord, NETCORD, and the National Bone Marrow Donor program to ensure the 
quality and standards of the cord blood units used for transplantation6. Thus far, over 8,000 
cord blood stem cell transplantation have been performed worldwide with successful 
treatments performed on 70 different types of diseases including acute lymphocytic and 
myelogenous leukaemia (ALL and AML, respectively), myelodysplastic syndrome (MDS), 
Hodgkin and non-Hodgkin lymphoma, neuroblastoma, thalassemia etc25,26.  
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Successful cord blood transplantation has been performed on both related and 
unrelated children and adults. The survival rate post transplantation is generally higher in 
children than adult patients due to the limited number of cord blood stem cells available in a 
single cord unit. The recommended minimum dosage for cord blood transplantation is 
1.7x105 CD34+ cells or >2.0x107 total nucleated cells/kg of recipient body weight24. 
However, delayed haematopoietic recovery and lower engraftment success are observed in 
cord blood transplants in comparison to bone marrow or peripheral blood stem cell 
transplantations23. This can be improved by using higher CD34+ cell dosages; it was found 
that a cell dosage of >2.7x105 CD34+ cells/kg reduced transplant related mortality by about 
four times6. However, the major limitation in the use of cord blood stem cell transplantation 
for adults is the amount of stem cells obtained from a single cord unit which restricts the rate 
of successful transplantation to mostly children or adults weighing less than 35 kg. 
The use of multiple cord blood units for transplantation in adult patients has been 
attempted and achieved some success. However, continued studies and clinical trials are 
being conducted to better develop selection criteria and prevent complications that could 
arise due to the combination of different resources21,27. Alternatively, combined use of stem 
cells with ex vivo expanded cord blood cells has also been experimented. Use of ex vivo 
expanded cord blood stem cells provides a promising opportunity for the manipulation of 
cord blood resources. Transplantation of cord blood stem cells with ex vivo expanded cells 
was intended to accelerate short-term haematopoietic engraftment and reduce the risk of early 
mortality or graft failure6,24. Current methods for expansion of cord blood stem cells include 
the use of different cytokine combinations in culture. However, ex vivo expansion of cord 
blood stem cells is not straight-forward and the final cellular product must also meet stringent 
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clinical standards for transplantation purposes. There is also the concern of unwanted stem 
cell differentiation during the expansion process, which may increase the risk of late graft 
failures28. Directed differentiation of cord blood stem cells to various blood cell types could 
also provide other potential applications, such as an alternate resource for blood for 
transfusion29.  
 
2.1.4 Haematopoietic stem cell culture practices 
 Traditionally, ex vivo expansion and directed differentiation of HSCs have been 
performed in serum-containing cultures. Many studies have been performed in gas-permeable 
blood bags and tissue culture flasks/well-plates, which can be sustained for prolonged periods 
(16 weeks)30. The addition of serum provides a rich supplement in nutrients and growth 
factors that promotes cell proliferation and sustains cell survival, which is particularly 
applicable to HSC cultures. However, the use of serum presents challenges for clinical 
applications. Consequently, serum-free culture conditions for ex vivo expansion has been 
explored. However, serum-free cultures typically require the use of large amounts of growth 
factors or cytokines, at abnormally high concentrations, which renders this approach cost 
inefficient. Specific roles for different cytokines used in ex vivo cultures have been 
extensively studied and reviewed in past literature31,32. Some of the cytokines that have been 
used for multi-lineage expansion include SCF, FL, macrophage-derived growth factor 
(MDGF) and granulocyte-colony stimulating factor (G-CSF)33. Expansion of specific 
lineages, such as megakaryocytes, utilises SCF, IL-3, IL-6, IL-9 and thrombopoietin (TPO)34-
36
.  
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Another common method used for culturing HSCs in vitro is the stromal-based co-
culture system using the murine stroma-5 (MS-5) cell line, HESS-5 cell line, or human bone 
marrow stroma Stro-1+ cells to support serum-free cell cultures37-39. A comparison between 
allogeneic and autologous Stro-1+ mesenchymal stem cell (MSC) populations showed better 
performance in expanding CD34+CD38+ cells and higher clonogenic potential of HSCs co-
culture with stroma from allogeneic sources40. Co-culture systems benefit from stromal cell 
secreted cytokines and cell-matrix interaction, which enhances cellular activities. However, 
approval of stromal based cultures for clinical applications can be tenuous, particularly those 
of xenogenous origin. Preparation of a stromal cell layer for the co-culture system also 
increases labour, culture time, and complexity of the culturing process. Total cell expansion 
of progenitors in co-culture systems do not show significant improvement from that achieved 
in cytokine cultures.  
Bioreactors used for expanding HSCs have also been explored. Expansion of cord 
blood mononuclear cells (MNCs) performed in a rotating wall vessel (RWV) biorector was 
compared to cell culture in a standard T-flask. Growth performance in the RWV bioreactor 
was found to be superior to the T-flask as it was able to provide a more homogeneous cell 
culture environment which enhances contact between HSCs and accessory cells while also 
optimising the effective utilisation of cytokines41. Cells cultured in microgravity (in the 
RWV) versus earth gravity also showed better engraftment potential42. Other types of 
bioreactors that have been tested for ex vivo expansion/differentiation of HSCs include 
perfused bioreactors, stirred-tank bioreactors, fixed bed, airlift, and hollow-fiber 
bioreactors43.  
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Cytokine-based / 2D cultures do not resemble the in vivo environment due to the lack 
of cell-matrix interactions which has been the basis for many 3D cell culture studies to 
induce hematopoietic proliferation and differentiation44,45. 3D culture systems for creating a 
culture environment that mimics the bone marrow haematopoietic microenvironment have 
therefore been attempted. The use of scaffolds to create a 3D culture environment has been 
tested in various systems. Nanofiber scaffolds conjugated with different amino groups have 
shown to enhance cell adhesion and affect the expansion outcome of HSC cultures46. It has 
also been shown that a 3D co-culture system developed using stromal cells seeded in non-
woven fabrics was more superior to its conventional 2D stromal co-culture in terms of 
progenitor expansion47,48. Additional factors such as extracellular proteins were found to be 
secreted in the 3D configuration47. These studies have shown that ex vivo expansion in 3D 
cultures has several advantages: cellular growth and responses in the 3D configuration appear 
to resemble that in the in vivo system, and the lack of exogenous growth factors also did not 
inhibit multi-lineage differentiation of cells in the 3D configuration49,50. These observations 
suggest the possibility of eliminating the use of growth factors in haematopoietic cultures 
which save significant costs in maintaining or expanding haematopoietic resources. However, 
extraction of cells grown in 3D scaffolds is not straight-forward as it may cause damage to 
the cells (reduced viability) or achieve only partial dissociation51. 
 
2.1.5 Culture parameters for ex vivo expansion and differentiation 
Successful ex vivo expansion and directed differentiation of HSCs rely on the careful 
manipulation of key process variables affecting cellular environment. These include pH, 
dissolved oxygen and carbon dioxide tensions, nutrients, metabolites, and growth factor 
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concentrations used for the cell culture (Table 2.1). Culture parameters can greatly affect the 
growth and differentiation of cells by inhibiting or destroying cells in culture if certain 
parameters are not maintained at the right levels. It is therefore important not only to 
understand the effects of each cell culture parameter but also determine the right 
concentrations and levels that are necessary for a well-balanced cell culture environment. 
 
Table 2.1 Culture parameters affecting HSC cell environment 
Physicochemical 
Factors 
Nutrients & Metabolites Cytokines 
pH 
Dissolved oxygen tension 
Dissolved carbon dioxide 
tension 
Temperature 
Glucose 
Glutamine 
Glutamate 
Lactate 
Ammonia 
Stem cell factor (SCF) 
Flt3-ligand (FL) 
Interleukin (IL)-3, 6, 11 
Thrombopoietin (TPO) 
Etc. 
 
Culture pH, dissolved oxygen and carbon dioxide tensions, and chamber temperature 
affect the cell’s physicochemical culture environment. In standard culture practices, cells are 
grown in culture at a pH of 7.40, 20% oxygen, and 5% carbon dioxide in a 37oC fully 
humidified chamber. However, previous studies showed that the inducement of proliferation 
and differentiation of different blood cell lineages in vitro operate at different optima. 
Specifically, a higher pH (7.60) enhanced the differentiation and maturation of both 
megakaryocytic and erythroid progenitors52,53. In contrast, in vitro granulopoiesis was found 
to operate optimally at a lower pH (7.21); the lower pH enhanced granulocyte colony 
stimulating factor receptor (G-CSFR) expression which promoted granulocyte proliferation 
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and differentiation54. Oxygen tension is a critical factor in processes of haematopoiesis; in 
culture, it can greatly affect the expansion of cells by modulating the production of cytokines, 
surface markers and transcription factors55. Oxygen demand varies for different cell lineages 
at different maturation stages - low oxygen concentration (5%) is better for progenitor cell 
expansion while high oxygen (20%) promotes the growth of mature megakaryocytes and 
erythrocytes53. Low oxygen tension was also found to enhance granulocyte differentiation56. 
These findings strongly suggest the presence of in vivo pH and oxygen gradients where 
different sites in the bone marrow simultaneously participate in different haematopoietic 
cellular activities.  Very few studies have been conducted on the effects of temperature. Most 
cell cultures maintained at 37oC achieve healthy cell growth.  However, in one study, a 
slightly elevated temperature of 39oC was found to enhance megakaryopoiesis in CD34-
enriched cord blood cultures57. The above findings highlight the fact that process variations 
in the cellular environment affect different cell populations and their behaviours in vitro. 
Availability of nutrients and removal of unwanted metabolites in a cell culture is 
important for supporting basic cellular activities and maintaining the overall healthiness of 
the cells. Serum containing culture medium provides a multitude of nutrients that supports 
HSC proliferation and differentiation. However, the lack a defined serum as well as serum 
variability, pose significant limitations.  Serum-containing cultures are therefore not ideal for 
expanding/differentiating cells that will be used in clinical applications. Instead, defined 
serum-free media are used for these purposes. Traditionally, in mammalian cell cultures, 
nutrient and metabolite concentrations are frequently monitored to ensure optimal cell growth 
and production of cellular products58-62. Nutrients and metabolites frequently monitored in 
cell culture bioprocesses include glucose, glutamine, glutamate, lactate, and ammonia. 
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Glucose and glutamine, the main sources of carbon and nitrogen respectively in metabolic 
pathways, provide essential components and energy to the cells such that they can participate 
and perform various cellular activities. In contrast, lactate and ammonia are the by-products 
of cell metabolism and need to be maintained at low levels so that they do not become toxic 
to the cells. High levels of lactate or ammonia inhibit cell growth and extreme levels can 
cause both apoptotic and necrotic cell death63. In general, ammonia is more toxic than lactate; 
levels of ammonia must therefore be closely monitored to prevent damage to the cells. In a 
study of mouse embryonic stem cell (ESC) culture, ammonia levels were maintained at 
below 3mM to ensure healthy cell growth and prevent any inhibitory effects on the cell 
culture64. Monitoring of key nutrients and metabolites in a bioprocess operation is essential 
for maintaining the right balance of these factors to run at optimal conditions. 
Growth factors and cytokines provide key functional signals to the cells and regulate 
processes such as self-renewal, survival, proliferation, and differentiation of HSCs. Each 
growth factor/cytokine has various unique functions, both positive and/or negative in nature, 
and can act on either a specific cell lineage or multiple lineages. Early acting 
cytokines/growth factors that have been identified for the survival and expansion of 
haematopoietic stem and progenitor cells include SCF, FL, IL-3, IL-6, and IL-165-67. Other 
cytokines responsible for the differentiation of progenitor cells into specific lineages include 
TPO which stimulates megakaryopoiesis and thrombopoiesis35,68, EPO which triggers 
erythropoiesis (the production of red blood cells)69,70, GM-CSF which controls the 
differentiation of myeloid progenitors and production of granulocytes, and IL-5 which 
regulates eosinophil production71. The selection of the growth factors/cytokines for in vitro 
HSC cultures, their concentration and the combinations in which they are used, can 
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significantly affect stem and progenitor cell activity, differentiation and expansion72,73. Many 
investigators have attempted to study and characterise these effects for the ex vivo expansion 
and differentiation of HSCs32,67,72,74-76. However, traditional approaches have been mostly 
based on dose-response methods that are limited to a one factor at a time analysis77. 
Interactions between different growth factors and other process parameters such as nutrients 
and metabolites cannot be defined using these methods. A much more robust mathematical 
approach is required to identify and quantify each effect and their respective interactions in 
order to tailor culture processes for optimal production of a specific haematopoietic cell 
population. 
A balanced combination of all the above factors (pH, oxygen, nutrients, metabolites 
and growth factors etc.) contributes to the cellular environment of an ex vivo culture. Ideally, 
a cell culture environment resembling that of the in vivo process is desired. However, due to 
the heterogeneity, complexity, and the transient nature of the in vivo cell environment, 
determining process requirements that mimics the in vivo process is not a straightforward 
task. Utilisation of robust mathematical methods such as DOE is necessary to provide a better 
understanding and characterisation of the in vitro process. This will facilitate the elucidation 
of complex cellular mechanisms and provide process information that is needed to define an 
in vitro cell culture environment. 
 
 
2.2 DESIGN OF EXPERIMENTS 
 DOE is a highly effective and efficient methodology for investigating a process of 
interest in order to obtain the maximum amount of information about the process using 
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minimum effort (i.e., experimentation)77. In traditional experimental approaches, such as the 
dose-response methodology, a process is studied one factor at a time; meaning each factor is 
varied individually while other factors in the process remain unaltered. This approach has 
several limitations: (1) it does not reveal process interactions between different factors and 
(2) it often does not paint the “true” picture of the process and can therefore result in 
misleading conclusions78. The optima obtained from dose-response experiments are often not 
the true optima of the process77. In contrast, DOE allows us to study a process under greater 
scrutiny and precision. The availability of different types of DOE designs allows a tailored 
approach to the needs/goals of the experiment. A distinct advantage in using DOE is its 
ability to reveal both individualistic and interactive effects of a process using the minimum 
number of experimental runs77. This saves significant time and operational costs, but more 
importantly, it reveals a complete and accurate picture of the process which allows the 
experimenter to determine the process optima. As a result, DOE is widely used in many 
different types of industrial applications such as chemical and semiconductor processing. 
Comparison studies, screening experiments, response surface studies, and regression 
modelling can be performed using different DOE designs. 
 To date, use of DOE for cell culture studies is still rather limited; much of the 
research continues to rely on traditional dose-response methods. However, a small number of 
investigators who have used DOE for studying in vitro HSC cultures include the use of 
fractional factorial designs to perform screening experiments79,80, and the use of central-
composite or full factorial designs to perform process characterisation35,76. In the study 
performed by Yao and colleagues, concentrations of nine different growth factors and eight 
different serum substitutes were optimised via two-level factorial designs and the method of 
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steepest ascent, which resulted in 27-fold expansion of CD34+ cells in serum-free conditions 
after one week80. In another study investigating megakaryocyte maturation, 13 different 
cytokines were screened using the Placket-Burman design (PBD) followed by 
characterisation using a two-level factorial design35. It was found that TPO in the presence of 
SCF, IL6 and IL3 significantly stimulated in vitro megakaryopoiesis while EPO and IL-8 
inhibited megakaryocyte maturation35. Use of DOE for performing characterisation studies 
provided a 3D process representation describing cytokine effects and interactions for the 
process of interest. However, full process characterisation which considers all the process 
factors including physicochemical parameters, nutrients, metabolites, and growth factor 
concentrations has not yet been established. Due to the complexity of their interactions, 
process investigation of these factors in combination is not straight-forward. The successful 
application of DOE methodologies to resolve the complexity in HSC cultures will not only 
yield invaluable information for HSC bioprocessing but also provide a novel approach for 
other cell culture studies. 
 
2.2.1 DOE experimental strategy 
 Complex systems, such as those encountered in the cell culture can be undertaken 
using a systematic approach through a series of DOE methods (Figure 2.2). This systematic 
approach breaks down a highly complex problem into sections and provides solutions to the 
problem in a sequential manner which ultimately allows the experimenter to develop a 
realistic process model from the knowledge obtained at each stage of the process. This 
approach involves three main steps: screening, characterisation, and optimisation, which are 
performed sequentially using the appropriate experimental design(s) chosen at each stage81 
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(Figure 2.2). The objective in the first stage, screening, is to identify factors that have a 
significant influence on the process, and accurately discriminate against factors that have 
little or no influence at all. Hence, the ultimate goal of the screening process is to quickly 
(using the minimum number of experiments) and effectively identify critical factors within 
the range of operation. In the second stage, characterisation, the goal is to obtain a more 
detailed and quantitative description about the process by way of 3D surface response plots to 
describe process characteristics. This is achieved by designing experiments for the 
parameters previously identified in the screening step so that both main and interactive 
contributions of the critical parameters are revealed. In optimisation, various approaches can 
be taken to reveal the optimal operating regimens for the critical process parameters 
investigated and yield the best conditions for a target process. In this case, multiple objectives 
can be defined and a common ground between the various requirements can be maximised 
using an iterative process from tools in the DOE software. These characteristics show how 
DOE is efficient for studying complex systems involving multiple factors and having 
multiple output considerations. The outcome of this systematic framework is a reproducible 
and statistically valid elucidation of bioprocesses that do not require a priori assumptions for 
the process of interest. 
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Figure 2.2 Proposed DOE approach for studying complex cell culture systems 
 
 
2.2.2 Factorial Designs 
Two-level factorial designs are the basic building blocks for many DOE designs and 
are therefore the most commonly applied design method. Factorial designs are very effective 
in studying both main and interactive effects rendering them extremely useful for response 
surface studies or process modelling82. A basic two-level full factorial design involves all the 
possible combinations of the high and low values of the various independent process factors 
under investigation and yields a total number of 2n experiments for n number of factors. 
Specifically, in a two-factor factorial design, the design points relate to the four corners of a 
square, representing full coverage of the experimental space, and yields four (22) 
experimental runs. Similarly, a three-factor factorial design yields eight (23) experimental 
runs and is depicted by points in a cube (Figure 2.3a). Basic two-level factorial designs are 
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mainly used to study linear relationships between process factors and their responses but are 
still capable for revealing both main and interactive effects independently. Other variations of 
the factorial design for the purpose of screening and response surface modelling using 
second-order models will be discussed in the following sections. 
 
 
Figure 2.3 Types of DOE designs. (a) A basic two-level three-factor factorial design consists 
of eight experimental conditions (b) A three-factor centre-composite design (CCD) consists 
of eight factorial points, a centre point and six axial points. 
 
 
As previously discussed, most cell culture bioprocesses involve a multitude of 
parameters. This increase in the number of factors in an experimental study results in a rapid 
increase in the number of DOE experimental runs required in a full factorial design. For 
instance, in a seven-factor experiment the required number of experimental runs would be 27, 
which equates to 128 experiments. This is a significantly large number of experiments to 
perform, which can be costly, labour intensive and extremely time-consuming, thus making 
full factorial designs an impractical option for process screening. Often when a large number 
of factors (more than five) are involved, screening is performed and two-level fractional 
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factorial designs are used to identify the influencing parameters. Fractional factorial designs 
derive from full factorial designs, where only a fraction of the full design is used to perform 
the screening. The assumption made in these designs is that higher-order interactions are 
often negligible, therefore only the main factors and low-order interactions are estimated in 
the design. The number of experimental runs are reduced in this case as factors in the design, 
both the main and interactive effects, are aliased with each other.  
The effectiveness of the fractional factorial design depends on the resolution of the 
design which are defined as Resolution III, IV, and V82,83. A Resolution III design is one that 
has no main effects aliased with another main effect but they are aliased with two-factor 
interactions. Hence, Resolution III designs allow the estimation of the main effects, but the 
latter is biased by two-factor interactions. A Resolution IV design has no main effects aliased 
with another main effect or a two-factor interaction, but two-factor interactions may be 
aliased with each other. In practice it means that Resolution IV designs allow the estimation 
of main effects which are unbiased by two-factor interactions, although two-factor 
interactions in such designs are not estimable. Finally, a Resolution V design is one that has 
no main effects or two-factor interactions aliased with each other. Hence, Resolution V 
designs allow the estimation of both main effects and two-factor interactions independently. 
Higher-order interactions, three or more interactions, are usually assumed to be negligible. In 
conclusion, a design with a higher resolution represents a more thorough design since fewer 
factors are aliased with each other, but require a greater number of experiments. In most 
screening studies, a Resolution IV design is sufficient to perform accurate screening as the 
main factors are not aliased with any two-factor interactions, which are often significant in 
most processes. A table of experiments required for full and fractional factorial designs is 
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displayed in Figure 2.4. As symbolised by the colours, experimenters can proceed with 
Resolution V designs in great confidence (green); Resolution IV designs should be used with 
caution (yellow); Resolution III designs should be avoided (red) as much as possible. 
     
Figure 2.4 A matrix of full and fractional factorial designs and the number of experiments 
required for each design. (Adapted from Design Expert 6.0) 
 
 
2.2.3 Response surface modelling  
 The most common design used for characterisation studies is the central composite 
design (CCD). The CCD derives from two-level factorial designs with additional axial points 
and a centre-point integrated into the basic 2n design. The centre-point is used to estimate the 
curvature in a second-order model and is replicated for estimating pure experimental error. 
Axial points are used mainly to estimate the quadratic terms in a second-order model82. CCDs 
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are therefore used for modelling 2nd order response surface curves. The position of the axial 
point depends on α, the axial distance, which varies according to the extent of the region of 
operation of the various process variables. The value of α can range from 1 to √n, where n is 
the number of factors in the experiment. The choice of α value affects the design rotatability, 
which relates to the robustness and stability of the design. A rotatable design is one that 
provides equal variance in the estimation of predicted values at any two locations in the 
design space82. A CCD with an α value of √n is referred to as a spherical design and is nearly 
rotatable or considered rotatable. A CCD with an α value of 1 is a cubodial or face-centred 
design. Though they are not rotatable, face-centred designs are often applied in many 
experimental studies where operating ranges are restricted but are still very effective in 
providing full process characterisation for the defined process regime. Another popular 
design is the Box-Behnken design, which is an independent quadratic design using three 
levels on each factor including a centre-point. But unlike the factorial designs, it takes the 
midpoints on the high and low end of the process space. This avoids any single experimental 
process to be at the extreme values of all the process factors, which can be useful in situations 
where there is a process limitation. The centre-point is also used here for the estimation of 
error and curvature. Other available designs include other spherical response surface method 
(RSM) designs and Equiradial designs82. 
 
2.2.4 Optimisation methods 
 Optimisation of process conditions can be performed via several methods. One of the 
most commonly used methods is the location of a stationary point in the response surface 
model84. This stationary point can represent a maximum response, a minimum response or a 
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saddle point84. The ultimate goal in the RSM is generally to obtain an optimum in the process 
under investigation and the generation of a 2nd order model allows ease in the identification 
of these regions. Another commonly used method is the method of steepest ascent80,84 which 
is a process that guides the experimenter to move in the direction of maximum increase in the 
response84. Although this method is not as precise as the RSM, it allows one to quickly 
identify process conditions close to the area of optimal operation. 
 
2.2.5 DOE for cell culture applications 
 With the availability and diversity of a wide array of DOE designs, many different 
applications can be found for the elucidation and optimisation of complex cell culture 
bioprocesses. The variety of DOE designs also provides flexibility in the design and approach 
of an experimental study and allows the experimenter to test the system using different 
methods. Use of DOE, as mentioned before, is a highly efficient and effective method for the 
study of complex systems; process screening can be performed using minimum effort 
(number of experiments) saving significant time and labour costs. Most importantly, the 
approach to the definition of cell culture bioprocesses is no longer at random or based on 
tedious single-factor analysis as DOE readily provides a systematic, reliable and effective 
approach toward the investigation and optimisation of complex cell culture bioprocesses, and 
produces information rich data/models that can be used for predicting cell culture outputs. 
Such precision and quality of information is necessary for achieving a well-defined culture 
environment that produces consistent cell culture products meeting high clinical standards. 
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2.3 PROCESS MONITORING TECHNIQUES 
Process monitoring and process control of a bioprocess operation is necessary to 
ensure the quality and reproducibility of the product output. Cell based products intended for 
clinical applications, in particular, demand the highest quality and purity. In order for us to 
deliver stem cell therapies from the bench-top to the bedside, a tight control of the bioprocess 
operation is essential. Online, real-time process monitoring provides vital information that is 
needed to perform accurate control of the bioprocess of interest. Current monitoring 
techniques for cell culture bioprocesses, though extensive, have not been widely applied to 
stem cell cultures. Simultaneous monitoring of key process variables is limited to only certain 
parameters such as pH and oxygen. In this section, we will discuss existing monitoring and 
measurement tools applicable to the various process variables of interest: (a) pH, dissolved 
oxygen tension, carbon dioxide tension, and temperature; (b) nutrients and metabolites; (c) 
growth factors/cytokines; and (d) cell viability and concentration. Table 2.2 summarises the 
major measurement and/or monitoring techniques currently used for various applications 
which will be discussed in the following sections. 
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Table 2.2 Summary table of monitoring and measurement techniques for cell culture studies 
Technique Applications Advantages Disadvantages 
Electrochemical 
Sensors 
pH, O2 Fast, easy to use 
Large pH range 
Electrical/magnetic interferences 
Frequent calibration needed 
Invasive method 
Fouling and biocompatibility 
Optical sensors pH, O2, CO2 Fast, easy to use 
No electrical or magnetic 
interferences 
Turbidity issues 
Limited pH range 
Biosensors Metabolites 
Cytokines 
Easy to make and use Limited enzyme stability 
Frequent calibration 
Invasive method 
Sterilisation issues 
Commercial 
bioanalyser 
Metabolites, 
pH, O2, CO2 
Easy to use 
Accurate, reliable, quick 
Available as online systems 
High / costly maintenance 
Bulky instruments as online 
systems 
HPLC Metabolites 
 
 
Highly accurate and reliable 
Wide application 
Possible online system 
Long sample analysis time 
Mostly applied as an off-line 
method 
NIR 
Spectroscopy 
Metabolites Rapid analysis 
Multi-analyte measurement 
Can be used as online system 
Signal overlap 
Broad bands 
Poor sensitivity 
NMR 
Spectroscopy 
O2 
Metabolites 
Cytokines 
Cells 
Non-invasive 
Rapid analysis 
Obtain O2 and cell distribution 
A wealth of information 
Labelling required 
15N & 31P NMR; low sensitivity 
Signal to noise issues 
Very expensive 
Immunoassays 
(ELISA) 
Cytokines Well-established method 
Highly sensitive 
Accurate and reliable 
Wide range of applications 
High reagent cost 
Large sample volume 
Labour-intensive 
Not an online method 
Multiplex 
immunoassays 
Cytokines High throughput 
Highly sensitive 
More cost-effective 
Small sample volumes 
Initial setup cost 
Cross-reactivity 
Flow cytometry Cytokines 
Cells 
Multi-cellular quantification 
Single cell analysis 
Sorting capabilities 
High throughput 
Wide application 
Expensive equipment 
Not suitable as online method 
Cell counters Cells Fast, accurate, reliable 
Fully automated 
Easy to use 
Limited applications 
In situ 
microscopy 
Cells Good stability  
Automatic control and image 
analysis 
Limitations in differentiating cell 
types 
Large amount of image data 
Micro-CT Cells Non-invasive 
Non-destructive 
Qualitative analysis 
Radiation exposure 
Raman Cells Non-invasive 
Relatively little sample 
preparation 
Low sensitivity 
High concentrations required 
 52 
 
2.3.1 pH, oxygen, carbon dioxide, and temperature 
The most common devices used for monitoring pH and oxygen are electrochemical 
sensors. The basic operation of an electrochemical sensor consists of a working electrode and 
counter electrode separated by a layer of electrolyte. The main advantages of electrochemical 
sensors are its sensitivity, simplicity and low cost. Sensors are also reliable over a wide range 
of values. They are therefore frequently used in many industrial applications and suitable for 
in situ process monitoring. Unfortunately, they do not show long-term stability for 
continuous monitoring in cell culture bioprocesses and require frequent recalibration during 
the bioprocess operation. Furthermore, electrochemical sensors are susceptible to both 
electrical and magnetic interferences, and are sensitive to changes in the electrolyte levels. 
An alternative to electrochemical sensors is optical sensors, which rely on the 
absorbance or luminescence of an indicator dye immobilised in a cellulose or polymeric type 
support85,86. Since optical sensors are based on optics, they do not suffer from any magnetic 
or electrical interference but suffer from optical interferences due to turbidity or bubbles 
inside bioreactors. On the positive side, they offer fast measurements, excellent resolution, 
good sensitivity, stability, and are non-invasive to the cell culture environment. Long term 
performance of optical pH and oxygen sensors has been demonstrated for up to 120 and 180 
days, respectively87,88. Multi-analyte sensors have also been designed to monitor pH, oxygen 
and carbon dioxide simultaneously86,89. However, due to its optical limitations and high 
sensitivity, probe position can sometimes influence the results obtained in different 
experiments. The pH range for optical sensors is also limited by the sensitivity of the 
indicator dyes used, which is typically over 2-4 pH units. Most cell cultures operate within 
pH 7-8 and will therefore not be limited by the narrow range of the optical sensors. 
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Nuclear magnetic resonance (NMR) spectroscopy is an extremely powerful, long-
established and well known technique in analytical chemistry. The depth and resourcefulness 
of this technology has rendered it as one of the best tools for studying physical, chemical, and 
biological properties of simple or complex compounds. Its powerful imaging capabilities 
make it a distinctly unique methodology. Scientists have manipulated this advantage for the 
characterisation of oxygen distribution within a cell culture system90,91, which was 
accomplished employing 19F NMR. Unlike the use of sensors, 19F NMR spectroscopy is 
capable of measuring the oxygen partial pressures inside the bioreactor. This technique is 
based on signal relaxation time of perfluorocarbons, which depends on oxygen concentration. 
Images of 19F relaxation times can also be generated to provide the spatial distribution of 
oxygen within the bioreactor. This technique requires F-labelling through the addition of a 
perfluorocarbon emulsion into the reactor system, which, due to the biocompatibility of the 
perfluorocarbons, does not have any negative effects on the cells or culture system90,92. 
However, high equipment costs and the need for skilled operators deter many from using this 
technique. 
Temperature measuring devices are divided into three basic groups: thermocouples, 
resistive temperature devices (RTDs) and thermistors. These contact devices are typically 
designed as probes which can be inserted into the bioreactor. Thermocouples are most 
commonly used as they give the fastest response and are highly economical. They are well 
suited for high temperature environments and microscopic applications. Unfortunately, they 
suffer from low sensitivity, poor stability, and exhibit a non-linear behaviour. RTDs, on the 
other hand, are the most stable and accurate temperature measurement devices. They exhibit 
a more linear behaviour, have a broad operating range, and show good repeatability, which 
 54 
 
makes them applicable in many industrial applications93,94. However, they are expensive 
devices that have a slower response time and lower sensitivity94. Slow response time will not 
limit cell culture monitoring since fast and drastic changes are not expected to occur within 
the bioreactor system. Response time in cell culture environments are generally in the order 
of several minutes. Finally, thermistors, though not as commonly used as thermocouples or 
RTDs, are suited for low cost applications over small temperature ranges. But despite their 
economical advantages and fast performance, thermistors exhibit non-linearity and have a 
limited measuring range. They are also comparatively more fragile devices than their 
counterparts. 
 
2.3.2 Nutrients and Metabolites 
High-pressure liquid chromatography (HPLC) is frequently used for metabolite 
analysis in industry and academia due to its widespread applicability for studying many 
different types of compounds. It has the ability to analyse multiple analytes simultaneously 
while at the same time yielding high resolution and highly reproducible measurements. The 
high pressure system also has added advantages over traditional liquid chromatography 
columns, making processing time much quicker. However, standard processing time for 
conventional HPLC still requires around 60-90 minutes and is therefore not applicable for 
real-time measurements. Instead, it is more suited as a reliable off-line measurement tool or 
as a comparison to other analytical methods. Although HPLC cannot support real-time 
measurements, it can be applied as an online system for simultaneous measurement of 
multiple analytes to obtain continuous data from the process operation95. The automated 
online system provides the advantage of requiring less labour than performing multiple off-
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line analyses and is useful for capturing transient effects that may otherwise not be detected 
from off-line measurements95.  
Biosensors are popular analytical devices for the recognition of biological 
compounds, pathogens, and toxic compounds. In cell culture applications, they are mostly 
used for nutrient and metabolite measurements and can be applied to a wide range of 
biological compounds. The most common type of biosensors designed for metabolites is 
primarily enzyme-based via electrochemical or optical detection96,97. Detection limits of 
glucose biosensors typically range from 4-150 µM and has a sensitivity of 0.2-1.0 µA/mM98. 
Biosensors are often used in cell culture bioprocess monitoring as in situ sensors which make 
them a relatively straight-forward application. However, the design of a stable sensor that can 
survive for an extended period in cell culture remains a challenge as they are prone to fouling 
and do not operate well particularly in serum-containing cell culture environments. Most in 
situ biosensors do not last for longer than 24 hr in a continuous cell culture environment99. In 
situ biosensors therefore have severe limitations in operational stability and biocompatibility. 
The more common setup for online applications is the incorporation of flow injection 
analysis (FIA) where a sample is taken through a sample port so the sensor is not in direct 
contact with the process medium61,100,101. This protects the sensors from fouling and allows 
the calibration of sensors to be performed conveniently without disrupting the process 
operation101.  Despite the apparent advantages in application design, ease of use, and 
reliability, one major drawback is enzyme instability. Enzymes are highly specific yet subject 
to denaturation making them unsuitable for continuous long-term (>7 days) monitoring. 
Recalibration and enzyme replacement are often necessary. Efforts to enhance enzyme 
stability via the integration of new materials and improved immobilisation techniques have 
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been made to extend their operational lifetimes, improve sensor sensitivity, response time and 
detection limits102-104.  
Commercial bio-analysers, such as the Yellow Springs Instruments (YSI) bioanalyser 
and the BioProfile (Nova Biomedical) analyser, are some of the more commonly used 
instruments for mammalian cell culture studies which provide good measurement 
performance for routine practises. These systems are capable of measuring various nutrient 
and metabolite parameters such as glucose, glutamine, glutamate, lactate and ammonia, 
electrolytes such as sodium and potassium, and pH, dissolved oxygen and carbon dioxide. 
Commercial bioanalysers are easy to operate, self-calibrating and can perform readings 
within 2-3 min. Commercial bioanalysers are retrofitted for automated sampling to perform 
online bioprocess monitoring. The typical measuring range for glucose and lactate in a 
Bioprofiler is 0.2-15 g/L and 0.2-5 g/L respectively. However, commercial bioanalysers are 
extremely expensive to maintain and require a regular change of reagents in order to support 
and maintain the equipment’s performance. As an off-line system, they provide a good 
reference point and are often used for performing routine measurements. As an online 
system, bioanalysers can be utilised for bioprocess monitoring and control of 
nutrient/metabolite concentrations of cell cultures58.  
Near-Infrared (NIR) spectroscopy offers an attractive alternative to biosensors for 
performing rapid, simultaneous measurements of multiple analytes in real-time105,106. Typical 
sensitivity of NIR spectrometers has a standard error of prediction (SEP) range of 0.5-1.0 
mM. However, the distinct advantage of NIR spectroscopy is its ability to provide chemical 
information about the compounds, and not just their concentrations. Various configurations 
are possible for real-time monitoring: in an online system, samples are drawn directly from 
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the bioreactor in an automated loop107, while an in-line/in situ system assumes direct contact 
typically via a probe105,108. Alternatively, the most non-invasive method is to place an 
external probe outside the bioreactor through a window or by means of a fibre coupling 
scheme109. NIR spectroscopy requires low maintenance during operation and no sample pre-
treatment. Disadvantages of NIR spectroscopy include overlapping of signals, which tend to 
occur when bands are broad instead of distinct peaks. This makes monitoring of analytes at 
low concentrations difficult, particularly when the sensitivity and resolution here is not as 
high as other analytical systems. Other potential problems arising from long-term monitoring 
are likely due to environmental changes caused by temperature and optical interferences105. 
The development of reliable calibration models, often based on multivariate statistics, is 
therefore necessary to cope with process variations. This ensures that the system is more 
robust and sustainable over longer periods. Another instrument that is closely related to the 
NIR is the mid-infrared (MIR) spectrometer which interrogates in the mid-IR range. These 
regions are sometimes preferred as they reveal stronger absorbance and more distinct 
peaks108. However, MIR spectrometers are more expensive and are therefore less cost-
effective. 
The use of NMR spectroscopy to study cell metabolism is made possible through 1H, 
13C, 15N, and 31P NMR techniques which trace C-, N- and P-metabolites and their respective 
intermediates110-112. These metabolites include glucose, lactate and glutamine. Cell 
metabolism is not only important in assessing the cell’s physiological and energy status, it 
has also been recently suggested that metabolic rates could relate to HSC self-renewal113. 
One of the distinct advantages of NMR spectrometry is its ability to trace pathways and the 
fate of metabolites since it not only provides us with existing substrate concentrations, but 
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concentrations of intermediates and final products. This reveals the kinetics involved in 
various processes and allows the control of nutrients and toxic by-products in a biological 
system. Despite the wealth of information it can produce, instrumentation setup and data 
analysis for NMR are not straightforward. This technique also requires labelling of 
metabolites in order to trace their pathways and, in continuous cultures, often large amounts 
of labelling substrates may be required. The use of this technique is further hampered by the 
high cost of the equipment which is typically 5-20 times more expensive than NIR 
spectrometer or HPLC systems.  
 
2.3.3 Cytokines 
The golden standard for quantifying extracellular concentration of cytokines, 
hormones, and antibodies is the enzyme-linked immunosorbent assay (ELISA). The most 
common form of ELISA is the colorimetric or chemiluminescent sandwich ELISA, which is 
widely available commercially. ELISA is highly specific and sensitive, and requires only a 
small amount of sample for detection. Detection limit for a highly sensitive commercially 
available kit is in the range of 10-50 pg/ml depending of the protein of interest. Sensitivity 
limits can be as low as <1.0 pg/ml. Unfortunately, due to its long procedure (3-5 hours), 
ELISA can only be used as an off-line measurement reference. This technique also requires 
large amounts of substrates and consumables. Analysis of multiple analytes via ELISA is 
therefore not only time-consuming but can be rather costly114.  
In the last five years, platforms for multiple cytokine analysis have became readily 
(commercially) available. The multiple cytokine analysis technology exist in two basic 
formats: multiplex sandwich ELISA such as FAST Quant (Schleicher & Schuell) and bead 
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based immunoassays such as Luminex (Luminex Corporation). The use of multiplexing 
technology in these assay platforms offers significant advantages in cost and time savings 
over standard ELISA, by enabling the investigation of multiple analytes simultaneously115,116. 
This not only reduces significant time and cost but also allows the identification of patterns in 
analyte concentrations. Current systems such as the Luminex xMAP technology allow the 
identification of up to 100 analytes. Multiplex bead based immunoassays offer the same 
sensitivity and specificity as ELISA. However, the possibility of crosstalk in multiple 
immunoassay platforms is more likely to occur which can result in higher chances of a false 
positive or false negative116. The initial setup and equipment cost can be rather expensive and 
time-consuming but is more cost-effective as a long-term investment. Growing interest in 
understanding biological systems as an entity calls for the detection of an array of cytokines 
simultaneously making these systems more and more indispensible. 
Intracellular flow cytometry is a detection method that allows simultaneous 
identification of intracellular cytokine and cell surface markers117,118. The unique advantage 
in flow cytometry is its capability for single cell analysis which allows the identification of 
key functional subsets in a cell population and is therefore an attractive tool for detecting 
cytokine production within a cell population119,120. Though the technique is not as sensitive as 
methods such as the ELISA, sample preparation is much more straight-forward and less time-
consuming as there is no isolation procedures required for target purification121. Flow 
cytometry allows the detection of multiple cytokines in a single sample and multicolour 
staining facilitates co-expression investigation with surface markers as well as high 
throughput analysis of samples. Furthermore, cells can be sorted into specific cell populations 
which enable additional analysis of pure populations of the desired cells. Limitations of this 
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technique include high auto-fluorescence caused by permeabilisation and the inability of 
certain antibodies to work on fixed/permeabilised cells. 
Despite many advantages offered by the powerful techniques described above, online, 
real-time monitoring is not possible through these methods. Currently, optical biosensors 
based on surface plasmon resonance (SPR) technology are capable of the online, real-time 
monitoring of cytokine concentrations. Biosensor assays are also easier to develop than 
immunoassays and are able to detect molecules as small as 200Da. More importantly, optical 
biosensors can provide biomolecular kinetic information such as binding constants, relative 
affinities and rate constants122,123. Such information is not only useful in identifying specific 
biomolecular interactions but can also reveal process mechanisms as has been illustrated by 
the kinetic studies of IL-5 and GM-CSF involving complex-receptor interactions124,125. 
However, limitations in this technique include the stability of the sensors and high usage of 
consumables122. The sensitivity and accuracy of this technique is also not as good as other 
quantitative methods such as ELISA or real-time polymerase chain reaction (PCR). 
 
2.3.4 Cell tracking and monitoring 
Cell enumeration by vital dye exclusion is the most common and straightforward cell 
quantification method used in a laboratory. Cells are stained with a vital dye, cells that are 
dead stain positive against the dye, and are subsequently counted using a haemocytometer 
through a microscope. The method is relatively quick and easy to perform, and allows 
visualisation of the cells. However, when a large number of samples are involved, it can be 
laborious and time-consuming. This technique is also subjective to the operator’s judgment 
which can create high operator-to-operator variability in the results thus compromising its 
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accuracy. Furthermore, the dye exclusion method only distinguishes live-dead cells and not 
proliferating cells. Additional cell proliferation assays such as the bromodeoxyuridine (BrdU) 
labelling kit which measures the amount of cells in the S-phase (DNA-synthesis) is required 
to determine the number of proliferating cells in a cell culture. Other assays such as those 
based on the reduction of a tetrazolium salt compound (3-(4, 5-dimethylthiazolyl-2)-2, 5-
diphenyltetrazoilium bromide (MTT) or 3-(4, 5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) by metabolically active 
cells measures metabolic activity of cells in culture. 
Quantification of a large number of samples through manual counting is highly non-
practical, automated cell viability analysers such as the Vi-CELL series (Beckman Coulter) is 
necessary for processing large volume of samples quickly and accurately. The Vi-CELL 
technology performs a trypan blue dye exclusion assay using video imaging of the flow-
through cell and provides the cell concentration, viability count, and real-time cellular images 
simultaneously. The system is fully automated and is useful for bioprocess monitoring. 
Another common cell counting system is the Coulter Counter, which provides absolute 
counts on cell populations for cell sizes as small as 0.4 µm up to 1200 µm on the Multisizer 3 
Coulter Counter (Beckman Coulter). Use of Coulter counters provides accuracy, speed, 
versatility and excellent precision of results. However, these instruments are limited to cell 
counting purposes.  
Alternatively, a much more versatile technique is flow cytometry, which provides an 
accurate quantification of cell population and cell numbers126. The power of flow cytometry 
is in its ability for single cell analysis and the use of laser technology. Excitation of each and 
every single cell through the laser beam allows the capture of forward scatter, side scatter and 
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various fluorescent emissions. This makes the differentiation of different cell type population 
possible and various types of cellular analysis can be performed simultaneously. Specifically, 
cell immunophenotyping, cell population distribution, DNA/cell cycle analysis and the 
identification of many other structural and functional parameters, such as membrane 
integrity, gene expression and protein content, can be obtained by flow cytometry127. A 
further key advantage is its ability to differentiate and sort cell populations at very high 
acquisition rates of up to 50,000 cells/sec. Currently, flow cytometry is mostly used as an off-
line technique. Although online flow cytometry is possible, the equipment setup is 
complicated and highly inconvenient. Problems associated to fouling and contamination can 
also arise from sample withdrawal. 
In situ microscopy (ISM) has significant advantages in cellular tracking: to monitor 
cell growth, cell movement, and even cell differentiation in real-time. It is a relatively 
straightforward technique that has shown good system stability and robustness for online 
real-time measurements. Its application has been successful in real-time monitoring of 
mammalian cell cultures and can be set up to perform automatic control and image 
analysis128,129. Though the application is straightforward, instrumentation setup for the culture 
system requires effort, which can be rather costly. The design of a robust cell recognition 
algorithm is also critical for the use of this technology and can pose several challenges. Cells 
that are too close together or have unusual morphology will become more challenging to 
identify. The amount of image data acquired from continuous real-time monitoring is 
enormous and will therefore require a significant amount of effort to perform data analysis.  
Micro-computed tomography (micro-CT) is an extremely useful technique for bone 
tissue engineering to study bone growth, repair, vascular growth and biomaterial scaffolds. 
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This technology has been applied to monitor mineralisation and in vitro cell development 
within 3D scaffolds130,131. In these studies, cells were initially grown in media and seeded into 
various scaffolds. Weekly scans were then taken to monitor the matrix production and 
cellular growth within the matrix. These tests were successful in evaluating scaffolds used for 
bone tissue engineering applications and assessed the cell attachment, differentiation, and 
mineralisation in vitro. The use of micro-CT for these types of cell culture studies offers a 
quick and non-destructive method that requires minimal sample preparation as compared to 
histological studies. However, CT scanners are very expensive and computed tomography is 
still considered a moderate to high radiation diagnostic method; high resolution radiation 
between 100-1000 mGy can prove to be harmful. Currently, the effects on cells from direct 
exposure have not been thoroughly evaluated though a study has shown that repeated micro-
CT scans (up to 5 scans) did not have any negative effects on mineralised matrix production 
nor inhibited cellular function of the cells within the scaffolds130. This application is 
particularly useful in the study of cells grown in a 3D environment. 
NMR spectroscopy is a powerful and resourceful analytical tool that has been 
extended to the study of cell distribution. This is accomplished by diffusion weighted 1H 
NMR and 31P NMR used in combination to determine cell concentration distribution132. 
Diffusion weighted 1H NMR produces images that correlate to intracellular and extracellular 
water molecules, which are assigned according to intensity. Intensity represents cell density 
and cell presence is confirmed by 31P NMR data measuring the adenosine triphosphate (ATP) 
signals. 31P NMR spectroscopy is used extensively in measuring ATP signals and phosphate-
containing metabolites. This provides an indication of the cell’s activity and energy status. 
However, the resolution and sensitivity of 31P NMR in detecting the nucleotide pools is found 
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to be relatively low, and the analysis of living cells often suffers from high noise levels. The 
high equipment cost, sophisticated instrumentation setup, and need for skilled operators add 
to its disadvantage for bioprocess applications. 
Raman spectroscopy has also been used to study the in vitro differentiation of stem 
cells133. Via this technique, RNA and DNA peaks of the cells are identified; the magnitude of 
the nucleic acid peaks indicates stages of cell differentiation. The application of this 
technique is straightforward and requires little sample preparation. It is a non-invasive 
method that enables the monitoring of cells in situ and in real-time133. However, the 
sensitivity of the spectrometer is low compared to other spectroscopic methods and requires 
sufficiently high cell concentration of the sample to provide a reliable reading. Furthermore, 
only a limited number of cells can be analysed using this technique, which does not render it 
suitable for quantitative analysis. 
 
2.3.5 Need for cell culture monitoring 
The extensive overview of various cell monitoring and measurement techniques 
presents an array of technology currently available for the analysis of a multitude of factors 
concerning a cell culture. The use of these techniques provides a wealth of information to 
appropriately determine characteristics of the culture, cell behaviour, and cell product; some 
of these tools have since become indispensible in standard cell culture practises. However, 
there are many limitations as to whether each technique can be applied for continuous 
monitoring. Gene or protein analysis for example is currently not possible as a continuous 
method and sophisticated tools such as the NMR or HPLC for metabolite analysis are often 
too expensive or highly inappropriate as online systems; they are therefore not useful for 
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continuous cell culture monitoring or process control. The procedure of taking samples from 
a cell culture is also limited by labour requirement and the quantity of cell culture media 
needed for each sample analysis. Culture monitoring in current practises is therefore not 
readily available and result in cell cultures being carried out in a sub-optimal process 
environment, compromising the outcome of the cellular product. One of the major 
requirements in the delivery of clinical grade cell/tissue-engineered products is the 
production of a consistent, reliable and high-grade biological product. Process control of cell 
culture bioprocesses is therefore necessary for high-throughput and consistent bioprocess 
operation that can bring results from a laboratory-based research into a manufacturing 
production. This brief review highlighted the lack of an appropriate, convenient, and cost-
efficient monitoring system for cell culture bioprocesses which will ultimately impede 
research discoveries to be delivered to the needs of patients. 
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CHAPTER 3 
Goal and Objectives 
 
 
 
3.1 MOTIVATION 
Ex vivo expansion and directed differentiation of HSCs have many applications in 
HSC transplantation, transfusion, and cellular therapy. This tremendous contribution can 
bring about potential cures for many blood-related diseases, disorders and malignancies, and 
provide an alternative resource for blood. One such resource in high demand is the red blood 
cell with around 40 million pints transfused annually and demand continues to increase134. 
Successful in vitro manipulation of HSCs toward mature blood cells such as the erythrocyte 
is therefore an invaluable resource as blood donations do not meet these demands. However, 
process complexities due to a large number of influencing factors such as pH, oxygen, 
glucose, lactate and cytokines12,32,69,135, its transient nature (process dynamics), and the 
interplay of various processes such as self-renewal, proliferation, cell division136, 
differentiation and apoptosis137 make the manipulation of HSCs in vitro difficult. The lack of 
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knowledge in the nature of the process hinders precise definition of optimal extracellular 
process conditions necessary for the HSC bioprocess. This includes the identification of key 
cytokines and their specific concentrations needed to drive a stem cell culture bioprocess of 
interest. The production of stem cell products suitable for clinical applications requires 
precise process definition affecting cellular behaviour9. The second challenge that is faced 
subsequently is the translation of these results from a laboratory based research into patient 
therapy. Products used for clinical applications require quality and consistency of the highest 
demand. Cell culture bioprocesses that is used for the manufacture of clinical products 
require a highly defined culture system and bioprocesses that can be controlled optimally and 
reproducibly to meet good manufacturing practises9. However, due to the lack of process 
definition of these complex cell culture bioprocesses and the lack of real-time monitoring 
technology that is practical and economical for process control, delivery of manipulated HSC 
products as a viable therapy has not yet been achieved. Successful translation of stem cell 
products requires the integration and cooperation of basic scientific discoveries with 
pioneering engineering applications138. 
 
 
3.2 GOAL AND OBJECTIVES 
The overall goal of this thesis is to deliver engineering solutions via statistical design 
methods and advances in monitoring technology necessary to translate results from the 
laboratory into a manufacturing facility. The specific objectives are:  
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(1) to develop a systematic framework using a robust statistical method, such as 
DOE, for the identification and definition of critical culture parameters required for an 
optimal bioprocess operation and  
(2) to design and implement an online real-time in situ monitoring platform that will 
allow simultaneous monitoring of multiple process analytes for bioprocess control.  
Control of stem cell culture bioprocesses to ensure quality and reproducibility of the 
product requires both process knowledge and real-time information of a cell culture 
bioprocess operation. Use of a robust and efficient experimental design strategy, such as 
DOE, is necessary to obtain a quantitative characterisation of complex stem cell culture 
bioprocesses. To this end, characterisation and optimisation can be achieved by: (1) the 
development of a simple and systematic approach for studying complex HSC cultures, (2) 
demonstration of the effectiveness and efficiency of DOE methods in optimising a single-step 
culture and (3) the development of a DOE strategy to reveal process kinetics. As a case study, 
the in vitro erythropoiesis of cord blood stem cells will be taken to demonstrate the success of 
DOE methods in HSC process optimisation.  
The development of a robust monitoring platform that will allow real-time, online, in 
situ monitoring of multiple process analytes such as pH, glucose, oxygen and ammonia is 
necessary for bioprocess control. Development of a cell culture monitoring platform that is 
suitable for HSC or other cell cultures will include: (1) the design of biocompatible, 
functionally stable, miniaturised sensors suited for long-term cell culture monitoring, (2) the 
design of a unique multi-channel (many channels), multi-functional (many analytes) and 
multiplexable (stackable/expandable) data acquisition system that will allow simultaneous 
monitoring of different process analytes and (3) the design of a simple perfused bioreactor 
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system for HSC cultures. The successful integration of these three components will permit 
real-time, online, in situ, and long-term monitoring of culture parameters for any cell culture 
bioprocess of interest. Due to the diversity of expertise required in this project, a 
collaborative effort between the Biomedical Institute, Bioengineering department, and 
Chemical Engineering department at Imperial College London was established. 
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CHAPTER 4 
Materials and Methods 
 
 
 
 Chapter 4 encompasses all the experimental methods and materials used in this thesis 
which include: (1) the work involved in using DOE which includes process characterisation, 
(2) spatial profiling in a bioreactor, and (3) the work involved in the development of a novel 
real-time online monitoring platform for stem cell bioprocessing. The main focus in section 
4.1 is in the development and implementation of DOE strategies for the characterisation of 
cord blood stem cell differentiation. DOE strategies are divided into two parts: 
Characterisation I and Characterisation II. Part I focuses on the implementation of a simple 
strategy in approaching a complex process problem while part II attempts to integrate a factor 
of time and defining its influence on a culture process. Basic cell culture procedures and 
cellular analysis are also included in this section. Section 4.2 contains the experimental work 
and DOE design setup used in spatial profiling. A simple temperature study was performed 
as an example to illustrate and test the proposed DOE design and strategy. Section 4.3 
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contains all the work involving the uniquely designed online real-time monitoring platform 
which includes the development of the sensors, the data acquisition system and the bioreactor 
system suited for haematopoietic stem cell culture.  
 
 
4.1 PROCESS CHARACTERISATION OF IN VITRO ERYTHROPOIESIS 
4.1.1 Cord blood CD34+ Isolation 
Cryopreserved human umbilical cord blood was obtained from the London Cord 
Blood Bank (London, UK), in accordance with regulatory and ethical policies (Harrow 
Research Ethics Committee No. 05/Q0405/20). Cryopreserved human cord blood cells were 
thawed in a 37oC water bath and gently aspirated from the blood bag using a 10 ml syringe 
and 18G needle. The aspirated cord blood is placed drop-wise into two 50 ml centrifuge 
tubes, each containing 30% (v/v) foetal bovine serum (FBS; GIBCO Invitrogen) and Iscove’s 
Modified Dulbecco’s Medium (IMDM; GIBCO Invitrogen) and centrifuged at 180g for 10 
min. Supernatant is gently aspirated using a sterile Pasteur pipette and the remaining cells 
were re-suspended in 30% (v/v) FBS and IMDM solution. This wash procedure is repeated 
twice and cells were collected into a single 50 ml centrifuge tube. MNCs were isolated from 
whole cord blood cells using Ficoll-Paque PLUS (Amersham BioSciences) via density-
gradient centrifugation. Cord blood cells were suspended in 2% (v/v) FBS and IMDM, and 
the Ficoll-Paque PLUS solution was gently layered under the cell suspension before being 
centrifuged at 400g for 35 min. The middle buffy coat layer which contains the CD34+ and 
mononuclear fraction was gently removed using a sterile Pasteur pipette. 
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Freshly isolated MNCs were incubated with CD34 microbead kit reagents (Miltenyi 
Biotec GmbH) which contain an FcR blocking reagent and microbeads conjugated to 
monoclonal mouse anti-human CD34 antibody for 30 min at 4oC. After incubation, cells 
were subjected to microbead selection using high-gradient magnetic field in the MidiMACS 
and MiniMACS separators (Miltenyi Biotec GmbH). Cells were first passed through a 70 µm 
nylon mesh to remove any clumps before being applied into the MACS column. A typical 
purity of 92-96% in CD34+ cells was obtained after two column separations. The CD34+ 
fraction was measured by flow cytometry (see section 4.1.4.3). A simplified diagram 
illustrating cord blood extraction, density centrifugation and isolation procedure is shown in 
Figure 4.1. 
 
Figure 4.1 Cord blood isolation procedure. A flowchart of the isolation process which 
includes cord blood extraction, Ficoll-Paque density gradient centrifugation, and magnetic 
bead CD34+ isolation. (Courtesy of Hwang, YS) 
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4.1.2 DOE Methods 
4.1.2.1 Characterisation I: Basic DOE Strategy 
Cell culture experiments driven by DOE were divided into three basic steps: 
screening, characterisation, and optimisation. In the screening step, seven different cytokines 
were selected from previous literature as those being more often utilised and showed some 
effects on in vitro erythropoiesis70,139-141. They include SCF, FL, IL-3, IL-6, GM-CSF, TPO 
and EPO. These cytokines make up seven independent process factors in the screening 
experiment, and a Resolution IV fractional factorial design was used to determine the 
significance of each cytokine of interest. A resolution IV design was chosen as it allows an 
accurate estimation of individual effects, without being convoluted with other individual 
effects or two-factor interactions83. The screening experiment generated 16 independent 
experimental conditions and four additional centre point replicates were included for pure 
error estimation (Table 4.1). Cord blood CD34+ cells were seeded at a density of 2x104 
cells/ml in each well containing the different DOE defined cytokine-cocktail media. After ten 
days, cells were evaluated for total cell expansion and red blood cell maturation. DOE 
analysis was performed on day 10 cells so as to ensure sufficient differentiation of the cell 
population that is distinctive to the effects of the respective cytokines. The significance of 
each cytokine is determined by the coefficient plots and half-normal plots obtained from the 
DOE analysis. 
For the characterisation study, results from the screening experiment which identified 
SCF and EPO as the only two cytokines affecting the process, was utilised to create a two-
factor face-centred CCD. The face-centred CCD encompasses all factorial points, a centre 
point and axial points with an α–value of 1.082. Three centre replicates were included for pure 
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error estimation and this design generated a total of 12 experimental runs. Cells were cultured 
for up to ten days prior to evaluation. The experimental data obtained for this CCD was fitted 
to a 2nd order polynomial model. Results were analysed using analysis of variance (ANOVA) 
and the response surface plots for each response of interest, cell expansion and red cell 
maturation, were plotted using MODDE 7 (Umetrics).  
 
Table 4.1 Screening experiment for in vitro erythropoiesis of cord blood stem cells: Seven 
growth factors which include early-acting, mid-acting and late-acting growth factors were 
SCF, IL3, IL6, FL, TPO, GM-CSF, and EPO. 
Std Run 
SCF 
ng/ml 
IL3 
ng/ml 
IL6 
ng/ml 
FL 
ng/ml 
TPO 
ng/ml 
GMCSF 
ng/ml 
EPO 
IU/ml 
1 7 0 0 0 0 0 0 0 
2 17 100 0 0 0 100 0 5 
3 2 0 100 0 0 100 100 0 
4 6 100 100 0 0 0 100 5 
5 1 0 0 100 0 100 100 5 
6 3 100 0 100 0 0 100 0 
7 14 0 100 100 0 0 0 5 
8 10 100 100 100 0 100 0 0 
9 16 0 0 0 100 0 100 5 
10 12 100 0 0 100 100 100 0 
11 18 0 100 0 100 100 0 5 
12 20 100 100 0 100 0 0 0 
13 4 0 0 100 100 100 0 0 
14 8 100 0 100 100 0 0 5 
15 15 0 100 100 100 0 100 0 
16 19 100 100 100 100 100 100 5 
17 5 50 50 50 50 50 50 2.5 
18 13 50 50 50 50 50 50 2.5 
19 11 50 50 50 50 50 50 2.5 
20 9 50 50 50 50 50 50 2.5 
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Optimisation of the process parameters was done by determining the overlapping 
regions of both responses, maximising both total cell expansion and red cell maturation 
simultaneously. This determines a region of operation where the most optimal cytokine 
concentration necessary for each factor can be found. The selected values for cytokine 
concentration were subsequently verified in a separate study and repeated (n = 6) in a 16-day 
cell culture. DOE design software used for generating all the experimental runs and for 
analysing the data were Design Expert 6.0.1 (StatEase) and MODDE7 (Umetrics). All 3D 
response surface graphs were obtained from MODDE7 while the ANOVA tables were 
generated from Design Expert. 
 
4.1.2.2 Characterisation II: Defining the influence of time 
 The time factor in a cell culture is defined as the feeding frequency and time-points in 
a cell culture. Feeding frequency determines how often culture media needs to be replaced. 
Time-points in the culture determine when a change in culture conditions i.e. cytokine 
concentrations needs to occur. As an initial step, a screening study was performed to 
determine the significance of feeding frequency and change in culture conditions at a random 
time-point. A feeding frequency of two days versus four days was tested and a random time-
point, day 6 of the culture, was taken into consideration for this experiment. A four-factor full 
factorial design was created and the process variables included three numerical factors – 
feeding frequency, SCF and EPO, and one categorical factor, change of media in relation to 
culture time-point. 
In the second part of this study, a more distinct definition of time-point is required. At 
this stage, the in vitro process was defined based on growth kinetics which is characterised by 
 76 
 
the lag phase, the growth phase, and the stationary phase/plateau. Though the in vitro process 
is reflective of both proliferation and differentiation simultaneously, it was difficult to 
delineate these effects. This study is a first attempt to characterise process dynamics, the use 
of growth kinetics was simply to provide a starting ground for dividing process phases. In the 
first phase (lag phase), slow growth was observed and this occurred during the first six days 
of the culture period. The second phase, the exponential/growth phase, was defined as cell 
culture from day 6 to day 10; this is when the highest growth rate of HSCs was observed. 
Finally, by the end of the culture (day 10-16), cell proliferation began to retard and the 
growth rate eventually reached a plateau. Cytokines used in this characterisation study 
included SCF and EPO; both were previously established in part I of the DOE 
characterisation study. In addition, a third cytokine, the insulin growth factor-II (IGF-II) was 
added as a mid-acting growth factor. IGF-II has been previously known to enhance in vitro 
growth of mature and primitive erythroid progenitors142,143 and showed promising growth 
performance in cell culture studies144. Concentration ranges selected for SCF, IGF-II and 
EPO were from 10-110 ng/ml, 0-100 ng/ml and 0.1-5 IU/ml respectively. A face-centred 
CCD was used to characterise and optimise growth conditions for each phase of the culture. 
Six centre replicates were included in each study, which yielded a total of 20 experiments in 
each characterisation study to be performed sequentially throughout the cell culture. An 
example of the DOE experimental matrix required for each phase of the culture is presented 
in Table 4.2. 
Experimental results in terms of fold expansion, viability and GPA expression for 
each DOE experiment were evaluated using Design Expert 6.0.1. Experimental results for 
each characterisation study were fitted into a 2nd order polynomial model via multiple linear 
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regression (MLR) to obtain the best fit to a model. Each DOE characterisation experiment 
was repeated two-three times to compare DOE models generated for each phase of the 
culture and to determine repeatability of models between different cord units. ANOVA tables 
summarised the results for each model and significance of the models in each DOE study. 
Response surface curves were generated to show a quantitative illustration of their 
relationships. Cytokine concentrations were subsequently optimised for each phase of the 
culture by maximising cell growth expansion and were subsequently verified (n = 3) for 
growth performance, clonogenic ability and surface antigen expressions. 
Table 4.2 DOE-designed experimental run for three process factors  
Std order Run order SCF (ng/ml) IGF-II (ng/ml) 
EPO 
(IU/ml) 
1 20 10 0 0.1 
2 7 110 0 0.1 
3 8 10 100 0.1 
4 18 110 100 0.1 
5 5 10 0 5 
6 16 110 0 5 
7 1 10 100 5 
8 10 110 100 5 
9 19 10 50 2.55 
10 2 110 50 2.55 
11 3 60 0 2.55 
12 11 60 100 2.55 
13 15 60 50 0.1 
14 13 60 50 5 
15 14 60 50 2.55 
16 9 60 50 2.55 
17 12 60 50 2.55 
18 4 60 50 2.55 
19 6 60 50 2.55 
20 17 60 50 2.55 
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4.1.3 Cord blood cell culture from DOE study 
Freshly isolated cord blood CD34+ cells were cultured in 10% (v/v) FBS and IMDM 
plus the growth factor cocktail defined by DOE. Cells were cultivated in 24-well plate 
systems (Corning) at a seeding density of 2-5x104 cells/ml and fed every three days starting 
from day 4 of the culture by completely replacing the old culture medium for characterisation 
study I (Chapter 5). For characterisation study II (Chapter 6), cells were fed every two days 
after day 4. All cultures were maintained in a fully humidified chamber at 37oC, 5% carbon 
dioxide and 20% oxygen environment. Cytokines used for screening in characterisation study 
I included recombinant human SCF, IL-3, IL-6, FL, TPO, GM-CSF (all from GIBCO 
Invitrogen) and EPO (R&D systems). Results from the DOE experiment indicated that the 
optimal cytokines and concentrations to be used in this single-step study (Chapter 5) were 75 
ng/ml SCF and 4.5 IU/ml EPO. Cytokines used in characterisation study II were SCF, IGF- II 
(Peprotech) and EPO. Cord blood CD34+ cells (> 95% purity) cultured in a three-step (multi-
step) cytokine cocktail optimised from the DOE results were as follows: 50 ng/ml SCF, 100 
ng/ml IGF-II and 3.00 IU/ml EPO from day 0 to day 6; 110 ng/ml SCF, 17 ng/ml IGF-II and 
3.75 IU/ml EPO from day 6 to day 10; 74 ng/ml SCF and 3.98 IU/ml EPO from day 10 to 
day 16.  
 
4.1.4 Cellular Analysis 
4.1.4.1 Cellular growth 
Cellular growth and cell viability were evaluated at each passage during the culture. 
Cells were manually counted using a haemocytometer under the Leica DM-IL inverted phase 
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microscope (Leica). Cell viability was determined by a dye-exclusion method using 
Erythrosin-B stain solution (ATCC) which stains only dead cells reddish-pink. Fold 
expansion, defined by the increase in total cell numbers from the starting population, was one 
of the main criteria that guided the DOE studies.  
 
4.1.4.2 Cell staining 
Morphology of the cultured cells was observed on a cytospin. The cytospin is a cell 
preparation technique where cells are spun onto the microscope slide for staining/observation 
purposes. A cell suspension of 1x106 cells/ml was prepared in PBS and 100 µl of the cell 
suspension was loaded into a well in the cytospin assembly. Cells were spun for 3 min at 
100g. The cuvette and filter in the cytospin assembly was then gently removed to avoid any 
damage to the fresh cytospin and the slide was air-dried for 5-10 min in preparation for 
immunohistochemistry. Cells were stained with either Wright-Giemsa stain (Sigma-Aldrich) 
for nuclear-cytoplasmic differentiation or Brilliant Cresyl-Blue stain (Sigma-Aldrich) for 
reticulocytes identification. Wright-Giemsa stain was performed in a Coplin jar via the dip-
method. Slides were dipped for 10 sec in Wright-Giemsa stain and subsequently dipped in 
deionised (DI) water for approximately 2 min. For reticulocytes staining, cells were first 
mixed with Brilliant Cresyl-Blue stain in a microcentrifuge tube and incubated for 15-30 min 
at 37oC before making the cytospin. Cells were visualised on the Olympus BX51 microscope 
(Olympus UK Ltd) and images were captured using the DP50 camera (Olympus UK Ltd). 
Fluorescence microscopy was also used to verify the expression levels and distribution of 
cellular surface antigens for CD45 and GPA. Staining procedures for surface antigens is 
described in the next section. The F-view unit (Soft Imaging System GmbH), a high 
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resolution cooled CCD digital camera, was used for capturing images in fluorescence 
microscopy. 
 
4.1.4.3 Flow cytometric analysis 
 Surface expression of cultured cells for CD45, CD71, and GPA were analysed via 
flow cytometry using the Epics-Altra (Beckman Coulter) flow cytometer, equipped with a 
488 nm Argon (Ar) laser. At each cell culture passage, 0.5-1.0x106 cells were harvested and 
incubated at 4oC for 30 min with directly labelled anti-human CD45-fluorescein 
isothiocyanate-immunoglobin G1 (FITC-IgG1), CD71-phycoerythrin-IgG2a (PE) and 
Glycophorin-A-phycoerythrin cyanide-5 (GPA-PC5)-IgG2b antibodies (all from BD 
Biosciences) in PBS buffer containing 2% (v/v) FBS and 0.1% (w/v) sodium azide (Sigma-
Aldrich). Negative controls were cells which are not stained with any antibodies. Isotype 
controls for each fluorescent signal (FITC, PE and PC5) were made up using FITC-IgG1 
isotype control, PE-IgG2a isotype control and PC5-IgG2b isotype control (all from BD 
Biosciences). Freshly isolated CD34+ cells were stained with CD45-FITC-IgG1, CD34-PE-
IgG1 (BD Biosciences) and CD38-PC5-IgG1 (Beckman Coulter). Their corresponding isotype 
controls were FITC-IgG1 isotype control, PE-IgG1 isotype control (BD Biosciences) and 
PC5-IgG1 isotype control (Beckman Coulter). After staining, cells were washed twice with 
PBS buffer prior to analysis. If fixation is required, cells were normally fixed in 0.2% (w/v) 
para-formaldehyde solution and stored in 4oC for 24 hr prior to analysis. Freshly isolated 
CD34+ cells from cord blood units were also evaluated for CD45-FITC-IgG1, CD34-PE-IgG1 
(BD Biosciences) and CD38-PC5-IgG1 (Beckman Coulter) expression. Data acquisition 
using the Epics-Altra is typically performed immediately or within three days following 
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fixation, and a total number of 30,000 ungated events was recorded for each sample. Data 
analysis and off-line colour compensation for the FITC-PE, PE-PC5, PE-FITC, and PC5-PE 
fluorescent panels were performed using WinList (Verity). 
 
4.1.4.4 Clonogenic assay 
In vitro clonogenic assays for the erythroid (colony-forming unit-erythroid; CFU-E 
and burst-forming unit-erythroid; BFU-E), granulocyte-macrophage (CFU-GM), and multi-
lineage (CFU-GEMM) cells were assessed using methylcellulose-based media, MethoCult 
GF H4434 (Stem Cell Technologies) which is supplemented with recombinant human SCF 
(50 ng/ml), GM-CSF (10 ng/ml), IL-3 (10 ng/ml) and EPO (3 IU/ml). For freshly isolated 
CD34+ cells, 500-1,000 cells were seeded into 35 mm culture plate and for cord blood 
cultured cells, 500-20,000 cells (depending on the day of culture) were seeded into each 
plate. Seeding densities are optimised according to the clonogenic ability of the cells as 
recommended by the manufacturer’s technical manual (Stem Cell Technologies). All assays 
were performed in duplicates. Plates were scored after 14-16 days of incubation in a fully 
humidified chamber at 37oC.  
 
4.1.4.5 RNA analysis 
 The total RNA from cord blood cultured cells was isolated using the RNeasy Mini kit 
(Qiagen). First, cells were disrupted in buffer RLT supplemented with 1% β-Mercaptoethanol 
and homogenised in a QIAshredder spin column, centrifuged at maximum speed for 2 min. 
Ethanol was then added to the cell lysate to promote binding of RNA to RNeasy membrane. 
Total RNA that bound to the membrane column was washed twice with Buffer RW1 before 
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ethanol was removed using buffer RPE. RNA was then eluted in a 1.5 ml collection tube 
using RNase-free water. RNA quantification was performed on a UV spectrometer and the 
A260/A280 ratio of greater than 1.70 is required to ensure quality of RNA sample. 
Total RNA was reversed transcribed into complimentary DNA (cDNA) using the 
reverse transcription system (Promega). First, 1 µg of each sample was prepared with 
Diethylpyrocarbonate (DEPC) water in a microcentrifuge tube and heated at 70oC for 10 min. 
RNA samples were centrifuged at maximum speed for 5 sec and cooled in ice for 5 min. The 
running cocktail consisting of 4 µl MgCl2 (25 mM), 2 µl RT 10x buffer, 2 µl 
deoxyribonucleotide triphosphate (dNTP) mix (10 mM), 0.5 µl ribonuclease inhibitor 
(Rnasin), 0.6 µl avian myeloblastosis virus reverse transcriptase (AMV RT) (15 U) and 1 µl 
random primers (0.5 mg) was then added to each sample to make up 20 µl of sample volume. 
All samples are then placed in a thermocycle program that ran for 10 min at room 
temperature, 40 min at 42oC and 5 min at 4oC. The final cDNA samples were stored at -20oC.  
cDNA pools were amplified using the Platinum Taq DNA-polymerase (GIBCO 
Invitrogen) in a G-Storm GS1 thermal cycler (Gene Technologies Limited) for 30 cycles. 
Each sample contains 45.6 µl of mastermix, 1 µl of each primer (sense and anti-sense), 2 µl 
of cDNA sample and 0.4 µl of Taq polymerase. PCR mastermix consisted of 5 µl 10x PCR 
buffer, 1.5 µl MgCl2 (50 mM), 1 µl dNTP mix (10 mM) and 38.1 µl of DEPC-treated water. 
Sequences of the gene-specific primers for RT-PCR can be found in Table 4.3. Temperatures 
for each amplification step were optimised specifically for each primer (50.4oC for α-
haemoglobin; 59.3oC for β-haemoglobin, 56.9oC for γ-haemoglobin; 53.0oC for GATA-1; 
56.9oC for HOXB4; 53.0oC for GAPDH). The denaturation step was performed at 94oC for 
30 sec, and the annealing/extension step was at 70oC for 1 min for all primers. K-562 cells 
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(ATCC) were used as the positive control for this test for γ, β and α–haemoglobins and 
GATA-1, while HL-60 cells (ATCC) were used as the negative control. 
RT-PCR samples were processed via agarose gel electrophoresis for separation and 
visualisation. Agarose gel was made by mixing 2 g of agar with 100 ml of 1x TBE solution, 
dissolved in a microwave and adding 10 µl of EtBr (10 µg/ml) just before being casted to 
solidify. Solidified gel is then transferred to the electrophoresis system. Samples were 
prepared by mixing 2 µl of Blu/Orange loading dye and 10 µl of RT-PCR sample. A DNA 
reference sample consisting of 5 µl of 100bp DNA ladder and 1 µl of Blu/Orange loading dye 
was also made up. Samples were loaded quickly into each well in the gel and subjected to 
electrophoresis at 80 V for the first 10 min and 110 V for 50 min. Gels were visualised in a 
gel-documentation system (Dyversity; SynGene). 
 
Table 4.3 Gene-specific primers used to characterise cord blood cultured cells 
Gene of interest Forward sequence Reverse sequence 
α-haemoglobin CACGCGCACAAGCTTCG AGGGTCACCAGCAGGCAGT 
β-haemoglobin CAAGAAAGTGCTCGGTGCCT GCAAAGGTGCCCTTGAGGT 
γ-haemoglobin TGGCAAGAAGGTGCTGACTTC TCACTCAGCTGGGCAAAGG 
GATA-1 CAGGTACTCAGTGCACCAAC TGGTAGAGATGGGCAGTACC 
HoxB4 CCTGCATGCGCAAAGTTCA AATCCTTCTCCAGCTCCAAGA 
GAPDH GCAGGGGGGAGCCAAAAGGG TGCCAGCCCCAGCGTCAAAG 
 
 
4.1.4.6 Protein analysis 
Cord blood CD34+ cells (day 0) and cultured cells from days 7 and 14 were collected 
for Western Blot analysis. Cells were centrifuged into a cell pellet and stored at -20oC till 
analysis. Frozen cell samples were lysed in 150 ul of cold RIPA lysis buffer (Santa Cruz 
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Biotechnology), incubated at 4oC for 30 min and centrifuged 10,000 RPM for 15 min to 
pellet the cell debris. Protein-containing supernatant was collected for protein quantification. 
Total amount of protein was quantified using the bicinchoninic acid (BCATM) Assay 
Kit (Peirce Biotechnology). The BCA quantification method is based on the reduction of 
Cu2+ ions to Cu1+ by proteins in an alkaline environment which causes the formation of a 
blue-coloured complex. The highly sensitive and selective colorimetric reagent, BCA, reacts 
with the Cu1+ cation to form a BCA/copper complex which exhibits a strong linear 
absorbance at a wavelength of 562 nm. Bovine serum albumin (BSA) was used as a known 
protein standard and diluted at various concentrations in phosphate buffered solution (PBS) 
ranging from 0-500 µg/ml to create a standard curve. 25 µl of each sample is loaded onto a 
96 well plate followed by 200 µl of BCA working reagent. Plates were covered and 
incubated in an orbital shaking incubator at 37oC for 30 min and then read on a microplate 
reader at a wavelength of 560 nm. Protein concentrations in each sample were quantified 
against the BSA standard curve. 
From each sample, 40 µg of proteins were loaded onto each lane of the gel in sodium 
dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE). Protein samples were 
mixed with 2x SDS-PAGE sample buffer which consisted of 0.125 M Tris-HCl at pH 6.8, 
4% SDS, 20% (v/v) glycerol, 10% β-mercaptoethanol and 0.005% (w/v) bromophenol blue. 
The sample mixture was heated at 95oC for 10 min for protein denaturation and placed in ice 
prior to gel loading. A protein ladder consisting of a range of proteins from 40-200kDa was 
included in each gel. 
SDS-PAGE gels were prepared individually using the gel assembly kit for a 10-well 
gel. A 12.5% resolving gel was made by mixing 4.81 ml of resolving buffer, 4.16 ml of 
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Protogel acrylamide mixture (National Diagnostics), 1 ml 0.9% ammonium persulfate (APS; 
VWR) and 15 µl of TEMED (N, N, N’, N’ tetramethyl-ethylenediamine; VWR) and gently 
poured into gel assembly, allowing it to polymerise for 15-20 min. The gel is finished off 
with a stacking gel layer and allowed to further polymerise for about 45 min. The stacking 
gel consists of 2.03 ml stacking buffer, 0.6 ml Protogel acrylamide mixture, 0.3 ml of 0.9% 
APS and 8 µl of TEMED. One-dimensional SDS-PAGE was performed in the EC120 mini 
veritical gel electrophoresis unit (Thermo Electron) and a constant voltage of 110 V was 
initially applied for 15 min or till the sample passes the stacking gel before a constant voltage 
of 150 V was applied for another 45 min or until the dye reached the bottom of the gel. Gels 
are allowed to equilibrate in 1x transfer buffer for 30 min before they are blotted onto 0.2 µm 
nitrocellulose membranes. Protein blotting was performed in the C140 Mini Blot Module 
(Thermo Electron) at a constant current of 30 mA for 50 min. The blotted membrane was 
then air-dried for at least 1 hr at room temperature prior to immunostaining. 
Western blot analysis of β and γ-haemoglobins (Santa Cruz Biotechnology), and 
GATA-1 (R&D Systems) were used to assess erythrocyte maturation determined by its 
expression at the protein level. GAPDH (Abcam) was used as the housekeeping gene. Red 
blood cells collected from cord blood were used as positive controls for β, γ–haemoglobins, 
and K562 cells were used as the positive control for GATA-1. HL-60 cells were used as 
negative controls for all proteins of interest. Protein membranes were then incubated 
overnight at 4oC in the primary antibody and 1 hr at room temperature for the secondary 
antibody. The primary antibody dilution for the haemoglobins and GATA-1 was 1:200 and 
1:20000 for GAPDH. Secondary antibodies were conjugated to horseradish peroxidase 
(HRP) and a dilution of 1:10000 was used for each antibody. Proteins were detected using the 
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SuperSignal West Pico chemiluminescent substrate (Pierce Biotechnology), a highly 
sensitive enhanced chemiluminescent substrate for detecting HRP on immunoblots. Western 
blot images were captured in the Dyversity gel-documentation system (SynGene) using the 
Genesnap program (SynGene).  
 
 
4.2 SPATIAL PROFILING USING DESIGN OF EXPERIMENTS 
4.2.1 Culture chamber and experimental setup 
 Culture chamber designed for HSC process monitor was a 2D perfused system that is 
identical in size to a standard 6-well culture plate. Specifically, the cylindrical chamber had a 
diameter of 31 mm and a height of 9 mm with two inlets and two outlets for perfusion at 
opposite ends (Figure 4.2a). The inlets are positioned at 1.0 mm from the bottom of the 
chamber while the outlets are positioned 1.0 mm from the top of the chamber (Figure 4.2b). 
This was designed so as to minimise the loss of cells due to perfusion and optimise the 
availability of fresh media to the cells. The material used to fabricate this chamber is 
polymethylmethacrylate (PMMA/Perspex) with the exception of the top cover, which is 
made of polydimethlysiloxane (PDMS), a soft and flexible mould that allows insertion of the 
sensors directly into the culture chamber via an 18G needle. Sensors were placed as close as 
possible to the bottom of the chamber, without touching the base; the estimated height of the 
sensing tip was approximately 1 mm above the base of the chamber. The chamber was then 
filled with 8 ml of water which was at 18-19oC. The maximum capacity of the culture vessel 
was 9 ml. 
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Three experimental setups were employed to simulate different cell culture scenarios. 
In the first scenario, a single heating element was used to represent a single large cell colony 
being present in a static culture environment (Figure 4.3a). In the second scenario, two 
heating elements were used to represent two large cell colonies in a static culture (Figure 
4.3b). In the third scenario, two heating elements were used to represent two cell colonies in 
a perfused culture operating at a flow rate of 0.01 ml/min. This equates to 14.4 ml of media 
exchange per day which is considered a high perfusion rate for this culture system. A high 
perfusion rate was selected to further demonstrate the applicability of this DOE approach 
under conditions that would result in a homogeneous environment more rapidly. The liquid 
used for perfusion was water measuring at 18-19oC. All experiments were repeated three 
times and the centre point in the DOE design was used to obtain an estimate for pure error. 
Figure 4.3 (a) and (b) depict the positions of the heating elements for the single (lower 
heating element only) and dual heat source set-ups. All three experiments were monitored 
using DOE- and randomly-generated sensor placement designs as described below. 
Temperature readings were obtained every 10 sec for up to 10 min. 
     
 
Figure 4.2 Design of bioreactor system for haematopoietic cell cultures. (a) Top view of the 
bioreactor (b) Side view of culture chamber 
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4.2.2 Temperature sensors and heating elements 
Temperature sensors used in this experiment were the IT-21 series, Type-T flexible 
implantable thermocouple probes (Physitemp Instruments Inc.) along with the Thermes high 
accuracy industry standard architecture (ISA) based data acquisition system (Physitemp 
Instruments Inc.) which has 16 data input channels. The data acquisition system has a 
resolution of 0.01oC, a reading accuracy of 0.2oC in the ambient temperature range of 15 to 
35oC, and a stability of +/- 0.1oC. Multiplexing capability of this system allows continuous 
readings of 16 channels per second. Temperature sensors have a diameter of 0.406 mm, they 
are flexible, and can be inserted through the PDMS cover of the bioreactor using an 18G 
needle. The sensors are fairly fragile but very fast responding. The latter provides a good 
basis for capturing small temperature variations.  
Heat sources to the chamber were provided by high density penny-bottom cartridge 
heaters (Tempco Electric Heater Corporation) that have an integrated thermocouple and a 
diameter of 6.35 mm. Side-walls of the cartridge heaters were surrounded by a ceramic block 
to minimise heat loss sideways to the environment while directing most of the heat upwards 
into the bioreactor. Heating elements were placed at the bottom of the bioreactor to generate 
point heat sources inside the culture chamber. Heating elements were set at 69-70oC for all 
experiments and controlled by a basic PID controller (Tempco Electric Heater Corporation). 
 
4.2.3 Design of experiment parameters 
 Response surface method (RSM) is a commonly used and highly effective method for 
defining 2nd-order polynomial relationships82. As described previously in Chapter 2, the 
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model consists of a standard 2nd-order quadratic equation used to fit experimental points in 
the design. In this case, a basic CCD consisting of four factorial points, a centre point, and 
four axial points was chosen. The α-value, depicting the position of the axial points, of this 
two-factor design was chosen to be 1.414 which covers the entire 2D process space of the 
cell culture chamber. The factor variables defining the design space is expressed in terms of 
the x-axis and y-axis in the 2D area of the culture chamber. The design matrix was created 
based on these criteria, and the number and position of the sensors were obtained, as shown 
in Figure 4.3c. Nine DOE sensor positions were determined for this face centred CCD 
design. DOE software used to generate the experimental points and for data analysis was 
MODDE 7.   
 As a comparison to the DOE method, two random designs for the positioning of 
sensors were chosen. In the first design (Figure 4.3d), five sensors were utilised and placed in 
the centre (one sensor) and the periphery (four sensors) of the culture chamber. In the second 
design (Figure 4.3e), seven sensors were employed and placed in the centre (one sensor), 
middle section (two sensors), and the periphery (four sensors) of the chamber. These two 
random designs were compared to the DOE-generated designs for effectiveness. Finally, a 
validation experiment for the DOE design was performed by placing three additional sensors 
at random (Figure 4.3f). These sensor positions were used to compare with the predictions 
obtained from the DOE analysis to experimental data. The verification experiment was 
performed for the single heating element experiment (Figure 4.3a). 
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Figure 4.3 Placement of heating elements and sensors. (a) Single heating element (b) Dual 
heating element (c) Nine DOE-design sensors (d) Five random positions (e) Seven random 
positions (f) Sensor positions for verification study. 
 
 
4.2.4 Data analysis 
 Temperature variations across the 2D culture chamber were estimated via MLR into a 
2nd order polynomial model using MODDE 7. The agreement of fitness to the model was 
determined by the R2 values. The p-value and lack of fit, describing the validity of the model, 
were obtained by ANOVA analysis. Contour maps showing the temperature spatial profiles 
for the 2D culture chamber were generated from the fitted model via point prediction. Point 
prediction values can be generated in the DOE software. Predicted values from the model 
were subsequently graphed using SigmaPlot (Systat Software Inc.) to generate spatial and 
temporal contour distributions for each temperature experiment in the single heating element, 
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dual heating elements, and perfused system settings. Finally, additional points in the DOE 
validation experiment for a single heating element setup were compared to model results at a 
95% confidence interval. 
 
 
4.3 ONLINE REAL-TIME PROCESS MONITORING  
4.3.1  Development of pH, oxygen, and ammonia sensors 
4.3.1.1 pH sensor 
 pH electrodes were fabricated via electrochemical deposition of iridium oxide thin 
films on Pt electrodes in galvanostatic mode. The main advantages of the iridium oxide 
electrodes are the wide pH range, low potential drift, super-nernstian response, good response 
time, and low sensitivity to redox pair interferences. The basic response of anhydrous iridium 
oxide films to pH is due to an Ir(III) to Ir(IV) redox transition associated with the reaction 
and has a slope of 59 mV/pH. However, hydrated iridium oxide exhibits a super-Nernstian 
response, resulting in a slope of approximately 90 mV/pH, which corresponds to better 
sensitivity of the sensor. Finally, the hydrated iridium oxide films were coated with a Nafion 
layer which prevents its instability to anions and enhances its resistance to biofouling. Size of 
the sensor is around 250 µm. 
 
4.3.1.2 Oxygen sensor 
 The oxygen sensors are basic amperometric oxygen transducers comprising of a Pt 
electrode coated with PDMS. The porous and hydrophobic PDMS layer allows permeation of 
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gases but restricts the passage of other soluble electroactive species which makes it possible 
to monitor the oxygen level without interference from reactive species such as H2O2. Since 
PDMS is highly hydrophobic, proteins will easily adsorb onto the surface of this material and 
the biocompatibility of this material is compromised. However, the adsorbed layer of protein 
is also permeable to small molecules such as oxygen and will therefore not change the 
analytical response of the amperometric sensor. 
 
4.3.1.3 Ammonia sensor 
 Ammonia sensors fabricated for the monitoring studies were polyvinyl-chloride 
(PVC)-based ion-selective electrodes (ISE). The polymeric membrane consists of 3.2 mg of 
ionophore (Nonactin), 128.2 mg of plasticiser Di-n-octyl sebacate (DOS), and a combination 
of 6.0 mg of polyethylene-glycol (PEG) and 62.6 mg of PVC-carboxylic acid (COOH) 
polymers dissolved in 1.2 ml of tetrahydrofuran (THF)145. The polymeric membrane was 
doped in PEG to improve surface resistance to protein adsorption and PVC-COOH to 
increase charge negativity on the polymer surface favouring protein repulsion. ISE 
membranes were made using disposable pipette tips dipped into casting mixtures and dried 
for 24 hr at room temperature. The tiny flexible membrane which solidifies at the bottom of 
each pipette tip forms the sensitive part of the ammonia electrodes. The internal electrode 
consists of an Ag/AgCl wire which was made by treating Ag wire for 20 min in 0.1 M FeCl3 
solution. Ag/AgCl wire was subsequently immersed into the internal filling solution and 
attached to the open end of the pipette tip using Parafilm. The size of the ammonia sensor is 
around 300 µm. 
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4.3.2 Data acquisition system and software 
 The data acquisition system designed for the real-time online monitoring platform 
consists of potentiometric, amperometric and ohmic modules which can be multiplexed for 
up to eight independent modules, as displayed in Figure 4.4. This multi-channel and multi-
parametric measuring system will allow continuous acquisition of many different analytes 
simultaneously in real-time. Each module can monitor up to 16 channels and consisted of a 
16-bit analog-to-digital converter (ADC) with input voltage range of 0-5 V at a 0.076 mV 
resolution146. The different types of modules were designed to meet the requirements of 
different types of sensors such as the amperometric, potentiometric or ohmic sensors. Data 
acquisition modules were controlled by a host PC through Universal Serial Bus (USB) 
connections. The software for configuring, collecting, managing and processing data was 
uniquely designed for cell culture bioprocessing using LabVIEW 7.1 (National Instruments 
Corporation). An example of the graphic user interface (GUI) front panel display and the 
configuration sub-panel are shown in Figure 4.5. Additional information regarding the 
technical specifications of this data acquisition system can be found in the publication by Yue 
et al.146. 
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Figure 4.4 Proposed real-time online monitoring platform for stem cell bioprocessing 
 
 
  
Figure 4.5 GUI front panel display (left) and configuration sub-panel (right) 
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4.3.3 Bioreactor and cell culture conditions 
The bioreactor designed for HSC bioprocessing has been described in section 4.2.2 
and is a simple perfusion system consisting of a cylindrical chamber with two inlets and two 
outlets for the exchange of media (Figure 4.6). Material used to fabricate the culture chamber 
is PMMA which is biocompatible for cellular growth. An example of a bioreactor in cell 
culture with several sensors placed for process monitoring is demonstrated in Figure 4.6. 
Various cells lines were used to test sensor performance in different cell culture 
conditions/environment, this included human leukemic cell line HL-60 cells (ATCC), 
NIH/Swiss mouse 3T3 fibroblast cell line (ATCC) and Shh Light II mouse fibroblast cells 
(ATCC). Media used for culturing leukemic cell line consists of 20% FBS (v/v) in IMDM 
and 1% penicillin/streptomycin (v/v) (P/S; GIBCO Invitrogen). Media used for culturing 
mouse fibroblast cells consists of 10% FBS (v/v) in Dulbecco’s Modified Eagle’s Medium 
(DMEM; GIBCO Invitrogen) containing 1.5 mg/L NaHCO3 (Sigma-Aldrich) and 1% P/S 
(v/v). Media used for culturing Shh Light II fibroblast cells consists of 10% FBS (v/v), 0.4 
mg/ml G-418 (Sigma Aldrich), 0.15 mg/ml Zeocin (GIBCO Invitrogen) in DMEM. HL-60 
cells were cultured at 2x106 cells/bioreactor while mouse 3T3 fibroblast cells and Shh Light 
II fibroblast cells were seeded at 2x105 cells/bioreactor. Each bioreactor was filled with 3-6 
ml of culture media. All cells were grown in static cultures and maintained in a 5% CO2, 20% 
O2 and 37oC fully humidified incubator for up to six days. 
For the ammonia experiments, cells were seeded on the same day when sensors were 
placed into the bioreactor (at the start of the experiment – day 0). Cells were allowed to 
adhere randomly within the bioreactor and the ammonia concentrations were monitored 
continuously throughout the culture period. For the pH and oxygen experiments, a slight 
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modification in the placement of cells was attempted and the fibroblast cells were 
intentionally seeded onto a specific area in the bioreactor in order to stimulate a region of 
higher cell density. To achieve this, cells were seeded two days prior to the start of the 
experiment. A quarter of the PDMS mould was cut out to allow cells to settle only into this 
area: only a quarter of the bioreactor will be covered with cells (Figure 4.7). Once the 
fibroblast cells have adhered onto the desired area, sensors were sterilised and placed into the 
bioreactor to begin continuous monitoring of the analyte of interest.  
 
  
 
Figure 4.6 Bioreactor designed for HSC bioprocesses (top). Sensor placed in bioreactor with 
cell culture (bottom) 
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Figure 4.7 Configuration of cell seeding for pH and oxygen experiments. Nine sensor 
locations based on DOE configuration. 
 
 
4.3.4 Toxicity study 
Each sensor type was tested for its toxicity to cells in culture. Mouse 3T3-Swiss 
albino fibroblast cells were seeded at a density of 2x105 cells in each bioreactor and cultured 
in static conditions for up to six days. Each experimental setup consisted of four bioreactors: 
two bioreactors contained nine real sensors of either pH, oxygen or ammonia, and one or two 
control bioreactors with no sensors placed inside. At the end of six days, sensors were 
removed and the growth of cells was observed from its morphology through the Leica 
inverted-phased microscope, and from manual cell counting using a haemocytometer. Cells 
were stained with Erythrosin B solution to determine the total cell viability. Cellular growth 
was compared to the control bioreactor which contained no sensors to determine if sensors 
had any toxic effects on the cells in culture. 
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4.3.5 DOE design parameters and data analysis 
Sensor placement in the perfused bioeactor system was determined by DOE as 
described in section 4.2.3. Briefly, spatial dimensions of the chamber were defined by x- and 
y-coordinates and utilised a CCD which has an α-value of 1.414. This generated a total of 
nine sensors required to perform a single DOE experiment. Each group of sensors, pH, 
oxygen and ammonia, were tested and placed in all nine DOE locations for continuous 
monitoring and spatial profiling. At the end of the culture, cells were counted and examined 
through the microscope at various locations in the bioreactor. Monitoring data obtained from 
cell culture experiments were processed in Design Expert 6.0.1 and MODDE 7. In the DOE 
software, the MLR or partial least squares (PLS) method were used to fit the experimental 
data into a 2nd order polynomial model to generate spatial and temporal profiles taken at 
various time-points throughout the culture process.                   
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CHAPTER 5 
In vitro erythropoiesis:  
Process characterisation and optimisation 
 
 
 
5.1 INTRODUCTION 
 Human umbilical cord blood is collected and stored worldwide in both public and 
private banks for stem cell transplantation and research purposes. One of the main areas of 
research is the ex vivo expansion and directed differentiation of cord blood stem cells toward 
specific lineages. Successful manipulation of these cells is of great clinical utility; bringing 
potential therapies for many blood related diseases and providing an alternate resource of 
blood. Currently, the average cost for processing blood transfusion in the US is reported at 
$2B per year, this cost is mostly associated to the testing of blood for its safe use147. One such 
resource in high demand is the red blood cell. Direct clinical applications of the red blood 
cell include transfusion for patients undergoing an operative procedure that will likely result 
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in major blood loss, patients who may also suffer from impairment in oxygen transport 
exacerbated by anaemia, or patients undergoing a chronic transfusion regimen or marrow 
suppressive therapy148. Ex vivo expansion and differentiation of HSCs toward red blood cells 
is therefore of great clinical interest. However, due to the complexity of stem cell 
mechanisms and our limited knowledge in their in vitro bioprocesses, successful 
manipulation of HSCs toward mature lineages that is useful for transplantation or transfusion 
is still limited by the quantity and quality of stem cell engineered blood products. 
Quantitative characterisation and optimisation of these in vitro bioprocesses has not yet been 
fully established.  
Traditional studies performed on HSC cultures are mostly based on a comparison of 
the outcomes from combining different cytokines69,70,75,149 or using a dose-response method 
to determine the effect of a single cytokine149. Typical combinations of cytokines being 
studied for in vitro erythropoiesis include EPO, FL, IL-3, SCF, GM-CSF and TPO. Studies 
based on comparing random combinations of cytokines and dose-response approaches 
provide limited information and do not often lead to an optimal process. The study performed 
by Detmer et al. for example investigated the effect of various bone morphogenetic proteins 
(BMP-2 to -7) with EPO or IL-3 and EPO, by testing one factor at a time at various 
concentrations of IL-3 and EPO149. The lack of a systematic approach in this process impedes 
the amount of information that can be extracted from performing the experiments and 
generally requires a larger number of experiments than DOE methods. The dose-response 
effect of BMP-4 was subsequently studied in this investigation to determine its effect on 
CD34+ cells149. It is clear from this example that comparison studies and dose-response 
methods cannot reveal interactive effects between the variables, thus they often do not 
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provide an accurate account of the process being studied. The approach used in these studies 
is therefore a highly inefficient and ineffective way of experimentation. 
DOE, on the other hand, can bring truthful insights and offer many advantages. DOE 
not only provides a more thorough and quantitative characterisation of the process but is also 
a much more efficient way of experimentation using the minimum number of experiments 
required83. The availability of an array of DOE designs allows the experimenter to perform 
many different types of process investigations, such as screening, characterisation, and 
process optimisation82,83. Previous studies have proven the effectiveness and efficiency of 
DOE methods for the characterisation of HSC cultures by showing successful screening and 
optimisation using fractional factorial designs and process characterisation using response 
surface modelling35,79,80. The study performed by Yao et al. used a fractional factorial design 
approach followed by the path of steepest ascent to optimise media supplements required for 
a serum-free condition for CB expansion80. Cortin et al. used a PBD to screen different 
cytokines and subsequently characterised the process of megakaryopoiesis using a CCD to 
obtain a fully developed quantitative model that describes the in vitro process35. In both 
methods, screening of a large number of factors was easily achieved and interactive effects 
from contributing factors were revealed. 
Cultures of HSCs, as previously discussed in Chapter 2, can be done through several 
approaches: from a serum-containing to serum-free and even stromal-based co-cultures. 
Traditionally, HSC cultures were performed in a serum-supplemented single-step cytokine 
cocktail wherein concentrations of cytokines are fixed throughout the culture period. In other 
configurations, multi-step cytokine, stromal-based co-cultures or a combination of both 
methods, have been experimented. A single-step cytokine culture entails the use of a fixed 
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combination and concentration of cytokines throughout the culture period while a multi-step 
cytokine culture uses different cytokines at different concentrations at various stages of the 
cell culture. This chapter focuses on the use of DOE as an experimental strategy for 
characterising and optimising process conditions for in vitro erythropoiesis of cord blood 
CD34+ cells in a single step. 
 
 
5.2 AIM AND HYPOTHESIS  
The aim of this study is to develop a simple DOE-based experimental strategy that 
can be readily applied for studying complex cell culture systems/stem cell bioprocesses. The 
basic hypothesis is that DOE can improve methods of experimentation in cell culture studies 
by providing quantitative results and better outcomes from the cell culture i.e. greater 
proliferation and/or differentiation in the process of interest.  
 
 
5.3 APPROACH TO STUDY 
The general approach is to first develop a simple DOE experimental strategy that can 
be easily applied to different bioprocesses of interest. The proposed DOE strategy consists of 
three simple steps: (1) screening of a large number of factors using fractional factorial 
designs, (2) process characterisation using response surface modelling, and (3) optimisation 
of process conditions using model-based point prediction. Specific details of the designs used 
for each step were previously described in section 4.1.2.1. The selection of cytokines that will 
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be used in this study was based on previous findings, of which the more commonly used 
cytokines for red blood cell differentiation were chosen. The selected cytokines were: SCF, 
IL-3, IL-6, FL, GM-CSF, TPO and EPO. The optimised process obtained from the DOE 
experiments were subsequently verified and analysed for red blood cell markers and 
phenotypes. These results were then compared to previous findings for a single-step cytokine 
culture that were not optimised using DOE to determine whether the hypothesis is valid. 
 
 
5.4 RESULTS 
5.4.1 DOE analysis 
The DOE screening experiment revealed that SCF and EPO were the only two factors 
significantly influencing the in vitro erythropoiesis of cord blood HSCs. A set of full 
experimental results reflecting the raw data from this screening study is displayed in Table 
5.1. This set of experimental results (all 20 runs in the DOE matrix) was obtained from a 
single cord blood unit. The screening experiment was repeated one more time using a 
different cord blood unit and led to the same conclusions as those from the first experimental 
study. The analysis of this data using DesignExpert 6.0.1 yielded coefficient estimates for 
each cytokine which is presented in the coefficient plot (Figure 5.1). The coefficient plot 
shows that the effects of SCF and EPO were not only large in magnitude but also significant 
(p < 0.05) for both the total fold expansion (Fold) and red cell maturation (%RBC) over a 10-
day culture. The %RBC represents the percentage of red blood cells in the population which 
is determined by their GPA expression in the flow cytometer. GPA is a marker for mature red 
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blood cells and is therefore a good indicator for differentiation of cell population toward the 
erythroid lineage. All other remaining cytokines in the coefficient plot had p-values > 0.05 
which indicate that they are insignificant to the process.  
 
Table 5.1 Full experimental results for screening study (raw data). All 20 experimental runs 
were performed using a single cord blood unit. 
 
Std Run 
SCF 
ng/ml 
IL3 
ng/ml 
IL6 
ng/ml 
FL  
ng/ml 
TPO 
ng/ml 
GMCSF 
ng/ml 
EPO  
IU/ml Fold %RBC 
1 2 0 0 0 0 0 0 0 0 0 
2 11 100 0 0 0 100 0 5 402.5 67.03 
3 6 0 100 0 0 100 100 0 2.335 0 
4 15 100 100 0 0 0 100 5 337.5 64.79 
5 10 0 0 100 0 100 100 5 0 0 
6 7 100 0 100 0 0 100 0 7.45 1.82 
7 17 0 100 100 0 0 0 5 4.78 13.44 
8 16 100 100 100 0 100 0 0 18.1 6.54 
9 13 0 0 0 100 0 100 5 0 0 
10 14 100 0 0 100 100 100 0 60.7 1.79 
11 4 0 100 0 100 100 0 5 12.35 19.18 
12 9 100 100 0 100 0 0 0 34.35 4.1 
13 3 0 0 100 100 100 0 0 3.11 5.67 
14 20 100 0 100 100 0 0 5 440 59.31 
15 1 0 100 100 100 0 100 0 9.2 3.49 
16 12 100 100 100 100 100 100 5 405 52.98 
17 19 50 50 50 50 50 50 2.5 376 47.01 
18 18 50 50 50 50 50 50 2.5 376 46.51 
19 8 50 50 50 50 50 50 2.5 475 51.92 
20 5 50 50 50 50 50 50 2.5 440 47.81 
 
 
Factors with a negative coefficient estimate imply that they may have a negative effect on the 
response; causing a retardation in the expansion and/or maturation capability of the cells. For 
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example, the effect of GM-CSF on %RBC suggests that the presence of GM-CSF in the 
culture media will reduce the maximum potential maturation of the cell population resulting 
in a lower %RBC value than its full potential. The half-normal plots (Figure 5.2) generated 
from the DOE analysis for both fold expansion and red cell maturation confirm the 
significance of main effects from SCF and EPO. They also suggest the presence of the two-
factor interactive effect (AG). 
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Figure 5.1 Coefficient plots for total fold expansion (Fold) and red cell maturation (%RBC). 
Only the p-values for SCF and EPO were < 0.05 i.e. significant. The coefficient of each 
cytokine gives the magnitude of their effect. Coefficients were normalised against the highest 
coefficient in each group. 
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Figure 5.2 (a) Half-normal plot for fold expansion. Significant effects are A (SCF), G (EPO) 
and AG (SCF-EPO). 
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Figure 5.2 (b) Half-normal plot for %RBC. Significant effects are A (SCF), G (EPO) and 
AG (SCF-EPO). 
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The characterisation study based on a two-factor face-centred CCD with SCF and 
EPO produced quantitative relationships that accurately describe the effects of SCF and EPO 
on the fold expansion and red cell maturation. The resulting output model equations 
representing these relationships are displayed in Table 5.2 and the full ANOVA analysis of 
the DOE experimental results is provided in Appendix A. Both models were significant and 
showed no lack of fit. The resulting models generated three-dimensional (3D) surface 
response plots for both total fold expansion (Figure 5.3a) and red cell maturation (Figure 
5.3b). Coefficient plots (not shown) and 3D surface plots (Figure 5.3a and 5.3b) revealed that 
the expansion of cord blood stem cells in culture is affected by both SCF and EPO while red 
blood cell differentiation is affected by only EPO. 
 
Table 5.2 Model equations for characterisation of cord blood CD34+ cells toward 
erythropoiesis. Factors are: A = SCF and B = EPO 
Characterisation for R-squared Model Equations (in terms of actual factors) 
Fold expansion 0.9650 Log(fold + 8.50) = 1.044 + 0.0499A + 2.269x10-3B 
– 4.885x10-4A2 +2.721x10-3AB 
RBC% 0.9795 (%RBC + 0.67) = 5.546 + 0.0728A + 27.432B – 
3.049B2 
 
 
Process optimisation can be done by setting criteria in the desired responses. In order 
to determine the optimal operating regime and cytokine concentrations required for 
maximum red blood cell production (i.e. high cell expansion and high %RBC in the cell 
population), the two response surface plots were overlapped to reveal the region where both 
optima are met (Figure 5.3c). This region is represented by the area shaded red in Figure 5.3c 
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and meets the criteria of achieving a fold expansion greater than 1500 and percentage of red 
blood cells greater than 67%. The optimal cytokine concentrations for the most optimal 
process operation can then be selected from this overlapping regime; the final DOE cytokine 
concentrations selected were 75 ng/ml of SCF and 4.5 IU/ml of EPO. 
 
 
 
Figure 5.3 (a) Response surface plots for SCF and EPO on total fold expansion. The total 
fold expansion is defined as the fold of increase over the initial seeding density. 
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Figure 5.3 (b) Response surface plot for SCF and EPO on red cell maturation. Red cell 
maturation is defined as the percentage of red blood cells in the population determined by 
their GPA expression levels detected in the flow cytometer. 
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Figure 5.3 (c) Overlapping region for optimal cell expansion and RBC maturation. The 
sweet-spot (red shaded area) is determined by conditions that meet the following criteria: fold 
> 1500 and %RBC > 67%. 
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5.4.2 DOE verification 
The DOE optimised cytokine concentrations (75 ng/ml SCF and 4.5 IU/ml EPO) 
were verified in a 16-day culture (n = 6). Cells were analysed for a pan-haematopoietic 
marker, CD45, and two erythroid markers, CD71 and GPA. CD45 is generic haematopoietic 
cell marker but is lost in mature haematopoietic cells including red blood cells. CD71 is a 
marker for erythroid progenitors and reticulocytes, but is lost when reticulocytes mature into 
red blood cells150. GPA is expressed normally at the stage of erythroblast through mature red 
blood cells150. Accelerated maturation of cord blood stem cells toward the erythroid lineage 
was evidenced by the rapid increase and high percentage of CD71 and GPA expression 
(Figure 5.4). By day 4, 80% of the cells expressed CD71 and 26% expressed GPA. By day 7, 
almost 80% expressed both CD71 and GPA, and a reduced expression of CD45 (from 57% to 
26%) was observed (Figure 5.4). On day 13, the expression of CD45 reduced to 2.9% while 
the expressions of CD71 and GPA reached as high as 97%. The progression of surface 
antigen expressions for the cord blood cultured cells toward red blood cell maturation can 
also be observed from the flow cytometry plots (Figure 5.5). Both the 3D and 2D flow 
cytometry plots are displayed in figures 5.5a and 5.5b respectively. In comparison to other 
standard cytokine cocktails, a significantly faster maturation is achieved in this DOE cocktail. 
One such study was compared to the DOE cocktail in Table 5.3; the DOE optimised culture 
showed higher expressions of CD71, GPA, and lower expressions of CD45 indicating a more 
mature population of erythroid cells found in both days 7 and 10 of the DOE culture.  
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Figure 5.4 The progression of surface antigens (CD45, CD71 and GPA) expressed in the 
cord blood cultured cells (n = 3-6). A decreasing trend observed in the CD45 expression 
while and increasing trend is observed in both CD71 and GPA expression. 
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Figure 5.5 (a) 3D flow cytometry plots for cord blood cultured cells in 75 ng/ml SCF and 4.5 
IU/ml EPO. FSC-SSC indicates gated population shown in the forward scatter versus side-
scatter. Surface antigens CD45, CD71 and GPA are shown in all 3D plots. 
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Figure 5.5 (b) Flow cytometry data in 2D plots. Low expression of CD45 observed on days 
10 and 13 and high expression of GPA observed on days 10 and 13 versus day 4. 
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Cells cultured in 75 ng/ml SCF and 4.5 IU/ml EPO yielded high total cell expansion. 
Cellular growth reached an average total fold expansion of up to 18,307 by the end of 16 
days in culture (Figure 5.6a); the maximum fold expansion obtained in one culture was 
36,900 and the minimum fold expansion achieved was 3,029. The huge difference observed 
in cellular expansion between experiments is related to cord-to-cord sample variability. 
Cellular growth of cord blood stem cells in this cytokine culture followed a typical growth 
profile which consisted of a lag phase, a log phase, and a plateau. In its log phase, the average 
growth rate is 7.8 fold per day which equates to a doubling time of roughly 3 hr, a rapid cell 
expansion. A comparison in the maximum fold expansion achieved in this study to other 
studies showed an overall improvement of 18-fold than the total average obtained from all 
studies using a single-step cytokine cocktail. An example of the comparison in growth 
potential from one such study is shown in Table 5.3. The DOE cocktail achieved 3.5 fold 
greater expansion by day 7 and 17.8 fold by day 10.  
CFU assays relate to the clonogenic capability of the cord blood cultured cells. The 
assays showed an overall increase in the number of erythroid progenitors, which are the 
CFU-E and BFU-E colonies, in the first seven days of culture compared to its starting 
population - CD34+ cells (Figure 5.6b). The BFU-E colonies are earlier erythroid progenitors 
than CFU-E colonies. The maximum number of total erythroid progenitors was achieved on 
day 4, reaching over 260 colonies/1000 cells plated. Cells from day 4 showed significantly 
larger numbers of BFU-E colonies than CFU-E colonies while cells from day 7, a more 
mature population, showed higher numbers of CFU-E than BFU-E colonies. The total 
number of erythroid progenitors from day 7 also decreased by more than half of its total 
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number at day 4. By day 10, only a small number of CFU-E colonies remained in the cell 
population (less than 20 colonies/1000 cells plated) indicating a small population of 
immature erythroid progenitors. 
 
Table 5.3 Comparison of DOE cocktail to a standard single-step culture.  
 
 DOE cocktail* Standard cocktail* 
Day 7 Fold 136 38 
CD45 25.8% 89.6% 
CD71  91.1% 84.1% 
GPA  76.2% 45.5% 
Day 10 Fold 1853 110 
CD 45 4.9% 96.5% 
CD71 96.1% 78.3% 
GPA 91.5% 49.5% 
 
*DOE cocktail consists of 10% FBS, 75ng/ml SCF and 4.5IU/ml of EPO in IMDM while the 
standard cocktail consists of 100ng/ml IL-3, 50ng/ml of FL and 2 IU/ml EPO (results 
obtained from Kie et al.) 
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Figure 5.6 Growth profile and in vitro clonogenic assay. (a) Cell growth in total fold 
expansion (n = 6). (b) In vitro clonogenic assays were performed at days 0, 4, 7 and 10. 
Assays were normalised to a seeding density of 1000 cells/plate (n = 2-4). 
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Red cell maturation was also evidenced in the morphology of stained cells. 
Indications of red cell maturation such as the expulsion of cell nucleus was observed on day 7 
and day 10 cells, and a small number of enucleated red blood cells were observed in day 13 
and 16 of the culture (Figure 5.7a). Most cord blood cultured cells were around 15-20 µm in 
diameter and larger cells (~30-35 µm) resembling reticulocytes were observed from day 7 
through day 13. Cells appear slightly larger than normal as they were cytospun onto the glass 
slide. The presence of reticulocytes is confirmed by brilliant Cresyl-blue staining; 
reticulocytes stain deep blue as seen in day 13 while other haematopoietic cells do not stain 
(Figure 5.7b). On day 13, shrinkage in cell size was also observed and a small population of 
cells measuring ~12 µm and lacking of a nucleus began to appear (Figure 5.7a). Fluorescence 
microscopy showed a larger number of cells expressing CD45 at the beginning of the culture 
as compared to those at the end of the culture (Figure 5.7b), consistent with observations 
made in the flow cytometry data. More importantly, expression of GPA on the cells’ surface 
differed between cells early in the culture versus those late in the culture. Expression of GPA 
on day 4 cells were granulated and scattered throughout the cellular surfaces while GPA 
expression on day 13 cells were much more homogeneous on the cell surface and has a 
brighter intensity on several cells (Figure 5.7c). Surface expression and distribution of GPA 
on day 13 cells resembled the expression on our cord blood red cell control (Figure A1 in 
Appendix A). 
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Figure 5.7 Cell morphology of cord blood cultured cells. (a) Giemsa-Wright’s stain for 
nucleic-cytoplasmic differentiation: Day 7 cells (left) and Day 13 cells (right). (b) Cresyl-
blue stain for reticulocytes: Day 4 cells very little / no stain; day 13 cells have many dark 
blue stain. (c) Comparison of CD45 and GPA surface antigen expression using fluorescence 
microscopy - day 4 versus day 13 cells stained for FITC-CD45 and PE-GPA. 
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RT-PCR and western blot results confirmed differentiation of cord blood cultured 
cells toward the erythroid lineage in the gene and protein level. mRNA expressions of γ, β, 
and α-haemoglobins and GATA-1 were observed from day 6 through day 14 cells (Figure 
5.8a). Alternatively, no HOX-B4 expression was observed in any of the cultured cells from 
day 6 to day 14 indicating a lack of stem cell expression as early as day 6 of the culture. 
HOX-B4 is a haematopoietic stem cell marker while GATA-1 is a marker for red blood cells. 
The α and β-haemoglobins are normally expressed in adult red blood cells while the γ-
haemoglobin is only found in foetal red blood cells. Expressions of β, γ-haemoglobins and 
GATA-1 were also present at the protein level, but appeared only at a later stage than their 
mRNA expressions which was expected. Positive expressions of all three erythroid proteins 
appeared on day 14 cells and not on day 0 or day 7 cells (Figure 5.8b). Protein expression of 
β-haemoglobin and GATA-1 was strong; notably the expression of β-haemoglobin (the adult 
haemoglobin) was stronger in cultured cells than that from cord blood foetal red cells. 
Conversely, protein expression of γ-haemoglobin (foetal haemoglobin) was weaker in the 
cord blood cultured cells than that from cord blood foetal red cells (the positive control). 
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Figure 5.8 Gene and protein expression profiles. (a) RT-PCR results for GAPDH, HOXB4, 
α, β, γ-haemoglobins and GATA-1. Positive controls: Cord blood CD34+ for HOXB4; K562 
cell line for all others; negative controls: HL60 cell line. (b) Western blot results for GAPDH, 
γ, β-haemoglobins and GATA-1. Positive controls: Cord blood RBC; negative controls: 
HL60 cell line. Protein expression is reflected at a later stage than mRNA expression and is 
observed on day 14 but not day 7.  
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5.5 DISCUSSION 
5.5.1 DOE as an experimental strategy 
 This study has successfully demonstrated the ease and efficacy of DOE as a quick 
and effective screening, characterisation, and optimisation tool. Specifically, DOE provided a 
well-illustrated quantitative representation of the relationships between SCF and EPO on the 
in vitro erythropoiesis of cord blood stem cells, and obtained a significant improvement on 
total cell expansion, with over 18-fold in comparison to other single-step cytokine cocktails, 
and faster red cell maturation of the cord blood cells overall. A DOE approach to HSC 
process characterisation and optimisation therefore provides a highly effective and efficient 
experimental strategy that can be used to tailor the production of clinical grade blood 
products. 
DOE screening methods are excellent tools for investigating a large number of factors 
and reducing these parameters based on their level of contribution. The fractional factorial 
design is a commonly used design method for screening due to its ability to accommodate a 
large number of factors and tailor experiments at different levels of resolution according to 
the goal of the experiment. In this study, the use of fractional factorial design allowed quick 
screening of seven different cytokines performed in a single study using 16 experimental 
conditions. Other investigators, such as Yao et al., have also used such designs for screening 
and subsequently optimising concentrations of media supplements using the path of steepest 
ascent80. The advantage of my DOE approach in comparison to the study performed by Yao 
et al. is the production of a quantitative model that can be used to describe the in vitro 
process. Optimisation using the path of steepest ascent is less precise than the development of 
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a response surface model. However, in both studies, the fractional factorial design has proven 
to be highly advantageous for the screening of cell culture supplements and cytokines used in 
various types of culture media and experiments. It has helped to determine key factors 
rapidly (minimum experiments) and reduces the amount of work required to study and 
optimise a culture process of interest.  
For process characterisation, many different types of designs are available to fit 
experimental results into a 2nd order polynomial model. In this study, a face-centred CCD 
was utilised to quantify main and interactive effects of SCF and EPO on cell expansion and 
red cell maturation. The ANOVA analysis (Appendix A) and response surface plots (Figure 
5.2a and 2b) revealed both main and interactive effects of SCF and EPO on cell expansion 
but only a main contribution from EPO on red cell maturation. This finding is consistent with 
the current knowledge on erythropoiesis; EPO being the main driver of this differentiation 
process151-153. More importantly, the 3D surface response plots generated from DOE 
represent a quantitative model on the expansion and differentiation of cord blood stem cells 
into erythrocytes which has not been previously established. This not only illustrates the 
exact relationships between the factors and responses, but it also allows us to predict and 
determine the best operating regimes for the bioprocess of interest, as demonstrated here 
(Figure 5.2c). A similar approach was taken by Cortin et al. to determine the optimal 
conditions for in vitro megakaryopoiesis of cord blood stem cells. In their study, the group 
utilised the PBD for screening. The advantage of using this design is the small number of 
experiments required to screen more than 10 process factors. However, a fold-over (repeat) 
of the design is necessary to verify results obtained from the PBD study. Still, the PBD can 
sometimes be confusing due to the number of factors aliased to each other which makes it 
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challenging to determine real effects from each factor. In this study, since there were only 
seven factors involved, use of the PBD is not extremely advantageous in terms of reducing 
the number of experiments required. The resolution IV fractional factorial design proved to 
be more beneficial in providing the most reliable results using the least amount of effort. 
Also of significance is the efficiency of the DOE experimentation process in terms of 
time and labour savings in comparison to traditional dose-response methods. Since 
experiments are varied only one factor at a time in most dose-response studies, it would 
generally require a larger number of experiments to be performed in order to obtain the 
resolution roughly close to that obtained in DOE studies. For this case study, it would require 
a minimum of 14 experiments to first determine if each of the factors significantly affects the 
process and subsequently a matrix of 50 experimental conditions for the two factors, with 
each factor being varied at five different concentrations. A minimum total of 64 experiments 
is therefore required using dose-response, and in comparison with the DOE approach which 
required only 26 experimental conditions in total, clearly shows significant time and labour 
savings. DOE-based experimentation for process characterisation can be easily applied to any 
other stem cell bioprocesses of interest to provide a more thorough and quantitative process 
illustration as performed here. 
Although the DOE approach has been successful in screening, characterising and 
optimising process requirements in a rapid and efficient manner, the outcome from this DOE 
study still requires high concentrations of cytokines, particularly EPO, to perform an optimal 
process. Normal physiological levels of serum EPO ranges in the 1.1-27.3 mIU/ml154, a 100-
fold lower concentration than what is typically used in cell culture 1-3 IU/ml. In this study, 
the optimised DOE cocktail demands a 4.5 IU/ml of EPO, an even higher concentration of 
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EPO which can result in a costly bioprocess operation. One of the challenges in setting up a 
DOE experiment is to first determine the range of process operation as this greatly affects the 
results from the DOE study. The complexity of the cell culture environment adds further 
obstacles to the optimisation of a bioprocess, other factors such as feeding frequency or 
glucose concentrations may influence process requirements. In this study, effects of other 
parameters have not yet been considered. 
 
5.5.2 A comparison: DOE optimised process versus other studies 
 DOE optimised cytokine concentrations used for this single-step cytokine culture 
demonstrated significantly better performance in terms of total fold expansion, red cell 
maturation and clonogenic ability of the cultured cells than previous studies using a single 
step. Total fold expansion in a typical study achieved 15-1000 fold after 14-18 days in 
culture69,70,155. In this study, as much as 36-fold (average of 18-fold) higher expansion was 
achieved than the currently best reported study155; indicating that the DOE approach has 
resulted in improved growth factor concentrations and an effective combination. However, 
when compared to the multi-step cytokine cocktail cultures (those that vary cytokine 
combinations and/or concentrations throughout the culture period) and co-culture systems, 
the DOE culture lags by about 10 fold or more. The multi-step and co-culture systems 
resulted in an average of 200,000 fold expansion in 16 days144,156,157. However, co-cultures 
are not ideal due to the possibility of cross-contamination from stromal sources and are much 
more labour-intensive than a standard cytokine culture. Interestingly, in one study, no co-
cultures were utilised in the procedure and they were still able to achieve significantly higher 
cell expansion157. In this study, the use of erythroid differentiation medium which consisted 
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of 20% FBS (v/v) was included, however this is not likely to fully explain for the 
significantly higher expansion achieved in this culture procedure. The multi-step cytokine 
cultures have shown an effect of timing in which the cells are fed at different growth factor 
concentrations, on cellular dynamics. Hence, the DOE approach to cellular cultures and 
bioprocesses used in this study may be strengthened by factoring in time.  
Trends in the clonogenic capacity of the cord blood cultures corresponded well with 
the growth profile and flow cytometry data observed in this study. At the beginning of the 
culture (day 0-4), enriched CD34+ cells proliferated at an average rate of ~2.0 fold/day and a 
high level (81.3%) of CD71 expression was obtained by day 4 which indicate a high level of 
erythroid progenitors and this is reflected in the CFU-assays producing the largest number of 
CFU-E and BFU-E colonies, and a reduction in CFU-GEMM colonies. By day 7, no CFU-
GEMM colonies were found and the population consisted mostly of erythroid progenitors 
and maturing erythroid cells, as indicated by the increase in GPA expression in cells and 
reduction in BFU-E and CFU-E colonies. In comparing the clonogenic capacity to other 
studies, one study using a multi-step culture144 was used as a close comparison since there 
were no other single-step cultures that had sufficient CFU data for this comparison. The 
overall trend observed in erythroid colonies over the cell culture is the same in both cultures. 
However, the DOE culture achieved higher BFU-E and CFU-E numbers on day 4 and 
sustained more colonies on day 10 than the multi-step cytokine culture.  
In terms of red blood cell maturation observed from flow cytometry data, an even 
more significant improvement was obtained here. Typical GPA expression of cord blood 
cultures from previous literature only reached ~15% at day 7 and 80% at day 14 for the 
single-step cytokine cultures while in this study, 80% of the cells already expressed both 
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CD71 and GPA by day 7. By day 10, over 90% expressed both CD71 and GPA markers and 
only 5% expressed CD45, the lost of CD45 expression indicates full maturation of the 
erythroid cells which is further reflected in the appearance of reticulocytes in the cell culture. 
The comparison to multi-step cytokine cultures also shown a better performance (maturation 
of cells) in this DOE optimised culture; the best maturation from the three studies reached 
~85% GPA in day 10 and ~89% in day 16. Accelerated maturation as observed in the DOE 
optimised culture is likely attributed by the high concentration of EPO used for the culture. 
 
5.5.3 Biological significance of study 
Cell culture optimised via the DOE method achieved accelerated expansion and 
maturation simultaneously. Expression of CD71, an early-mid stage erythroid progenitor 
marker, reached an average of 81.3% as early as day 4 of the culture. The expression of 
CD71 continues to increase to reflect complete maturation of stem cell progenitors toward 
the erythroid lineage and a lost in the CD45 expression indicates further maturation of the 
cell population. Fully functional mature red blood cells however do not express CD71 but 
only GPA150. In this case, the expression of CD71 on day 13 remained very high, indicating 
complete maturation of red blood cells has not yet been achieved at this stage but by day 16, 
a 20% lost in CD71 expression was observed but the results obtained from day 16 were 
somewhat questionable since the variability in CD45 and CD71 expression was large in 
comparison to the GPA expression. Based on observations from cell morphology, there is 
still sufficient evidence to indicate the presence of a small population (<10-20%) of red blood 
cells in day 16 culture. However, the cell population achieved in this DOE culture still mostly 
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consisted of premature erythrocytes and reticulocytes. The achievement of a high percentage 
of fully functional red blood cells remains a challenge. 
Expression of haemoglobins at the protein level indicates some promising results 
from this study. The high levels of adult haemoglobin obtained from cultured cord blood 
cells and low levels of foetal haemoglobin reflect the type of blood cells obtained from this 
study were that mostly relating to adult red blood cells even though the starting population 
(cord blood) consisted mostly of foetal red blood cells. Enucleation of red blood cells from 
embryonic stem cells, on the other hand, often led to the production of foetal blood cells158. 
Adult red cells are more suitable for transfusion. The production of adult erythroid cells in 
this study is therefore beneficial for the purposes of transfusion. 
 
 
5.6 CONCLUSION 
 The overall outcome from this study has been very successful: the DOE approach and 
proposed experimental strategy efficiently and effectively screened, characterised, and 
optimised the process under study (in vitro erythropoiesis of cord blood stem cells). The 
optimal DOE cytokine cocktail obtained from this study also generated higher growth 
potential and rapid differentiation toward the erythroid lineage in vitro in comparison to other 
single-step cytokine cultures. The DOE approach has therefore proven the validity of the 
proposed hypothesis, showing an improved method of experimentation and achieving 
significantly better results from the process outcome. These promising results underscore the 
efficacy of DOE methods not only in process characterisation but in process optimisation. 
However, DOE optimisation as a single step culture is mostly end-point driven which 
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explains the accelerated maturation and rapid expansion observed in this culture bioprocess. 
The process objective in this single-step study was simply to maximum the number of red 
blood cells by day 10 of the culture. Process dynamics within the culture process has been 
completely ignored. Chapter 6 presents a DOE approach in an attempt to characterise and 
optimise the in vitro erythropoiesis of cord blood stem cells as a multi-step process 
considering the factor of time.  
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CHAPTER 6 
In vitro erythropoiesis:  
Defining the influence of time in cell culture 
 
 
 
6.1 INTRODUCTION 
 In vitro expansion and directed differentiation of HSCs toward the erythroid lineage 
is a complex and dynamic process. Optimisation of this process not only entails the 
identification of process factors, in this case growth factors, but also in determining the 
concentrations in which they should be added into the culture media. However, for many 
haematopoietic processes, the need for specific growth factors may be transient through the 
early, mid, and late stages of the differentiation process. A process such as erythropoiesis in 
vivo requires factors such as SCF and FL as early-acting growth factors, GM-CSF as a mid-
acting growth factor and EPO as the late-acting growth factor to produce fully functional red 
blood cells (Figure 6.1)159,160.  
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In chapter 5, the DOE approach was used to perform process characterisation and 
optimisation for the in vitro production and maturation of erythrocytes from cord blood 
CD34+ cells using only a single step i.e. without varying growth factor concentrations 
throughout the culture period. Although the DOE-optimised single step process demonstrated 
significant improvements in comparison to other single step studies, optimisation performed 
in this single step culture was end-point driven, culture dynamics was not revealed. However, 
as seen from the in vivo process, process dynamics can change drastically throughout 
differentiation. Process kinetics is clearly quite significant and can greatly affect the outcome 
of the process. This study seeks to investigate the possibilities in using DOE to reveal process 
dynamics and further improve cell culture fold expansion using a multi-step cytokine culture.  
In vivo, erythropoiesis is distinctly defined by the development of erythroid 
progenitors from the HSC to the red blood cell (Figure 6.1), and as cells mature, different 
cytokines are required for the generation of different red cell progenitors159. In vitro studies 
have shown that the effects of different growth factors such as SCF and EPO were 
independent from each other at different stages of erythroid development161. Another study 
showed that early stages of in vitro erythropoiesis were EPO-independent and only the later 
stages were EPO-dependent160.  These studies support the idea that the in vitro expansion and 
maturation of HSC requires different growth factor conditions at different time-points during 
their differentiation process. Cytokine conditions for the in vitro process should therefore be 
optimised to meet the requirements of this dynamic process. This chapter discusses the 
results obtained in determining changes in process requirements for in vitro erythropoiesis 
with respect to time and limitations of the DOE method in resolving cell culture dynamics 
through the early, mid and late stages of differentiation. 
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Figure 6.1 Erythropoiesis as it occurs in vivo. Production of the red cell begins with the HSC 
leading to the production of multi-lineage colonies, the erythroid progenitors, the reticulocyte 
and finally the erythrocyte. Cytokines known to be involved in the various stages of the in 
vivo differentiation process include SCF, FL, IL3, IL6, GM-CSF and EPO. 
 
 
 
6.2 AIM AND HYPOTHESIS  
 The aim in this study is to develop an experimental strategy based on DOE for 
elucidating process dynamics of an in vitro process. The influences of time, such as the 
feeding frequency and identification of time-points during the culture where cytokine 
concentrations are varied, on the proliferation and differentiation potential of the in vitro 
erythropoiesis of cord blood stem cells is investigated. The hypothesis is that the influence of 
time of when the cells are fed and variations in cytokine cocktails and their concentrations 
can significantly affect the growth potential of cord blood stem cells in vitro i.e. a multi-step 
cytokine culture is better than a single-step cytokine culture and that with the aid of DOE, it 
is possible to reveal in vitro process dynamics effectively. This study will also be used as a 
measure to evaluate the advantages and disadvantages of an end-point driven versus a 
kinetics-driven process optimisation. 
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6.3 APPROACH TO STUDY 
The general approach to this study is to divide the culture period into sequential 
phases, which was subsequently chosen to reflect the growth kinetics (Figure 6.2). First, the 
influence of time on cell culture kinetics was defined as the feeding frequency and the change 
in cytokine concentrations at various time-points in the cell culture. These effects were tested 
in a preliminary screening study. Once the influence of time is confirmed, DOE 
characterisation at each phase of the culture will be performed to determine cytokine effects 
and optimal concentrations required. The proposed work flowchart is shown in Figure 6.3. 
Each DOE characterisation study was performed via RSM using the face-centred CCD. 
Finally, the final combination of cytokine cocktails used in each phase for this multi-step 
cytokine cocktail will be tested in different cord blood cultures and these results will be 
compared to that obtained from the single-step cytokine culture (results from Chapter 5) to 
determine if the sequential optimisation of each step in the culture has made a significant 
improvement in the growth performance of this in vitro process. 
 
 
 
Figure 6.2 Division of culture period into three distinct phases defined by growth kinetics 
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Figure 6.3 Flowchart of DOE experimental strategy for multi-step cytokine culture 
 
 
 
6.4 RESULTS 
6.4.1 Preliminary screening analysis 
 The preliminary screening experiment demonstrated that the feeding frequency, 
change of growth factor concentrations, and the presence of EPO have a significant effect on 
the total cell expansion over the course of an eight-day culture. The half normal plot for total 
cell expansion (Figure 6.4a) shows that the most prominent effects arose from change of 
media and the presence of EPO and a smaller effect came from the feeding frequency. This 
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indicates that a change in cytokine concentrations in the middle of the cell culture 
significantly affects cellular expansion. A number of factors also appear to affect the viability 
of cells, from the half-normal plot (Figure 6.4b) it can be concluded that cell viability was 
affected by frequency and a combination of two/three-factor interactions, which included 
frequency-change-EPO, change-SCF, frequency-EPO and change-EPO.  
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Figure 6.4 (a) The half-normal plot for fold expansion. Factors A, B, D and BD are 
significant. The x-axis reflects the magnitude of each effect; the y-axis reflects the probability 
that effect is significant. All other points that lie close to the line reflect random error. 
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Figure 6.4 (b) The half-normal plot for cell viability. A number of factors appear to influence 
cell viability; this includes frequency and several two/three factor interactions. 
 
6.4.2 Characterisation and optimisation analysis 
 Characterisation and optimisation of cellular growth for phases I, II and III were 
slightly more challenging than previously attempted (Chapter 5) for a single-step cytokine 
cocktail. Although DOE characterisation for each phase was repeated three times, not all 
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DOE characterisation studies performed yielded significant models. From those that were 
significant, the repeats in the models within each phase, in some cases, were slightly 
different. In phase I, all models showed a general dependency on IGF-II and EPO but no 
significant effect in changing SCF concentrations on cellular growth (total cell expansion). In 
the first experiment, a strong contribution from changing EPO concentrations and an 
interactive effect between IGF-II and EPO were identified but the contribution of IGF-II was 
not very significant. The experiment was repeated and the results were modelled against 
variables from the initial findings. In this case, all parameters involved were significant 
including that of IGF-II. The response surface model generated from the second experiment 
differed slightly from the first experiment in shape of the curvature toward higher EPO 
concentrations (Figure 6.5). The optima on each plot also do not lie exactly in the same 
region although both have a tendency toward higher EPO concentrations. A model describing 
the relationships for fold expansion in the first experiment was generated by backward 
elimination and has an R2-value of 0.7886 and no significant lack of fit (p = 0.4874). The 
model describing relationships in the second experiment has an R2-value of 0.7546 and no 
lack of fit (p = 0.9487). A summary table for the equations of both models is provided in 
Table 6.1 and the full ANOVA output can be found in Appendix A. Although the R2 values 
for both models were not very high (< 0.90), they were both significant and showed no lack 
of fit. Optimal cytokine concentrations were optimised based on the model with the best fit 
(experiment 1) and the optimal operating regime lies in the region of 3-5 IU/ml EPO and 
varying concentrations of SCF and IGF-II. Two sets of cytokine concentrations were selected 
from the optimisation list and tested: (1) 70 ng/ml SCF and 5.00 IU/ml EPO and (2) 50 ng/ml 
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SCF, 100 ng/ml IGF-II and 3.00 IU/ml EPO and showed no significant difference. The 
cytokine cocktail with lower concentrations of EPO was chosen for economical reasons. 
 
Figure 6.5 Response surface plots for phase I studies: Characterisation for total cell 
expansion from day 0-6 of cell culture (a) Experiment 1: fold range is 0-48 (b) Experiment 2: 
fold range is 0-80. Cytokine ranges for both experiments are 0-100 ng/ml IGF-II and 0.1-5.0 
IU/ml EPO. Both experiments showed no dependency on SCF and has a tendency toward 
higher concentrations of EPO (3-5 IU/ml). 
 
 
 In phase II, all three models showed a dependency on EPO and SCF though in one 
model the effect of SCF was not significant (p = 0.20). In the other two experiments, 
relationships were almost identical as observed by their response surface plots (Figure 6.6) 
and the optima for each plot lie in the same area. However, the numerical values in each 
model output differed, which is not surprising, since cord-to-cord variability affects cell 
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culture performance. In the first experiment, the R2-value for this model was 0.5972 and has 
no lack of fit. In the second experiment, the R2-value was 0.8747 and has no lack of fit. The 
response surface plots for these two experiments are displayed as a comparison in Figure 6.4; 
both plots look almost identical. Model equations are summarised in Table 6.1 and the full 
ANOVA outputs are provided in Appendix A 
 
Figure 6.6 Response surface plots for phase II studies: Characterisation of total cell 
expansion from day 6-10 of cell culture (a) Experiment 1: fold range is 0-70 (b) Experiment 
2: fold range is 0-150. Cytokine ranges for both experiments are 10-100 ng/ml SCF and 0.1-5 
IU/ml EPO. Plots from both experiments look almost identical and share the same optimal 
regime of operation. 
 
 
The final numerical optimisation for phase II was based on the model that gave the best fit 
(Experiment 2), and this yielded an optimal regime around 110 ng/ml SCF, 0-80 ng/ml IGF-
II, and 3.68-3.80 IU/ml EPO. The final concentrations selected for phase II were 110 ng/ml 
2F 2G
Investigation: DOE2M (MLR)
Response Surface Plot
MODDE 7 - 11/08/2008 15:53:44
SCF EPO EPO SCF 
 
 
(A) (B) 
Fold Fold 
 141 
 
SCF, 17 ng/ml IGF-II and 3.75 IU/ml EPO. Generation of DOE models in phase II cultures 
were more consistent than that in phase I cultures. 
 In the final stage (Phase III), cell expansion was evaluated from day 10 to day 16. 
Three independent DOE experiments were performed but only one provided results that 
produced a significant model; the other two experiments did not provide a good fit to any 
model and showed only a dependency on EPO. In the experiment that provided significant 
results, fold expansion showed a strong dependency on SCF and EPO concentrations and the 
model fit has an R2 value of 0.8620 and has no lack of fit. High concentrations of both 
cytokines, particularly EPO, appear to enhance cellular growth at this stage. Their 
relationships are displayed in a response surface graph on Figure 6.7. For the other two 
experiments, an attempt to fit the data on a model using SCF and EPO showed very poor fit. 
One of them is shown in Figure 6.7b and the model equations can be found in Table 6.1. Full 
ANOVA outputs can be found are in Appendix A. As observed from the response surface 
plots, experiments which did not yield a good model showed no correlation or resemblance to 
the experiment with a good model. It has also been noted that the maintenance of cell culture 
up to this stage became more challenging; expansion was significantly slower due to 
increased maturity of overall cell population thus there is less variation in cellular growth due 
to changes in cytokine concentrations. A numerical optimisation initially based on cellular 
growth gave an optima at 74 ng/ml SCF, 0 ng/ml IGF-II and 3.98 IU/ml EPO.  
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Table 6.1 Summary table of model equations from characterisation studies. A = SCF, B = 
IGF-II and C = EPO 
Experiment ID Model Equation (in coded factors) 
Phase I (Expt. 1) Fold = 44.18 + 1.84B + 6.46C – 5.32C2 – 4.75BC 
Phase I (Expt. 2) Fold = 71.10 + 8.92B + 10.27C – 9.57C2 – 7.21BC 
Phase II (Expt. 1) Fold = 62.09 + 6.85A + 9.87C – 10.78C2 
Phase II (Expt. 2) Fold = 135.90 + 15.31A + 26.50C – 28.00C2 
Phase III (Expt. 1) Fold = 10.89 + 1.23A + 2.06C – 2.08A2 – 2.05C2 
Phase III (Expt. 2) Fold = 3.72 – 0.11A + 0.94C + 1.09A2 
 
 
Figure 6.7 Response surface plots for phase III studies: Characterisation of total cell 
expansion from day 10-16 of cell culture (a) Experiment 1: fold range is 0-11 (b) Experiment 
2: fold range is 0-5.8. Cytokine ranges for both experiments are 10-100 ng/ml SCF and 0.1-5 
IU/ml EPO. Models with poor fit (experiment 2) showed no resemblance to the model with a 
good fit (experiment 1). 
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6.4.3  DOE verification 
The three-step DOE optimised cytokine culture achieved an average fold expansion 
of 27,940 (n = 3) with a maximum fold expansion of up to 64,300 fold achieved in one 
culture and the minimum fold expansion of 5,400 fold (Figure 6.6a). Cord-to-cord variability 
caused significant differences in the outcomes of cord blood cultures in the verification study. 
The unit that produced lowest proliferation had the smallest number of CFU-GEMM colonies 
from the initial starting population; only 5 colonies versus 25-34 colonies from other cord 
blood units used in this study. The low CFU-GEMM count indicates a lower proliferative 
capability of this unit compared to the others, which explains for the low total fold expansion. 
A comparison in the growth potential of the three-step cytokine culture versus the single-step 
showed no statistically significant differences due to the large variability in growth 
performance (Figure 6.8a). However, both the maximum and minimum expansion achieved 
in the three-step culture are still better than those achieved in the single-step culture: for the 
minimum fold expansion, the three-step produced 5,400 fold while the one-step produced 
3,029 fold; for the maximum fold expansion, the three-step produced 64,300 fold while the 
single-step produced 36,900 fold.  
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Figure 6.8 Cellular growth and clonogenic capability of cord blood cultured cells in three-
step DOE cocktail. (a) Total fold expansion over 16 days; a comparison between the three-
step and single-step culture (b) Colonies formed through 12 days. 
(B) 
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Clonogenic ability of cultured cells showed increasing colonies toward the erythroid 
lineage with the largest number of BFU-E and CFU-E colonies achieved on day 6 of the 
culture (Figure 6.8b). The number of CFU-GEMM and CFU-GM did not seem to decrease as 
much on day 4 as those observed from the single-step cytokine culture (Figure 5.4) indicating 
longer maintenance of immature progenitors in this culture. Expression of erythroid surface 
antigens (CD71 and GPA) is similar to those achieved from the single-step cytokine culture. 
A rapid increase in CD71 and GPA expression is observed (Table 6.2) with almost 60% 
expressing GPA by day 6 and over 90% by day 10 of the culture; results were similar to that 
achieved in the single-step cytokine culture. Cell morphology of cultured cells stained with 
Wright-Giemsa and brilliant Cresyl blue were also similar to those observed from the single-
step cytokine culture. Some of the cells observed during culture on day 16 resembled those of 
red blood cell morphology, having a biconcave shape (Figure 6.9). Observations from the 
surface antigen expression, cellular morphology and CFU-assays were consistent with the 
results made in the previous study (Chapter 5) indicating a definitive differentiation toward 
the erythroid lineage. Therefore, differentiation toward the erythroid lineage has not been 
compromised using three-steps at varying cytokine concentrations. 
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Table 6.2 Surface antigen expression for CD45, CD71 and GPA. Numbers reflect the 
average expression +/- 1SD (n = 4 except day 16 data: n = 2) 
 
 CD45 CD71 GPA 
Day 4 12.9 + 10.0% 90.7 + 4.2% 25.2 + 25.9% 
Day 6 19.3 + 12.8% 93.8 + 4.0% 59.7 + 7.4% 
Day 8 6.8 + 7.0% 97.7 + 1.3% 82.6 + 10.0% 
Day 10 4.8 + 3.2% 98.4 + 0.8% 94.2 + 2.6% 
Day 12 4.4 + 2.7% 97.0 + 1.5% 91.8 + 8.7% 
Day 16 1.8 + 0.7% 92.9 + 6.0% 90.3 + 11.0% 
 
 
 
Figure 6.9 Photograph of cord blood cells cultured in 24-well plate on day 16. Arrows 
indicate some of the cells which resemble a red cell morphology showing a biconcave shape. 
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6.5 DISCUSSION 
 Sequential characterisation of in vitro erythropoiesis using DOE produced three 
distinct response surface profiles for each phase of the culture. Phase I (day 0-6) was strongly 
dependent on concentrations of IGF-II and EPO while phases II (day 6-10) and III (day 10-
16) were dependent on SCF and EPO. Though most of the models were significant, 
repeatability of model results were not easily obtainable particularly for phase III studies – 
only one out of three experiments produced a significant model. Optimisation of cytokine 
concentrations for each phase produced a three-step cytokine cocktail. When the three-step 
cocktail was compared to the single-step, the average growth potential did not show 
statistically significant differences but the maximum and minimum total cell expansion from 
the three-step study were higher than that in the single-step study. The rate of erythroid 
differentiation in the three-step cytokine culture was also not compromised. In the following 
sections, a discussion relating to the challenges faced in using DOE as an approach for 
sequential characterisation and the improvements that can be made from what has been learnt 
in this study is presented. Advantages and disadvantages of the multi-step versus the single-
step approach are compared. The implications and practicality of this multi-step approach for 
bioprocess definition are also evaluated. 
 
6.5.1 Challenges in sequential characterisation 
6.5.1.1 Sample variability 
One of the major challenges faced in this study is reproducibility of DOE generated 
models for the sequential characterisation of in vitro erythropoiesis of cord blood stem cells. 
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Several problems were encountered and one of the major obstacles is attributed to significant 
cord-to-cord variability. Units received from the cord bank were all of research and 
development grade, which does not go through stringent quality control procedures. As a 
consequence, the quality of cord blood units received for this study was highly inconsistent 
and most of the units were of much poorer quality in comparison to those received for the 
single-step study (Chapter 5). Differences in the quality of cord blood samples generated 
significant variability in growth performance of cord blood cells between batches which 
contribute to the differences observed in model responses within each characterisation study. 
Samples of low quality also showed poorer overall growth performance and less distinct 
characteristics (less responsive) thus producing larger noise-to-signal ratios (pure error) 
within each DOE experiment, compromising the fit to the model. 
 
6.5.1.2 Division of time intervals 
The division of time intervals to define different phases of the cell culture is perhaps 
one of the most challenging tasks. The definition of an end-point for each phase is unclear as 
the in vitro kinetics for this process is still unknown. Furthermore, kinetics between cord-to-
cord samples can also vary significantly due to differences in the proliferative capacity of 
each cord unit and quality of the sample. The “end-point” of each phase for each cord sample 
may therefore differ slightly. The elucidation of process dynamics also seeks finer resolution 
in process characterisation and demands a greater distinction in culture performance between 
and within each phase. Cultures with more distinct characteristics make DOE characterisation 
easier, i.e. more reproducible models with better fit. In this study, significant models were not 
always achievable in all phases of the culture – cell culture performances were more distinct 
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in some phases than in others. Characterisation in phases I and III for example were less 
defined than that in phase II as cellular growth in the latter were significantly slower than in 
the log phase. Phase III, in particular, has a much weaker overall response to changes in 
cytokine concentrations as the overall population at this stage is more mature and less 
proliferative in nature.  
 
6.5.1.3 Concentration ranges 
 Cytokine concentration ranges define the process window. Concentration ranges in 
this DOE study were chosen to begin at low values for SCF and EPO, 10 ng/ml and 0.1 
IU/ml respectively, instead of beginning at zero concentration. This choice was made due to 
previous findings (Chapter 5) which determined both SCF and EPO to be critical factors 
contributing to this process, particularly for cell growth. An absolute zero concentration 
scenario is to be avoided as cells will not survive without the presence of any growth factors; 
an absolute zero condition can skew the response surface profiles quite significantly. In the 
case of IGF-II, which was added as a mid-acting growth factor, the effects of IGF-II are still 
unknown so the low concentration of IGF-II was selected to be at zero in order to distinguish 
effects in the presence or absence of this growth factor. Given these considerations, using low 
concentrations of SCF and EPO as the lower limits of the process reduces the process 
window as compared to that previously performed in Chapter 5. It will therefore require 
tighter process outputs (less variability in growth performance) in order to produce models 
that are reproducible and with better fits.  
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6.5.2 Improvements in DOE process strategy 
6.5.2.1 Process objectives 
 Conflicting results from this DOE characterisation study poses several queries as to 
the suitability of the experimental approach taken. One of the conflicting observations made 
was the lack of effect of SCF at the beginning of the culture and its significance only toward 
the middle and end of the culture. This is somewhat contradictory to what is known about 
SCF, as an early-acting growth factor. Similarly, the influence of IGF-II at the beginning to 
the culture was also somewhat questionable as IGF-II was thought of as a mid-acting growth 
factor. These observations begin to question suitability of the objectives that were used to 
define process conditions for each phase of the culture. In this case, the objectives for each 
phase were identical i.e. to maximise the total cell expansion of red blood cell progenitors. 
The inclusion of EPO in all of the culture conditions ensured definitive differentiation toward 
the erythroid lineage. However, this limits the process window particularly in the beginning 
of the culture where cells were in their most immature state. Should the process objective at 
the beginning of the process then be slightly different from that used for the later stages? Will 
this change process dynamics of the culture significantly and impact the final outcome? 
These questions pose valid concerns that should be studied further to unveil the effects of 
process dynamics in the final outcome of the culture. 
 
6.5.2.2 Significance of each phase 
Characterisation study performed by a division of different phases is a valid approach 
but has several limitations. As observed from this study, the distinction between different 
process conditions become less defined at the later stage (phase III) of the process. This is 
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largely due to the increase in cell population maturing toward the same lineage i.e. less 
proliferating capacity and is likely to become less responsive toward small changes in 
cytokine concentrations. Failure to repeatedly produce models with a good fit in phase III 
studies reflects these challenges. The only factor that consistently played a significant role in 
cellular growth in the phase III models was EPO concentration which is not surprising as this 
is consistent with the in vivo process.  
Observations made in this study suggest that culture definition at the later stages of 
the process may also not be as crucial as those performed at the initial stages. At the 
beginning of the culture, where the highest number of CD34+ cells and the greatest 
proliferating and differentiating capacity of the culture are found, it is crucial to define 
culture parameters influencing this process most accurately here. Process definition at the 
early stages of the culture will ultimately influence responses from the later stages and can 
significantly change the dynamics of the process. Process definition at the early stages of the 
process is absolutely critical and it is highly recommended that a quantitative characterisation 
of the initial phases of the cell culture by way of a response surface model is performed. 
Quantitative characterisation at later stages of the process could then potentially be omitted 
and a simple optimisation strategy instead of using RSM can be taken. 
 
6.5.2.3 Different DOE approaches 
 In terms of the DOE designs and experimental approach toward cell culture process 
characterisation, different design strategies have been undertaken by other researchers and 
briefly discussed in Chapter 5. In the study performed by Yao et al., use of fractional factorial 
designs for screening growth factors and serum substitutes suited for cord blood stem cell ex 
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vivo expansion was performed79. At the beginning, two fractional factorial designs (a Res III 
and Res IV) were used to screen nine different growth factors and eight different serum 
substitutes independently. After identifying the significant factors, a higher resolution 
factorial design (Res V) was used to determine the first-order linear relationships of each 
factor to the process of interest. Using these first-order models, they performed an 
optimisation step via the path of steepest ascent to determine the optimal concentrations of 
each contributing factor. This approach has several advantages: (1) it is relatively simple and 
straight-forward and allows screening of a large number of process factors. (2) Optimisation 
of the process factors using this method does not require a highly defined model and is much 
quicker way to determine optimal operating conditions. However, this also means that the 
process relationships achieved in these studies are less defined, since they are only an 
approximation toward the optimal operating regime. They do not account for process 
interactions which may or may not be significant in the process of interest, but is certainly a 
much more straight-forward approach in optimising cytokine concentrations. This approach 
is highly effective if one can consider process interactions to be negligible in comparison to 
main process effects, which can very likely be the case in some cell culture processes where 
main effects control the bulk of the process.  
Another approach taken by Cortin and his colleagues, briefly discussed in Chapter 5, 
was to perform two levels of screening, first at a lower resolution using a PBD, followed by a 
high resolution (Res V) fractional factorial design, and then process characterisation using a 
CCD35. Although this approach is useful in screening large numbers of factors while 
requiring only a small number of experiments by way of the PBD, single factors in this 
design are highly confounded with two-factor interactions which as shown in this study can 
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produce conflicting results between the repetitions. The deduction of key factors using PBD 
is therefore not as straight-forward. Characterisation using CCD is a highly useful tool for 
producing second-order response models, as performed in Chapters 5 and 6 of this thesis, and 
can reproduce quantitative models for the processes of interest. However, it may be faced 
challenges due to culture variability and discrepancies in model outcomes particularly in 
processes that are less responsive to changes.  
 
6.5.2.4 Improved DOE approach 
 After reviewing different DOE approaches, the recommendations for an improved 
DOE approach to sequential characterisation of cord blood cell cultures are as follows: 
Screening experiments are an essential part of the DOE characterisation and optimisation 
process. Screening can be performed using either the fractional factorial design or PBD 
depending on the suitability of the parameters and comfort-level of the experimenter 
regarding each technique. In each phase of the sequential characterisation, a screening 
experiment should be performed to first identify contributing factors to the process. If the 
number of factors being studied is no more than 10, the fractional factorial design is 
recommended. Preferably, a resolution IV design should be used to avoid too many 
confounding factors in the design matrix.  
 In the next step, process characterisation particularly at the beginning phases of the 
culture is critical. Use of an appropriate response surface design such as the CCD is 
recommended. Selection of concentrations ranges at this stage of the process is also crucial as 
it will determine the process window. Since a screening experiment prior to this step has been 
performed and confirmed the significance of each factor, significant factors used in the 
 154 
 
characterisation study may begin at low concentration ranges. Optimal cytokine 
concentrations are determined from the response surface plots. Finally, for phases at the later 
stages of the process, optimisation of cytokine concentrations via the path of steepest ascent 
can be taken instead of the RSM approach. This eases variability in the DOE output and 
could still reproduce process conditions close to the optima. The proposed revised and 
improved DOE approach is shown in Figure 6.10. 
 
 
Figure 6.10 Improved DOE approach for sequential characterisation 
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6.5.3 Multi-step versus single-step 
 Even though the average total fold expansion in the three-step cytokine culture 
statistically did not show significant improvements than the single-step cytokine culture due 
to large process variability, several benefits in the three-step cytokine culture should be 
highlighted. The multi-step approach, as previously mentioned, was aimed at revealing 
process dynamics of an in vitro process. The multi-step approach is thus more “kinetics”-
driven than the single-step approach which is an end-point driven process. The multi-step 
approach also provides a global analysis rather than a local analysis of the process of interest 
since it studies variations and changes occurring through the cell culture. It also gives a more 
accurate account of the process dynamics while the single-step may not be reflective of all 
stages of the process. Another significant advantage is the flexibility of the multi-step 
approach to accommodate for variations in process demands. However, the multi-step 
approach requires a significantly larger amount of time and labour to optimise and is not as 
simple or straight-forward as the single-step approach. A summary of the advantages and 
disadvantages of these processes is shown in Table 6.3. 
 
Table 6.3 Summary of advantages and disadvantages of the multi-step versus the single-step 
Multi-step approach Single-step approach 
“Kinetics”-driven End-point driven 
Global analysis Local analysis 
More accurate account of the process Not entirely reflective of all process stages 
Flexible approach Simple, straight-forward approach 
Tedious and more time-consuming Significant time-savings and expense 
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6.6 CONCLUSION 
 Sequential characterisation using DOE in this study produced successful models that 
illustrated some of the process dynamics in vitro. However, due to large cord-to-cord 
variability and challenges in process resolution, reproducibility of process models for later 
stages of the process was particularly more difficult. Process response at later stages in the 
process was less pronounced than at the early or mid stages. Several adjustments and 
improvements can be made to better define characteristics of this dynamic process. Some of 
the important considerations include definition of culture phases, cytokine concentration 
ranges, process objectives for each phase, and suitability of DOE designs used in each step. 
Overall, the outcome from the DOE three-step cytokine cocktail produced slightly better 
results (greater expansion) than that achieved from the single-step cytokine cocktail, even 
though the average numbers were not statistically different; both the minimum and maximum 
expansion achieved from the three-step process are better than that achieved in the single-
step process. The multi-step approach was also able to show variations in the process 
responses at the beginning, middle and end of the culture, providing more insight into the 
process dynamics. Ideally this “kinetics”-driven approach is preferred as it is not only able to 
better optimise the process based on process requirements closely reflecting to their needs in 
“real-time” but provide a scientific insight and explanation to the dynamics of in vitro 
bioprocesses.  
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CHAPTER 7 
Spatial profiling using DOE: A temperature study 
 
 
 
7.1  INTRODUCTION 
 The emerging field of tissue engineering and regenerative medicine promises to 
drastically change clinical practice through cellular therapy. Tissue engineered products such 
as the bone, skin and blood cells are the future replacement therapy. Production of these 
engineered cells/tissue for clinical use requires highly reproducible, well-controlled, and 
optimised stem cell bioprocesses9,162.  In vivo, the body accomplishes organogenesis and 
homeostasis by maintaining a delicate balance between the differentiation, proliferation, and 
self-renewal of cells through the real-time, online, and in situ sensing of important 
parameters in the body and the local delivery/removal of nutrients/metabolites, hormones, 
and growth factors needed163. However, most current cell/tissue cultures are information-poor 
due to the lack of real-time monitoring technologies, and lack the spatial and temporal 
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resolution required to provide accurate and precise process control. To address limitations 
encountered in the in vitro system, online, real-time, in situ monitoring must be implemented 
to obtain the necessary information required for a tightly-controlled bioprocess operation.  
At present, online, real-time process monitoring can be achieved through several 
methods81. One of these methods include the flow injection analysis (FIA) unit which 
represents a relatively common practice61,164,165. In this case, a sample is drawn from the 
bioreactor and the overall sample concentration is measured externally. Although FIA is 
successful for bioprocess monitoring, it only provides bulk concentration measurements at 
specific time intervals. Bulk concentration measurements do not provide spatial information 
of the culture environment and are often considered a late indicator as it is unable to detect 
cell populations that are already suffering malnutrition/intoxication due to the dilution effects 
in bulk concentration measurements. Alternatively, in situ electrochemical biosensors can be 
employed, as proposed in our culture system, to measure culture parameter concentrations 
locally and in real-time. Furthermore, the use of in situ electrochemical biosensors is 
advantageous in that no sample is lost through the withdrawal from the culture system at any 
time. In contrast, existing online systems that utilise automated sample withdrawal tend to 
require large amounts of sample volumes. This impairs the ability to generate many or 
continuous readings, and results in a bioprocess operation, such as perfusion rate, potentially 
being dictated by the sampling rate and not by the actual requirements of the system. 
Conversely, the use of in situ biosensors is an invasive technique for cell culture processes 
and increases the exposure of contamination. Longevity of sensors in serum-containing 
medium is also another challenge that remains to be addressed. 
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Measurement of local concentrations is important because it reveals spatial variation 
of essential culture parameters. Ultimately, this could result in the identification of micro-
concentration gradients, which in vivo represent the stem cell niches that regulate the 
proliferation and differentiation processes153. Currently, majority of the cell culture systems, 
including static and perfused, are essentially non-homogeneous166. In a traditional two-
dimensional (2D) flask/well cultures, cells tend to aggregate together in colonies of varying 
sizes and randomly disperse themselves in the space available for growth. During cell growth 
and proliferation, cells metabolise by consuming nutrients, such as glucose and glutamine, 
while secreting waste products, such as lactate and ammonia. Production and consumption 
rates of nutrients and metabolites vary depending on cell type, colony size, and stage of cell 
maturation. Since the cell culture environment is non-homogeneous, local concentration 
gradients are created which directly affects cell populations locally. Specifically, cells 
experiencing high consumption/production rates of nutrients/metabolites/cytokines will 
inevitably be subjected to strain, which would affect their normal physiological status. 
Bioprocessing has sought to address these challenges by attempting to provide a 
homogeneous culture environment and employing perfusion to offer better supply of 
nutrients and removal of metabolites166. However, in vivo, concentration gradients exist and 
the body maintains homeostasis through in situ monitoring, circulation, and local transport. 
In contrast, in vitro, the spatial distribution of nutrients/metabolites is not monitored resulting 
in the sub-optimal control of feeding/removal of nutrients/metabolites into the culture system. 
To effectively obtain the spatial profiles of culture parameters using in situ 
biosensors, it is crucial to determine the appropriate number and position of biosensors 
required, especially in the absence of detailed a priori knowledge of the culture environment. 
 160 
 
Herein, I propose a novel strategy based on DOE as an approach towards statistical sampling 
to determine the location and number of sensors required to obtain information-rich data that 
will result in the generation of spatial (and temporal) profiles for important culture 
parameters. Specifically, in this study, the 2D space of a traditional well-plate culture system 
was mapped using the face-centred CCD which determined the optimal placement and 
number of sensors required for spatial profiling. 
 
 
7.2 AIM AND HYPOTHESIS 
The aim of this study is to test the feasibility and validity of using a DOE approach as 
a statistical method to determine spatial variations in a cell culture/bioreactor system. Due to 
the flexibility and robustness of DOE methods, the hypothesis is that DOE can be tailored to 
study spatial variations of an analyte of interest and produce spatial maps showing process 
variations. The uniqueness and advantage in this approach is in its ability to provide 
information-rich data using the minimum number of sampling required. 
 
 
7.3 APPRAOCH TO STUDY 
In order to test the feasibility of the DOE approach, a simple and straight-forward 
experimental setup was employed. This preliminary test did not utilise the culture of cells but 
has been designed to simulate cell growth in clusters/colonies with the 
production/consumption of metabolites/nutrients. In particular, miniaturised and highly 
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sensitive temperature sensors were used, which would correspond to any sensor of interest. 
Controlled heating elements were used as point sources to generate temperature variations 
within the culture system. The controlled heating elements, fixed at a certain temperature, 
were analogous to a constant production of metabolites by the cell clusters/colonies; mass 
transfer equations were corresponded to heat transfer equations. A DOE approach was used 
to statistically sample the space in order to obtain representative information, thus 
establishing the number and location of sensors required. The DOE results were compared 
with other experiments performed using a random and arbitrary number and position of 
sensors. Finally, DOE results were validated through comparison with experimental data 
using additional sensors placed at random positions. The DOE approach resulted in the 
elucidation of spatial and temporal profiles of temperature, which can be extended to any 
culture parameter with the use of appropriate sensors (assuming that their sensitivity is 
adequate). Utilising such information could result in achieving better control of cell culture 
bioprocesses. 
 
 
7.4 RESULTS 
7.4.1 DOE generated spatial and temporal profiles 
 Spatial and temporal progression of temperature profiles obtained for the three 
different experimental setups are displayed in Figure 7.1. Specifically, Figure 7.1a shows the 
single heating element experiment in a static culture where clearly, after 3 min, the location 
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of the single heat source can be identified.  In particular, at this time-point, the temperature 
spatial profile indicates that the temperature of the liquid increased around the position of the  
heating element to 21oC covering approximately less than a third of the area of the culture 
chamber – the remaining two thirds have a temperature of 19-20oC.  As time progresses, heat 
is continually added and by around 9 min, half of the chamber, close to the heating element, 
reached a temperature of 22oC whereas the other half had a lower temperature of 21oC.  The 
R2 value for the temperature profiles in the single heating element experiment is greater than 
0.90, indicating an excellent fit of the model (Table 7.1). Furthermore, the low p-value (p < 
0.05) confirms that the model predictions are significant.  
 
Table 7.1 R2 and p-values of fitted models from all three experiments 
Expt. No. Single heating element Dual heating element Perfused system 
Time R2 p-value R2 p-value R2 p-value 
3 min 0.968 0.001 0.859 0.034 0.747 0.129 
4.5 min 0.972 0.001 0.854 0.037 0.807 0.071 
6 min 0.912 0.011 0.894 0.018 0.763 0.112 
9 min 0.928 0.005 0.862 0.033 0.814 0.066 
 
 
Figure 7.1b shows results from the dual heating element setup in a static culture.  In 
this case, the locations of the two heating sources also begin to be identifiable after 3 min of 
heating. The overall rate of heating within the chamber is also higher as compared to the case 
in the single heating element which resulted in an overall higher temperature by the end of 9 
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min; the majority of the culture chamber had a temperature of 23oC. Although the R2 value in 
the dual heating element setup in a static system is lower than the single heating element 
setup (Table 7.1), it still confirms a reasonably good fit of the model, and the p-value being 
less than 0.05 confirming that the model predictions are significant.  
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Figure 7.1 Spatial and temporal temperature profiles. (a) Single heating element experiment 
(static). (b) Dual heating element experiment (static). (c) Dual heating element experiment 
(perfused). Temperature ranges are displayed in degree C. 
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Results from the final experiment with dual heating elements in a perfused system are 
shown in Figure 7.1c.  As anticipated, the dual heating sources resulted in an overall higher 
rate of heating compared to the single heating element thus an overall increase in chamber 
temperature.  However, due to the continuous perfusion of cold water into the chamber, the 
overall temperature increase is not as high as that reached in the second scenario, dual 
heating elements in a static culture. The extent of the homogeneity in the temperature spatial 
distribution is lower and a clear area of slightly lower temperature is identifiable along the 
path of fluid flow. The R2 values in this perfused experiment is lower than the static 
counterpart (Table 7.1) and did not provide a good fit for the model, which was confirmed by 
the high p-values (p > 0.05).  
In contrast, random designs used for monitoring temperature variations could not 
generate spatial profiles as performed by DOE. In the five-sensor random design, the 
temporal progression of point temperature profiles were generated for each sensor in a single 
heating element setup under static conditions, as shown in Figure 7.2a. These results obtained 
from the random placement of sensors show the progression of temperature over time at each 
sensor position, but could not provide detailed spatial profiles for the whole culture chamber. 
Therefore, the only meaningful observation concluded to describe the relationship between 
the temperatures at various locations is that the temperature around the sensors closer to the 
heating element (positions A and B) was higher than that of the sensors away from the 
heating element (positions C and D). Similar results were obtained for the second random 
design which utilised seven randomly placed sensors (Figure 7.2b). The lack of a systematic 
DOE approach does not allow the generation of spatial profiles from the randomly placed 
sensor locations. The only quantitative relationship that can be deduced from such designs is 
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to fit a line/curve through the five points aligning vertically (data not shown), which is not 
extremely informative as it does not result in a spatial profile that covers the entire space of 
the bioreactor. Consequently, increasing the number of sensors randomly does not provide 
for information-rich data that is generated via DOE methods. DOE provides not only spatio-
temporal profiles but also achieves that with the minimum required number of sensors and 
determines their location.  
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Figure 7.2 Temperature profiles of randomly placed sensors. (a) For five randomly placed 
sensors (b) For seven randomly placed sensors 
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7.4.2 Successful validation of DOE models 
In order to validate the accuracy of our DOE approach for spatial elucidation, values 
from the model predictions were compared with experimental results obtained from three 
randomly placed sensors in a separate experiment. Specifically, the actual temperature 
measurements from sensors at positions 10, 11 and 12 (Figure 4.2f) were compared to the 
predicted values from the DOE model for the single heating element scenario taken at various 
time points (3, 4.5, 6, and 9 min). This comparison is shown in Figure 7.3 where prediction 
values were set at a 95% confidence interval and the black dots represent the actual 
temperature measurements. These results confirmed that predictions from the DOE 
simulation are in agreement with actual experimental values at a 95% confidence interval, 
apart for one point in this experiment, position 10 taken at 3 min which was 0.4oC off the 
predicted range (Figure 7.3). This study confirms validity of the temperature models and a 
DOE approach toward spatial elucidation. 
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Figure 7.3 Validation results comparing prediction values to experimental values 
 
 
7.5 DISCUSSION 
The production of cells/tissue engineered for clinical applications renders the need for 
real-time, online, in situ monitoring of important culture parameters that will enable tight 
control, reproducibility, and optimisation of these complex cell culture bioprocesses. In 
addition, data obtained from the various monitoring platforms need to be harnessed to their 
full potential to provide “information-rich” profiles that represent the spatial and temporal 
progression of the bioprocess in operation. Currently, the only approach in determining the 
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position of sensors within bioreactor culture systems is entirely limited to computational fluid 
dynamics (CFD) analysis of the fluid flow within the bioreactors. This analysis results in the 
distinction between turbulent and non-turbulent locations and is extremely mathematical.  
Within the body and in the vast majority of tissue engineering culture systems, fluid flow is 
laminar; hence there are no areas of turbulent mass transport162,163. Furthermore, fluid 
dynamics studies do not provide any guidance for the optimal number or positioning of the 
sensors, and, in certain cases, the simulation results will not converge due to the geometry of 
the system. CFD has been used extensively in bioprocessing to incorporate flow, mass 
transport, and reaction kinetics in order to provide valuable information on 
nutrient/metabolite concentration profiles as well as cellular growth in bioreactor systems167. 
However, CFD simulation results are purely based on theoretical assumptions and 
approximations, and still need to be experimentally validated. In contrast, this novel DOE 
approach represents the use of statistical sampling to determine the optimal number and 
location of in situ sensors required to generate spatio-temporal profiles of important culture 
parameters, without requiring a priori knowledge of the culture system and its operation 
apart from its geometry. 
Using DOE, data obtained from the different sensor locations were analysed to 
provide an information-rich interpretation, thus generating spatial temperature profiles in the 
culture chamber. In contrast, the random designs provided only point temperature profiles at 
each sensor location and further information cannot be extracted to obtain spatial profiles. 
Consequently, the full picture of the concentration gradients can only be provided by DOE 
designs. The fit of the DOE models on both the single and dual heating element 
configurations under static conditions was, overall, superb. In contrast, in the perfused 
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condition, a lack of fit was observed. This lack of fit was attributed to the perfusion rate of 
0.01 ml/min, which equates to 14.4 ml/day corresponding to approximately two-volume 
change per day. This flow rate is considered a high flow rate for standard bioreactor 
operation. The high perfusion rate acts to homogenise variations within the culture chamber. 
Therefore, it is anticipated that perfusion with lower flow rates will have a minimal affect on 
the fit of DOE models.  
Model validation was confirmed by comparing actual measured values of three 
randomly selected sensor locations to the predicted values as determined by the DOE model. 
Specifically, the experimental data were within the 95% confidence intervals of the predicted 
values from the DOE model, thus affirming the validity and predictability of the DOE 
approach for spatial elucidation. However, since the current DOE design used herein to 
demonstrate this novel methodology fits only to 2nd order polynomial equations, more 
complex profiles cannot be revealed; other more sophisticated designs will have to be utilised 
for highly complex non-linear profiles. 
 
 
7.6 CONCLUSION 
Sensor positioning based on DOE designs produced information-rich data which 
generated spatial (and temporal) profiles for the temperature variation for the whole culture 
chamber. This easy to implement and powerful technique can be applied to other geometries 
and would offer knowledge of the local concentration gradients of important culture 
parameters allowing for the real-time, local, and ‘intelligent’ bioprocess control. The 
application of this approach to the monitoring, analysis, control, and optimisation of stem cell 
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and tissue bioprocesses for clinical applications can be significant.  Information-rich data, 
which are statistically significant, allow for the future development of “intelligent” 
bioprocess strategies that can respond in real-time to the needs (locally) of the cell culture. 
This ability closely mimics the situation in vivo and points to a novel modality in 
bioprocessing where information-rich data can be easily obtained. Coupling of the DOE 
methodologies for the screening, quantification, and optimisation of culture parameters to the 
DOE-based monitoring and information analysis presents a powerful, yet easy to implement, 
experimental tool. Adaptation of this strategy to other geometries, including 3D space, should 
not present significant problems. Inherently, the limitation is due to sensor sensitivity or 
parameter fluctuation and not due to the analysis.  
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CHAPTER 8 
Process monitoring of ammonia, pH and oxygen 
 
 
 
8.1  INTRODUCTION 
Advances in biotechnology and cell culture technology have led to an increasing need 
for process monitoring and optimal bioprocess control. Achievements in bioprocess 
engineering over the past two decades, both in terms of monitoring tools and control 
methods, have delivered both scientific and industrial advantages. From the industries’ 
standpoint, improvements in bioprocess operation equate to an increase in product yield, high 
cell culture viability, excellent process reproducibility and economical process operation168-
170
. From a scientific point of view, reproducibility of bioprocess conditions, as represented 
by Locher et al., is also imperative to reliable research as it distinguishes scientific 
(biological, chemical and physical) phenomena from artefacts in the bioprocess operation168. 
Process monitoring has not only enabled both scientists and engineers to distinguish and 
understand scientific observations but also obtain quantitative representations such as models 
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of culture bioprocesses105. Progress in the area of process monitoring is essential to control 
drifts in bioreactor operation, drastic changes in physicochemical parameters such as pH and 
dissolved oxygen should be avoided as it can significantly impact the growth, production 
kinetics, and product quality in the bioprocess171. So far, these advances have greatly 
benefited the operation of many biotechnological processes such as fermentation and 
mammalian cell cultures for the production of biological products such as monoclonal 
antibodies. In the same manner, stem cell culture bioprocesses require advanced and 
intelligent process monitoring tools and control systems to ensure the safety, reproducibility 
and quality of stem cell engineered products. 
As described in Chapter 7, online real-time monitoring of cell culture bioprocesses is 
of utmost significance for delivering cell/tissue engineered products as cellular therapies. Use 
of in situ electrochemical sensors and biosensors allows placement/positioning of sensors 
locally, which could potentially help to identify local concentrations in the cell culture 
environment172. It has been proposed and demonstrated in Chapter 7 the feasibility of using 
DOE to determine the minimum number and strategic placement of sensors required to 
achieve spatial profiling of culture parameters of interest. This chapter will illustrate the 
overall performance of the real-time online in situ monitoring platform in obtaining 
ammonia, pH, and oxygen concentration profiles in a serum-containing cell culture. In 
addition, an attempt to obtain spatial maps and temporal profiles of each culture parameter 
using the DOE approach is demonstrated. 
 One of the major challenges in utilising in situ biosensors is their longevity, 
performance, and biocompatibility for continuous monitoring in cell cultures. Protein build-
up due to the presence of serum in the culture media, around the surfaces of the sensor 
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membrane interferes with sensor reading and depreciates sensor sensitivity. This causes 
deviations in sensor performance from when it was originally calibrated, at the beginning of 
the culture, and decreases the longevity of the sensor. Biofouling of sensor electrodes is an 
irreversible process; it is therefore necessary to optimise the biocompatibility of sensor 
membranes to extend the performance and longevity of these sensors in a cell culture 
environment. Possible solutions include modification of the sensor surface membrane or 
coating of the surface with an appropriate biocompatible material such as PEG or 
poly(hydroxylethylmethacrylate) (polyHEMA)145. Surface modifications can be achieved by 
introducing functional groups such as carboxyl, amine and hydroxyl. Other methods for 
improving sensor biocompatibility include the alteration of existing surfaces by 
immobilisation of active agents such as anticoagulants or platelet adhesion inhibitors. 
Ammonia, pH, and oxygen sensors used in this system were coated with a biocompatible 
material suitable for the specific sensor application. In this chapter, the biocompatibility and 
performance of each sensor type for culture monitoring is presented. 
 
 
8.2 AIM AND HYPOTHESIS 
 The aim of this project is to develop an online real-time in situ monitoring platform 
that is capable of simultaneous multi-analyte process monitoring for stem cell culture 
bioprocesses. With the aid of this unique system, it is hypothesised that bioprocess 
information critical for monitoring the process can be achieved in real-time and culture 
conditions can be adjusted according to the needs to the culture. This mode of operation will 
ultimately result in an overall better bioprocess operation and better outcome/cell-product. 
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8.3 APPROACH TO STUDY 
 Sensors for various analytes such as ammonia, pH, oxygen, glucose and lactate were 
simultaneously developed. Each sensor type will first be tested individually and using the 
DOE approach described in Chapter 7, temporal and spatial profiles of each process analyte 
during a cell culture will be pursued. Sensors will also be tested for biocompatibility against 
3T3 fibroblast cells. Operational and functional stability of both the monitoring platform and 
biosensors designed for each analyte will be concurrently evaluated. Unfortunately, glucose 
and lactate sensors designed for this project were not stable enough for monitoring in cell 
cultures and is therefore not reported in this thesis.  
 
 
8.4 RESULTS 
8.4.1 Sensor biocompatibility 
 Ammonia, pH, and oxygen sensors were all tested for biocompatibility by measuring 
its toxicity against mouse 3T3 fibroblast cells. Figure 8.1 shows the normalised fold 
expansion of cells grown in bioreactors containing nine sensors in comparison to the control 
bioreactor which contained no sensors for three independent experiments. In the first study, it 
was discovered that the ammonia sensors were toxic to cells as no/very few cells were found 
in the bioreactor containing nine ammonia sensors for all three experiments after six days in 
culture (Figure 8.1). After a thorough investigation, two materials were identified that could 
be leaching from the membrane and be toxic to the cells. The first one is the ionophore called 
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nonactin which makes up 1-2% of the membrane; the other compound is the plasticiser, 
DOS, a synthetic organic compound making up 60% of the membrane. There is a greater 
likelihood that DOS leaching will result in higher toxicity levels in the cell culture due to its 
higher composition used in the membrane.  
Sensors of pH which were coated in a Nafion layer did not show any toxic effects on 
cells in culture: all three experiments showed excellent cellular growth in cultures containing 
nine pH sensors as compared to the control culture (Figure 8.1). Biocompatibility of pH 
sensors is therefore assured. Unfortunately for the oxygen sensors, toxicity results were 
inconsistent; two out of three experiments showed oxygen sensors were in fact toxic to cells 
(Figure 8.1). Growth performance of cells in bioreactors containing oxygen sensors were also 
not as efficient as observed those with the pH sensors. These results were surprising since the 
design of oxygen sensors was very similar to that of pH sensors with the exception of the 
material used in oxygen sensor membranes, which was PDMS. However, PDMS is known to 
be biocompatible and has shown no toxic effects on cells in culture, so there is no reason to 
suspect that the PDMS membrane is the cause of the problem. 
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Figure 8.1 Sensor toxicity to cells measured by total cell expansion after six days in culture (n = 
3). Values were normalised to the control bioreactor, a cell culture containing no sensors. 
Biocompatibility of pH sensors is assured while that of oxygen and ammonia sensors requires 
further improvement due to negative/inconsistent results. 
 
8.4.2 Performance of ammonia sensors in cell culture 
Cell culture experiments using ammonia sensors indicated good stability and 
sensitivity of the sensors over a week’s period in serum containing culture. Ammonia 
concentrations for the static culture showed an increasing trend over the first three days but 
had no further increase after this period (Figure 8.2a). Increasing ammonia concentrations 
corresponded to increasing cell density and cellular growth which were observed during the 
first two days in culture. However, since these sensors were toxic to the cells, as discovered 
in the toxicity studies, cells also began to die. Subsequently, all further cellular activities 
including cell death had terminated and the ammonia concentrations from the real-time 
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monitoring data reached a plateau. Not surprisingly, very few live cells were found at the end 
of the culture. The lack of biocompatibility of ammonia sensors was affirmed in the toxicity 
study described in section 8.4.1.  
Spatial and temporal profiles of ammonia concentrations inside the bioreactor were 
attempted via the DOE method. Results that were modelled were taken from the data shown 
in Figure 8.2a, one sensor (el53) had completely malfunctioned and was eliminated from the 
DOE analysis. Using the remaining eight data points, data was fitted into a model using the 
MLR method. Spatial maps of ammonia concentrations through a series of time points in the 
culture (12hrs, 1 day, 2 days and 4 days) are shown in Figure 8.2b, each has an R2 value of 
greater than 0.850 but still showed a lack of fit. The lack of fit to the model is a result of 
multiple outliers or points with significant variances and missing data-points as reflected in 
this case. Here, it was also impossible to verify the relevance of the ammonia spatial maps to 
cellular growth within the bioreactor, since most of the cells had died at the end of the 
culture.  
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Figure 8.2 Real-time ammonia data and spatial maps for static culture of mouse 3T3 
fibroblast cells. (a) Sensors el40 and el53 have malfunctioned. Three sensors (el8, el42 and 
el35) showed high noise levels toward the end of the culture period. Remaining four sensors 
showed stable performance throughout the culture period. A 44% success rate in sensor 
performance was achieved in this experiment. (b) Spatial maps generated in DOE using the 
MLR method; all models have an R2 value of greater than 0.850 but showed a lack of fit to 
the model. 
(A) 
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In terms of sensor reliability/failure rate, ammonia sensors were evaluated based on 
the following criteria: (1) sensors that failed completely and did not give any sensible reading 
throughout the cell culture (2) noisy sensors which gave a variability of greater than 0.75 mM 
(3) functional sensors that performed stably throughout the cell culture. From a survey of five 
independent experiments performed with ammonia sensors, an average success rate of 66% 
was achieved throughout the cell culture period and a complete failure rate (sensor 
malfunction not including noisy sensors) of 17% was observed (Figure 8.4). The success rate 
of functional ammonia sensors is considered rather low with only two thirds of the sensors 
produced being functional by the time it is assembled in the cell culture bioreactor.  
 
Figure 8.3 Reliability/failure data of ammonia sensors. A 66% success rate was achieved 
from five independent experiments, 17% of the sensors failed completely while 20% had 
noisy signals with the first experiment showing the worst performance.  
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In terms of overall sensor performance, the potentiometric characteristics of the PEG-
doped ISEs resembled those of a conventional membrane composition. The typical dynamic 
response of the PEG-doped electrode to step changes in ammonia concentrations in culture 
media is provided in Appendix B (Figure B.1). In PBS, the ammonia sensors displayed an 
almost Nernstian behaviour (52.2 +/- 4.4 mV/electrode) towards ammonium ions but in 
culture media, it displayed a sub-Nernstian inclination (32.4 +/- 2.2 mV/electrode) due to an 
increase in background signal caused by the presence of high K+ and Na+ species145. 
Ammonia sensors that behaved well showed long-term functional stability and sustained its 
sensitivity throughout the culture period. In terms of operational stability in cell culture, 
potentials of the ammonia sensors showed excellent stability, with a 2-3 mV drift over a 24 
hr period. The operational stability of ammonia sensors were tested in culture media for up to 
eight days (Figure B.2) and showed only a slight reduction in sensor sensitivity of up to 4 mV 
after eight days. From day 0 to day 7, there was only a reduction of 2 mV which occurred in 
the beginning, after the first day (Figure B.2). A comparison of the calibration curves at the 
beginning and end of the culture showed that sensors retained 90-95% of their initial 
sensitivity. Finally, measurements obtained in the data acquisition board designed for this 
project were comparable to a commercial acquisition system (Figure B.3). No significant 
differences were observed in sensor readings taken from the two boards. 
 
8.4.3 Instability of pH sensors in cell culture 
 Cell culture monitoring using pH sensors were unsuccessful as the trends observed in 
pH behaviour over the culture period did not correspond to that for a typical cell culture. Cell 
culture pH in a static system generally decreases over time due to the increase in cellular 
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activities thus increasing waste and metabolite concentrations which acidifies culture media. 
Independent pH measurements were taken using a pH meter and showed a decrease in the 
overall pH of the culture media but instead, results from pH sensor readings showed an 
increasing trend (Figure 8.4a). Sensors deteriorated even further by the end of day 5, with 
readings rapidly increasing above pH 8.0. These sensors have clearly malfunctioned at this 
point. Trends in pH variation in the control bioreactors (PBS and media only) also showed an 
increasing trend, particularly for sensors 12 and 30, sensors placed in culture media (Figure 
8.4b). Sensors 4A and 31 showed a much more stable performance in comparison but it still 
displayed an increasing trend in pH values. No attempt on spatial profiling was made on this 
set of data since all the pH readings were irrational; spatial maps of pH variation obtained 
from this dataset would be meaningless. 
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Figure 8.4 Real-time monitoring of pH in static culture for Shh light 3T3 fibroblast cells. (a) 
Cell culture with nine sensors placed in DOE locations. Trends in pH did not correspond to 
cell behaviour or observations from culture. (b) Sensors in control bioreactors (4A and 12 
were in media while 30 and 31 were in PBS) 
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One observation made regarding pH sensor performance and stability for long-term 
cell culture monitoring is the shift in calibration curves of all pH sensors used in the 
experiment. Upon recalibration after six days in culture, a significant shift in the offset of the 
sensor calibration curves and a lost in sensor sensitivity was observed (Table 8.1). Sensitivity 
of pH sensors was reduced to 85.9 +/- 7.2% from its initial values (Table 8.1). This lost in 
sensitivity is small considering the length of time it has been exposed to a serum-containing 
culture (six days). However, the shift in the offset value was large and has drastically moved 
the calibration curve along the y-axis, shifting all the pH readings from when it was 
originally calibrated. The causes for the shift in the offset are still unclear but they are likely 
related to instability of the membrane. The shift in the offset is likely to occur over the course 
of time during the cell culture. However, it was difficult to determine how much this offset 
has drifted each day during the cell culture so only an estimation of this drift per day can be 
made. For these reasons, it is very likely that the estimation of the calibration curves used for 
pH conversion was not very accurate which resulted in inaccurate pH readings throughout the 
culture study.  
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Table 8.1 Stability of pH sensors (n = 13). Slopes and offset values of pH calibration curves 
before and after cell culture. An average lost in sensitivity of 13.3% was observed. 
Significant shift in the offset values occurred for most all sensors (data provided by Anna 
Radomska). 
Sensor 
No. 
Slope before 
(mV/decade) 
Slope after 
 (mV/decade) 
Lost in sensor 
Sensitivity 
(%) 
Offset 
value 
(before) 
Offset 
value 
(after) 
6a 68.83 57.83 16.0 181 8 
30 63.17 58.30 7.7 188 85 
4a 61.88 41.67 32.7 130 52 
3a 58.67 54.67 6.8 206 14 
9a 66.67 58.33 12.5 164 34 
13a 68.81 55.17 2.0 175 -6 
27 54.50 52.83 3.1 46 22 
10a 62.34 50.83 18.5 100 -11 
31 53.33 52.67 1.2 228 156 
12 62.70 54.67 12.8 186 -19 
5a 66.67 56.83 14.8 172 34 
38 63.81 57.83 9.4 120 9 
11a 69.16 57.30 1.7 224 -20 
 
In terms of sensor sensitivity, the calibration curves for three individual pH sensors in 
media solution are shown in Appendix B (Figure B.4) and an average sensor sensitivity of 
61.5 +/- 2.5 mV/pH is achieved in the IrOx electrodes over the range of 3.5 to 9.9 pH values. 
Readings of pH also did not have issues relating to high noise levels as those encountered 
with the ammonia sensors; real-time readings were much more stable and less sensitive to 
external disturbances or interference. Sensor readings from the uniquely designed data 
acquisition system were almost identical to the readings obtained from a commercial data 
acquisition system (Table B.1), confirming the compatibility of the data acquisition system to 
pH sensors and its performance to be equivalent to a commercial system. 
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8.4.4 Performance of oxygen sensor in cell culture 
 Oxygen sensors performed well and stably for up to three days in serum-containing 
cell culture (Figure 8.5). On the third day, sensors were removed and cells, examined under 
the microscope, looked healthy and increased in cell density. Oxygen sensors were soaked in 
ultrapure deionised water for about 30 min to remove protein layer that may have adhered 
onto the surface of the membrane before being placed back into the bioreactor, a media 
change was also performed during this time. Unfortunately, four out of nine sensor readings 
subsequent to the third day were extraordinarily high. These values (sensors 12A, 14A, 6A 
and 9A) were irrational as they indicated readings of greater than the 21% oxygen saturation. 
Overall, sensor readings were much more stable during the first three days as compared to the 
last three days (Figure 8.5). However, it is unclear as to why some of the sensors have 
subsequently malfunctioned as the recalibration performed at the end of the experiment did 
not indicate these behaviours. All sensor readings from the last three days were generally 
higher than readings taken from the first three days. 
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Figure 8.5 Oxygen real-time data for Shh-light fibroblast static culture. Oxygen readings 
were stable and within operating range during the first three days only, subsequent to that, 
sensor readings were mostly out of range and appeared to be less stable than its performance 
during the first three days. 
 
Recalibration performed at the end of the culture showed only an average loss of 
9.3% in the sensitivity of sensor performance. Spatial maps for oxygen were created using 
DOE; the goodness of fit to the models were low (< 0.750) and showed a significant lack of 
fit suggesting that the models were not appropriate (Figure 8.6). A closer look at the 
individual data points showed one significant outlier within the data skewing the spatial maps 
toward a low oxygen regime in that particular area; this resulted in a slight mismatch in the 
spatial maps of oxygen to the cell map (where cells are located within the bioreactor – see 
Figure 4.7 for cell seeding map). The cause of the unexpectedly low oxygen reading from 
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this particular sensor is still unknown and it is unclear if it has been a contribution of 
physiological conditions or a malfunction in sensor or an interference causing an inaccurate 
reading. Areas where cells were located are expected to have lower oxygen concentrations, 
which in this case have been consistent for the four sensors locations at the “pie area” where 
cells were located (Figure 4.7). As a consequence of the contribution of both outliers, the 
overall spatial profile in oxygen concentration obtained from this study did not correspond to 
the cellular spatial map, where cells were confined to a specific area in the bioreactor. 
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Figure 8.6 Spatial maps for oxygen. Goodness of fit was poor and also showed a lack of fit. 
A significant outlier was identified which may also have skewed the profiles, causing a 
mismatch with the cell map shown in Figure 8.7. 
 
 Sensor calibration for oxygen was performed at two concentrations, 0 µM and 278 
µM which were equivalent to 0% and 21% oxygen saturation at room temperature 
respectively. The calibration curves for three independent sensors are displayed in Figure B.5 
in Appendix B. The recalibration data showing the loss in sensitivity of oxygen sensors after 
six days in culture is provided in Table B.2. The average lost in sensor sensitivity is 11.0% 
with a maximum at 35.5% after six days. The comparison of sensor readings between the two 
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boards (our system versus a commercial system) is shown in Table B.3. Readings taken from 
the two systems showed insignificant differences: readings were less than 5.0% mean 
difference. This data confirms the performance of oxygen sensors with our uniquely designed 
data acquisition system to be comparable to the performance in a commercial system. 
 
8.4.5 Operational stability of data acquisition system 
 The data acquisition system and GUI uniquely designed for simultaneous monitoring 
of multiple process analytes have been tested with ammonia, pH, and oxygen sensors in this 
study. When compared to a commercial system, the data acquisition system provided 
readings that were very close to those obtained from the commercial system for all three 
sensors (Appendix B). In terms of continuous process monitoring, initially, the system was 
tested for up to seven days for cell culture monitoring using a USB interface. Sporadically, 
there were problems with the USB interface communication which halted all data collection 
in the middle of a run. The alternate interface built into this system was the PCI bus and is 
currently switched into this connection. Since moving to the PCI connection, it had no further 
issues with data collection or interface communication. The system was able to collect, 
manage and store all real-time data from multiple process analytes efficiently and 
continuously for up to seven days of a process operation. This system was also tested 
independently for up to two months of continuous monitoring in the bioengineering 
laboratory performed by a colleague (X. Yue) in the project. Though the PCI is a much more 
stable and reliable communication interface, the hardware components were bulky and can be 
of slight inconvenience. The USB interface is therefore preferred due to its small and slick 
design, and convenience in use. A new USB card is currently being tested to replace the 
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existing/problematic card as it is more likely that the lost in USB communication was due to 
a hardware failure than a system failure. The new USB card will be installed into the system 
for future testing. 
 
 
8.5 DISCUSSION 
 Bioprocess monitoring and control are essential components in ensuring the product 
quality, reproducibility, and productivity of a bioprocess of interest. The proposed online 
real-time in situ monitoring platform capable of simultaneous monitoring of multiple process 
analytes can bring significant contributions in cell culture bioprocessing practises. So far, the 
system has been tested with ammonia, pH and oxygen sensors. Functional and operational 
stability of the monitoring platform is assured; the main hurdles are faced with sensor 
performances with each respective sensor. Initial design and testing of each sensor performed 
in BSA solution showed excellent sensor performance i.e. sensitivity and stability over long 
periods. However, when tested in cell culture, several problems arose. In the following 
sections, a discussion regarding the sensor performances is presented. 
 
8.5.1 Requirements for in situ sensors 
Use of in situ sensors is intended to capture any process variation within a cell culture 
bioreactor. However, there are several challenges in the use of in situ sensors for long-term 
cell culture process monitoring. The four main challenges that need to be addressed in the 
design of in situ biosensors include (a) biocompatibility of the sensors i.e. sensors must not 
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be toxic to cells and sterilisable, (b) sensor stability and sensitivity in cell culture 
environment, and (c) longevity of sensors for long-term monitoring of cell cultures. 
Longevity of in situ sensors in continuous cell culture process monitoring is still rather 
limited. A recent study done by Rodrigues et al. showed the performance of glucose and 
oxygen amperometric sensors in a continuous culture for up to 2.5 hr99. The glucose and 
oxygen microsensors were integrated in a PDMS cell culture chamber and positioned at the 
inlet and outlet of the chamber for continuous real-time process monitoring of HepG2 cells in 
culture. Sensors that were designed for this application showed good response sensitivity and 
stability in cell culture media but were only able to show their performance for up to 2.5 hr99. 
Longevity of electrochemical and biosensors in a cell culture environment is still one of the 
major obstacles that needs to be overcome particularly for glucose sensors which are known 
to have a short lifetime in cell culture. In the following sections, the overall performance of 
the ammonia, pH, and oxygen sensors in relation to the sensor requirements as stated above 
and recommendations for further development and improvements will be discussed. Table 
8.2 provides a summary of the current status and achievements made for each sensor. 
 
Table 8.2 Achievements and current status of ammonia, pH, and oxygen sensors. 
Requirements not achieved are highlighted in red. 
Sensor Biocompatible Sensitivity 
in BSA 
Sensitivity in 
media 
Stability in 
culture 
Longevity in 
culture 
Ammonia No Nernstian Sub-nernstian Some noisy 
sensors 
7 days 
pH Yes Nernstian Nernstian No No 
Oxygen Not clear Good Good Yes 3 days 
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8.5.1.1 Sensor membrane composition 
 Biocompatibility of sensor membranes is crucial to ensure its application in long-term 
monitoring of cell culture bioprocesses. Membrane layers that have been selected for the 
design of various sensors included PEG for the ammonia sensors, Nafion for the pH sensors, 
and PDMS for the oxygen sensors.  
PEG is a hydrophilic polymer and is commonly used as it can prevent the adsorption 
of protein on the membrane layer. PEG layer for the ammonia sensors have been doped with 
DOS in order to provide membrane stability. Unfortunately, the high concentration of DOS 
used in the membrane layer (60%) appears to be toxic to the cells, causing cell death in long-
term static cultures. Concentrations of DOS in the PEG layer could potentially be reduced; 
however this may affect the performance (sensor stability) for long-term cell culture 
monitoring. Studies to improve ammonia membrane composition in the effort to reduce the 
use of toxic components while maintaining stability of the membrane are currently being 
carried out.  
Nafion is a sulfonated tetrafluorethylene copolymer which is commonly used in the 
production of sensors due to its favourable physical properties such as its conduciveness to 
cations, resistivity to chemical attacks, and excellent biocompatibility – showing stability in 
both in vitro and in vivo applications173,174. Many electrochemical and biosensors using 
Nafion layers showed good biocompatibility. Similarly, in this study, there were no 
biocompatibility issues with the pH sensors which were coated in Nafion layer.  
Finally, PDMS is a widely used silicon-based organic polymer known to be 
chemically inert, non-toxic and biocompatible. Due to its good mechanical, optical and 
biological properties, PDMS membranes and materials have been widely used as a bio-
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interface for many different types of biosensing devices and for various cell culture 
applications175,176. The oxygen sensors which were coated in PDMS layers surprisingly 
showed inconsistent results from the biocompatibility and toxicity studies. It is still unclear 
why oxygen sensors coated in PDMS would be toxic to cells; however results obtained for 
oxygen toxicity study were inconsistent. The protocol for making oxygen sensors is currently 
being re-evaluated to determine the cause of the problem. 
 
8.5.1.2 Ammonia sensors 
Although sensor stability and longevity of ammonia sensors were assured for up to 
seven days in cell culture, the main problem lies in its toxicity to cells. Leakage from 
membrane components into the cell culture is undesirable and the minimisation of toxic 
leakage is necessary. In a previous experiment performed by another colleague using only 
two ammonia sensors in a perfused cell culture system, no toxicity effects were observed; 
cellular growth was achieved with good cell viability at the end of a seven-day culture. 
However, in this study where nine sensors were placed in a static cell culture with only a 
media change performed on the third day of the culture, the accumulation of toxic leakage 
from nine sensors (instead of two in the perfused system) and the lack of continuous media 
displacement showed that leakage from ammonia sensor membranes can eventually become 
a problem. It is therefore necessary to improve membrane biocompatibility of ammonia 
sensors to ensure its performance in any cell culture environment.  
The second problem faced with the ammonia sensors is the lack of functional 
reliability resulting in high failure rate and high noise levels observed in sensor readings. 
Currently, two thirds of the sensors being produced achieved functional and operational 
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stability after being assembled in the culture bioreactor. The poor performance in sensor 
reliability is due to the fragility of sensor packaging itself and the lack of consistency in the 
manufacturing procedure. An improvement in the assembly of sensor components is 
currently being looked into and a more careful approach to the making and handling of 
ammonia sensors will be taken for future studies. 
 
8.5.1.3 pH sensors 
The main problem associated with the pH sensors is the shift in the calibration curve 
mainly relating to the offset value. The cause for this shift in the offset is currently still 
unknown but a possible explanation that has been suggested is the formation of chloride 
complexes from iridium (III) to (IV) which led to the loss of the oxide film; causing 
irreversible changes in the offset calibration values. Coating of sensors using Nafion did not 
appear to prevent destabilisation of the sensors in the presence of chloride ions. It appears 
that some modification in the membrane layer/coating has to be made to improve its stability 
and prevent the formation of soluble complexes. Sensor stability in cell culture environment 
affects overall longevity of the sensors. If the stability of pH sensors cannot be achieved for 
up to six days, shorter time lengths can be used which will simply result in more frequent 
sensor replacement. Other in situ pH sensors such as those designed by Krommenhoek et al. 
were tested for up to 10 hr in fermentation batch culture and the long-term drift rate was 
determined to be at 1.2 mV/hr177. The sensitivity of their sensors was -58 mV/pH unit while 
the sensitivity of pH sensors designed for this study was around -61.5 mV/pH unit, both are 
close to the ideal Nernstian behaviour. 
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8.5.1.4 Oxygen sensors 
Of all the three sensors, oxygen sensors showed the most promising results by 
achieving functional stability for up to three full days in continuous cell culture and obtaining 
spatial maps that somewhat corresponded to where cells were positioned. The achievement of 
functional stability for up to three days is of great significance as current in situ oxygen 
sensors have only been tested for up to 15 hr in a continuous fermentation culture by 
Krommenhoek et al.177 and up to 2.5 hr in cell culture media by Rodriguez et al99,177 . The 
electrochemical sensor from Krommenhoek et al. achieved a sensitivity of 0.96 nA/mg 
O2/L177 while the oxygen sensors designed in this study achieved a sensitivity of 0.17 nA/µM 
O2, which is equivalent to 5.35 nA/mg O2/L. Higher sensor sensitivity is achieved in this 
study. Unfortunately, biocompatibility of the oxygen sensors remains questionable as the 
results showed inconsistent findings. Membrane packaging of oxygen sensors are currently 
being improved and biocompatibility tests will be repeated before further experiments are 
pursued.  
  
8.5.2 Analyte spatial profiling using DOE 
 Limitations in obtaining the spatial profiles for each process analyte of interest 
currently lie in the lack of sensitivity and functional stability of the sensors and not by 
limitations of the DOE method. Weaknesses in the performance of the sensors are reflected 
by variability in the readings of the sensors and in some cases, the lack of functional stability 
over the course of time. Significant noise levels due to the lack of sensor stability or 
environmental interferences does not provide a good basis for obtaining models in the spatial 
profiles with good fits. The DOE software, such as the one used in these experiments 
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(MODDE7 from Umetrics), can however accommodate the presence of “bad” process data or 
missing values in the DOE matrix. In the default setting, when all process responses are 
available, the MLR method is used to obtain a model fit. When a missing data is present, the 
partial least squares (PLS) method is used instead. In the PLS mode, up to two “bad” process 
data can be accommodated and still achieve a reasonable fit to the process model. However, 
if the process data for most points in the DOE are scattered randomly, this will be reflected in 
a poor fit or lack of fit in the model. Based on the results currently observed from the 
ammonia and oxygen sensors, the overall functional stability of each sensor type needs to be 
improved as significant process variability in the data points were observed thus generating 
models with poor fit or even a lack of fit in some cases. 
 
 
8.6 CONCLUSION 
 The successful integration and functional operation of ammonia, pH, and oxygen 
sensors with the uniquely designed multi-channel, multi-analyte data acquisition system was 
achieved in this study. Operational stability of the hardware and software components for the 
online real-time monitoring platform has been established for continuous cell culture 
monitoring for up to seven days. Oxygen sensors were also stable for up to three days in 
continuous cell culture. Real-time process information obtained for ammonia and oxygen 
generated spatial and temporal maps that have not yet been performed elsewhere. These 
information-rich DOE models can elucidate spatial variations that exist within a bioreactor 
and will allow us to improve process homogeneity. Currently, the elucidation of process 
variations using the DOE method is impaired by sensor sensitivity and stability which 
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resulted in poor model fits. Even though there are still several problems associated with each 
sensor type, the achievements made in this study has brought us yet another step closer to the 
realisation of an intelligent online real-time monitoring system capable of simultaneous 
process monitoring and ultimately process control for stem cell culture bioprocesses. The 
success of this intelligent system will help to overcome many of the bioprocess limitations 
currently faced in stem cell cultures, and accelerate the translation and scale-up of stem cell 
cultures from a research environment to a manufacturing production. 
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CHAPTER 9 
Overall Conclusions and Future Work 
 
 
 
 
9.1 OVERALL CONCLUSIONS 
 The main goal in this thesis is to develop statistical design strategies and an online 
real-time in situ monitoring system for the characterisation, optimisation, and control of 
haematopoietic stem cell culture bioprocesses. Overall conclusions as a result of the efforts 
toward this goal are summarised in the following sections. 
 
9.1.1 Single-step process characterisation 
In this study, successful expansion and accelerated differentiation of cord blood stem 
cells toward the erythroid lineage was achieved via a simple DOE experimental strategy. The 
investigation not only demonstrated the efficiency and effectiveness in using DOE for the 
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characterisation and optimisation of complex cell culture bioprocesses such as those in HSCs, 
but also produced quantitative models that can be used to describe the process of interest. 
Optimisation based on the DOE models provided optimal process conditions which produced 
results far more superior to comparable studies achieved without using the DOE method. 
However, the optimisation of this process as a single-step cytokine culture is end-point driven 
and does not reveal in vitro process dynamics. 
 
9.1.2 Multi-step process characterisation 
Sequential characterisation in order to reveal in vitro process dynamics was much 
more challenging than defining a single-step cytokine culture using DOE. Challenges in 
sequential characterisation include definition of culture phases, process objectives, 
concentration ranges, and selection of DOE designs. In this study, three independent process 
models were successfully generated using the proposed DOE approach. These models reflect 
differences in process requirements and provide some insights into the process dynamics. A 
slight improvement in growth performance was also achieved in the three-step cytokine 
culture versus the single-step without any compromise in erythroid maturation. However, 
optimisation of the three-step culture required significantly more time and effort than the 
single-step culture. Benefits in using the multi-step approach must be weighed against the 
single-step according to process goals. The conclusion from this study still presents the multi-
step DOE approach as a powerful tool for revealing process intricacies and is important for 
achieving a better understanding of in vitro cell culture bioprocesses. 
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9.1.3 Spatial profiling 
 As a statistical method, DOE was successfully applied to the sampling of analytes in 
a process area of interest and generated information-rich data by way of spatial and temporal 
profiles for the parameter of interest, in this case, temperature. Sampling using DOE also 
provided a way to minimise the use of sensors while still maximising the amount of 
information extracted from process data. The success in this approach allowed knowledge of 
local concentration gradients that will ultimately lead to real-time, local and “intelligent” 
bioprocess control. In an ideal system, such bioprocess operation and control is one that will 
resemble processes occurring in our body (in vivo). 
 
9.1.4 Cell culture process monitoring 
 In this study, successful integration and functional operation of a uniquely designed 
online real-time in situ monitoring platform was achieved for the monitoring of pH, oxygen 
and ammonia. Compatibility of each sensor type with the data acquisition system was 
demonstrated and readings obtained from this system were comparable to those obtained 
from a commercial system. Oxygen sensors achieved sensor longevity of up to three days in 
continuous culture and only require slight modifications to improve the biocompatibility of 
the sensors. Ammonia sensors also appeared to be stable for up to seven days in culture but 
have severe toxicity on cells and may require significant modifications. The pH sensors were 
most biocompatible but lost significant sensitivity in cell culture. Although results from 
sensor performances were somewhat disappointing, this study is a key step toward stem cell 
culture bioprocessing efforts that brings us closer to the realisation of a real-time monitoring 
system that is economical, convenient, and practical for stem cell culture bioprocesses. 
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9.2 FUTURE WORK 
 Experimental studies performed for DOE characterisation and optimisation of HSC 
cultures have demonstrated the efficiency and effectiveness of DOE methods in studying 
complex culture bioprocesses. As a single-step, process optimisation using DOE was 
straight-forward, but as a multi-step that is kinetics-driven challenges in process optimisation 
arose. Utilisation of DOE for spatial elucidation of process analytes showed promising 
applications for cell culture process monitoring. The successful integration and operational 
performance of the unique online real-time monitoring platform designed for stem cell 
culture bioprocesses has also been demonstrated. However, functional stability of sensors in 
cell culture was not established and the generation of spatial profiles from sensor process data 
was difficult. The following sections will discuss possible research directions toward 
achieving better DOE characterisation strategies for revealing process dynamics and future 
developments needed in the real-time monitoring platform for stem cell culture bioprocesses. 
 
9.2.1 DOE strategies for revealing process dynamics 
 Sequential characterisation of cell culture bioprocesses can be improved by 
performing factor screening at each stage of the culture to identify main influences on the 
process of interest. This screening step is necessary as the effects of certain factors, as 
supported in Chapter 6 and in other studies, may be transitional. A resolution IV fractional 
factorial design is still recommended as it is very useful in identifying individual effects 
independently. Subsequent to the screening process, factors influencing the culture can be 
characterised using the CCD design. Process screening and characterisation should be 
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performed sequentially as demonstrated in the new workflow proposed in Figure 6.10. 
Process ranges selected for each factor in this case can begin at low concentrations since the 
screening step pre-determines the significance of each factor. For the later stages of the 
process, optimisation using the path of steepest ascent can be taken to optimise process 
conditions that are required for this stage of the process. 
 Definition of culture phases is one of the key considerations in the multi-step process 
optimisation. In reality, it is almost impossible to determine the ideal/optimal number of 
phases required for each cell culture process of interest as this “number” may vary from 
process to process or even sample to sample. As a starting point, definition of culture phases 
based on growth kinetics is a good consideration. A comparison to the in vitro process and an 
attempt to mimic that may also be worthwhile considerations. Ultimately, the decision to 
determine the number of phases in a culture will also be dependent on the feasibility and 
practicality of the approach since more phases will mean more characterisation experiments, 
labour, and expenses required.  
 The process objective for each phase of the culture is an important consideration. In 
this study, the objectives in each phase were identical which may not have been the ideal 
approach but it also depends on the overall goal of the experiment. However, it is important 
to realise that the objective in each phase may significantly affect the results in subsequent 
phases. A careful consideration of the objective must therefore be taken. Definition of the 
process objective in each phase also allows flexibility in the control of the cell culture 
outcome. 
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9.2.2 Future developments for the monitoring platform 
Functional stability and sensor sensitivity for each type of sensors (ammonia, pH and 
oxygen) must be improved in order to achieve more stable and reliable process readings 
during a continuous cell culture. This will significantly improve models of the spatial maps 
obtained via the DOE method and provide a better account of local concentration gradients. 
In addition, biocompatibility of ammonia and oxygen sensors has to be assured, and any 
modification made to membrane composition should not compromise sensor sensitivity. 
Multiple analyte process monitoring using all three sensors simultaneously will then be tested 
for this system to demonstrate operational functionality of the system for multi-analyte 
monitoring. The development of glucose and lactate sensors is also being pursued to deliver 
monitoring of nutrients and metabolites in a cell culture. 
Future sensor developments that will provide significant advantages in process 
applications should include miniaturisation and the design of multiple analytes bounded into 
a single sensor unit. Miniaturisation of the sensor unit will allow more precise readings 
obtained at the specific sensor locations and minimise the invasiveness of each probe unit. 
Bundling of sensor units will also minimise invasiveness and provide greater convenience in 
the use of multiple sensors. 
Wireless communication for the data acquisition system is highly desirable as it will 
minimise the use of connectors and wires running through the incubators. The ability to 
achieve wireless communication in sensor readings will greatly enhance the uniqueness and 
convenience in the use of this online real-time monitoring system. A control algorithm that is 
suitable for stem cell culture bioprocesses must also be designed and tested to achieve 
optimal bioprocessing practises. 
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APPENDIX A 
ANOVA analysis for DOE characterisation studies 
 
 
ANOVA for characterisation studies from Chapters 5 and 6 are presented in Appedix A. Tables 
A.1 and A.2 are for Chapter 5. Tables A.3 to A.8 are for Chapter 6.  
 
 
Figure A.1 GPA-PE positive control using red blood cells obtained from the cord  
Cord blood red blood cells 
GPA-positive-control 
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Table A.1 ANOVA for fold expansion of cord blood cultured cells in DOE optimised cocktail 
Response: Fold Transform: Base 10 log      Constant:  8.5 
ANOVA for Response Surface Quadratic Model 
Backward Elimination Regression with Alpha to Exit = 0.050 
 
  Coefficient t for H0 
Removed Estimate Coeff=0 Prob > |t| R-Squared MSE 
 B2  -0.22 -1.78 0.1256 0.9650 0.040 
 
 Sum of  Mean F  
Source Squares DF Square Value Prob > F 
Model  7.78 4 1.94 48.31 < 0.0001
 significant 
A   1.28 1 1.28 31.86 0.0008 
B   0.83 1 0.83 20.68 0.0026 
A2  4.40 1 4.40 109.31 < 0.0001 
AB  0.67 1 0.67 16.56 0.0048 
Residual 0.28 7 0.040 
Lack of Fit 0.22 3 0.073 4.77 0.0827  
Pure Error 0.062 4 0.015 
Cor Total 8.06 11 
 
Std. Dev. 0.20  R-Squared 0.9650 
Mean  2.16  Adj R-Squared 0.9451 
C.V.  9.29  Pred R-Squared 0.8356 
PRESS             1.32                            Adeq Precision                  16.259 
 
Coefficient  Standard 95% CI 95% CI 
Factor  Estimate DF Error Low High 
 Intercept 2.73 1 0.083 2.54 2.93 
 A-SCF 0.46 1 0.082 0.27 0.66  
 B-EPO 0.41 1 0.091 0.20 0.63  
 A2 -1.22 1 0.12 -1.50 -0.95  
 AB 0.41 1 0.10 0.17 0.65 
 
Final Equation in Terms of Actual Factors: 
 
 Log10(Fold + 8.50)  = 1.04438   
   +0.049933   * SCF 
   +2.26926E-003  * EPO 
   -4.88514E-004  * SCF2 
   +2.72105E-003  * SCF * EPO 
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Table A.2 ANOVA for red cell maturation of cord blood cultured cells in DOE optimised 
cocktail 
Response: %RBC Transform: Power Lambda: 1     Constant: 0.666 
ANOVA for Response Surface Quadratic Model 
 
Analysis of variance table [Partial sum of squares] 
  Sum of  Mean F  
Source Squares DF Square Value Prob > F 
Model 5091.88 3 1697.29 127.42 < 0.0001 significant 
A 79.50 1 79.50 5.97 0.0404 
B 3605.40 1 3605.40 270.67 < 0.0001 
B2 2144.75 1 2144.75 161.01 < 0.0001 
Residual 106.56 8 13.32 
Lack of Fit 91.08 4 22.77 5.88 0.0572  
Pure Error 15.49 4 3.87 
Cor Total 5198.44 11 
 
 Std. Dev. 3.65  R-Squared 0.9795 
 Mean 54.89  Adj R-Squared 0.9718 
 C.V. 6.65  Pred R-Squared 0.8920 
 PRESS 561.59  Adeq Precision 29.486 
 
  Coefficient  Standard 95% CI 95% CI 
 Factor Estimate DF Error Low High  
  Intercept 64.04 1 1.38 60.86 67.22 
  A-SCF 3.64 1 1.49 0.20 7.08  
  B-EPO 27.41 1 1.67 23.57 31.25  
  B2 -27.44 1 2.16 -32.43 -22.46  
 
 
  Final Equation in Terms of Actual Factors: 
 
   (%RBC + 0.67)1  = 
  +5.54600 
  +0.072800   * SCF 
  +27.43206   * EPO 
  -3.04942   * EPO2 
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Table A.3 ANOVA for response surface model of phase I characterisation study (Experiment 1) 
Response: Cell expansion  
ANOVA for Response Surface Quadratic Model 
 
  Sum of  Mean   F  
Source  Squares DF Square  Value          Prob > F 
Model              765.62 4 191.41 13.06 0.0001 significant 
B              33.86 1 33.86 2.31 0.1509 
C 417.32 1 417.32 28.47 0.0001 
C2     133.95 1 133.95 9.14 0.0091 
BC         180.50 1 180.50 12.31 0.0035 
 
Residual          205.25 14 14.66 
Lack of Fit      152.08 10 15.21 1.14 0.4874 not significant 
Pure Error       53.17 4 13.29 
Cor Total       970.87 18 
 
Std. Dev. 3.83  R-Squared 0.7886 
Mean 41.38  Adj R-Squared 0.7282 
C.V. 9.25  Pred R-Squared 0.5526 
PRESS 434.36  Adeq Precision 11.414 
 
 
  Coefficient  Standard 95% CI 95% CI 
Factor Estimate DF Error Low High  
Intercept 44.18 1 1.28 41.44 46.92 
B-IGFII 1.84 1 1.21 -0.76 4.44  
C-EPO 6.46 1 1.21 3.86 9.06  
C2 -5.32 1 1.76 -9.09 -1.54 
BC -4.75 1 1.35 -7.65 -1.85 
 
Final Equation in Terms of Coded Factors: 
 
   2E fold  = 
  +44.18 
  +1.84   * B 
  +6.46   * C 
  -5.32   * C2 
  -4.75   * B * C 
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Table A.4 ANOVA for response surface model of phase I characterisation study (Experiment 2) 
Response: Cell expansion  
ANOVA for Response Surface Quadratic Model 
 
  Sum of  Mean F  
Source Squares DF Square Value Prob > F 
Model 2700.38 4 675.09 10.76 0.0003 significant 
 B 795.66 1 795.66 12.69 0.0031 
 C 1054.73 1 1054.73 16.82 0.0011 
 C2 433.82 1 433.82 6.92 0.0198 
 BC 416.16 1 416.16 6.64 0.0220 
  
Residual 878.07 14 62.72 
Lack of Fit 369.33 10 36.93 0.29 0.9487 not significant 
Pure Error 508.73 4 127.18 
Cor Total 3578.44 18 
 
Std. Dev. 7.92  R-Squared 0.7546 
Mean  66.06  Adj R-Squared 0.6845 
C.V.  11.99  Pred R-Squared 0.5682 
PRESS 1545.23 Adeq Precision 11.050 
 
  Coefficient          Standard 95% CI 95% CI 
Factor Estimate DF Error Low High  
Intercept 71.10  1 2.64 65.44 76.76 
B-IGFII 8.92 1 2.50 3.55 14.29 
C-EPO  10.27 1 2.50 4.90 15.64 
C2  -9.57 1 3.64 -17.37 -1.77 
BC  -7.21 1 2.80 -13.22 -1.21 
 
  Final Equation in Terms of Coded Factors: 
 
   2L  = 
 +71.10 
  +8.92   * B 
 +10.27   * C 
  -9.57   * C2 
  -7.21   * B * C 
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Table A.5 ANOVA for response surface model of phase II characterisation study (Experiment 1) 
Response: Cell expansion  
ANOVA for Response Surface Quadratic Model 
 
  Sum of  Mean F  
Source Squares DF Square Value Prob > F 
Model 1993.74 3 664.58 7.41 0.0028 significant 
A  469.22 1 469.22 5.23 0.0371 
C  974.17 1 974.17 10.87 0.0049 
C2  550.35 1 550.35 6.14 0.0256 
  
Residual 1344.90 15 89.66 
Lack of Fit 962.38 11 87.49 0.91 0.5930 not significant 
Pure Error 382.53 4 95.63 
Cor Total 3338.65 18 
 
Std. Dev. 9.47 R-Squared 0.5972 
Mean  56.42 Adj R-Squared 0.5166 
C.V.  16.78 Pred R-Squared 0.3812 
PRESS  2065.97 Adeq Precision 7.906 
 
 
  Coefficient  Standard 95% CI 95% CI 
Factor Estimate DF Error Low High  
 Intercept      62.09 1 3.16 55.36 68.82 
 A-SCF 6.85 1 2.99 0.47 13.23  
 C-EPO 9.87 1 2.99 3.49 16.25  
 C2 -10.78 1 4.35 -20.05 -1.51  
 
 
 Final Equation in Terms of Coded Factors: 
 
   2F  = 
  +62.09 
  +6.85   * A 
  +9.87   * C 
  -10.78   * C2 
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Table A.6 ANOVA for response surface model of phase II characterisation study (Experiment 2) 
Response: Cell expansion  
ANOVA for Response Surface Quadratic Model 
 
  Sum of  Mean F  
Source Squares DF Square Value Prob > F 
Model 13080.17 3 4360.06 34.90 < 0.0001 significant 
A 2344.57 1 2344.57 18.77 0.0006 
C 7022.50 1 7022.50 56.21 < 0.0001 
C2 3713.09 1 3713.09 29.72 < 0.0001 
 
Residual 1874.08 15 124.94 
Lack of Fit 1270.25 11 115.48 0.76 0.6735 not significant 
Pure Error 603.83 4 150.96 
Cor Total 14954.25 18 
 
 Std. Dev. 11.18 R-Squared 0.8747 
 Mean 121.16 Adj R-Squared 0.8496 
 C.V. 9.23 Pred R-Squared 0.8055 
 PRESS 2908.62 Adeq Precision 16.597 
 
  Coefficient  Standard 95% CI 95% CI 
Factor Estimate DF Error Low High  
Intercept 135.90 1 3.73 127.96 143.84 
 A-SCF 15.31 1 3.53 7.78 22.85  
 C-EPO 26.50 1 3.53 18.97 34.03  
 C2 -28.00 1 5.14 -38.94 -17.05  
 
Final Equation in Terms of Coded Factors: 
 
   2G  = 
  +135.90 
  +15.31   * A 
  +26.50   * C 
  -28.00   * C2 
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Table A.7 ANOVA for response surface model of phase III characterisation study (Experiment 1) 
Response: Cell expansion  
ANOVA for Response Surface Quadratic Model 
 
  Sum of  Mean F  
Source Squares DF Square Value Prob > F 
Model 125.73 4 31.43 23.42 < 0.0001   significant 
 A 15.23 1 15.23 11.35 0.0042 
 C 42.44 1 42.44 31.62 < 0.0001 
 A2 13.81 1 13.81 10.29 0.0059 
 C2 13.42 1 13.42 10.00 0.0065 
  
Residual 20.13 15 1.34 
Lack of Fit 13.17 10 1.32 0.95 0.5623  not significant 
Pure Error 6.96 5 1.39 
Cor Total 145.86 19 
 
 
 Std. Dev. 1.16 R-Squared 0.8620 
 Mean 8.83 Adj R-Squared 0.8252 
 C.V. 13.12 Pred R-Squared 0.7303 
 PRESS 39.34 Adeq Precision 12.830 
 
   Coefficient Standard 95% CI 95% CI 
Factor Estimate DF Error Low High  
 Intercept 10.89 1 0.39 10.06 11.72 
 A-SCF 1.23 1 0.37 0.45 2.01  
 C-EPO 2.06 1 0.37 1.28 2.84  
 A2 -2.08 1 0.65 -3.46 -0.70  
 C2 -2.05 1 0.65 -3.43 -0.67  
 
 
  Final Equation in Terms of Coded Factors: 
 
   2K  = 
  +10.89 
  +1.23   * A 
  +2.06   * C 
  -2.08   * A2 
  -2.05   * C2 
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Table A.8 ANOVA for response surface model of phase III characterisation study (Experiment 2) 
Response: Cell expansion  
ANOVA for Response Surface Quadratic Model 
 
  Sum of  Mean F  
Source Squares DF Square Value Prob > F 
Model 14.91 3 4.97 5.97 0.0063    significant 
 A 0.12 1 0.12 0.14 0.7119 
 C 8.85 1 8.85 10.63 0.0049 
 A2 5.94 1 5.94 7.13 0.0168 
  
Residual 13.32 16 0.83 
Lack of Fit 11.64 11 1.06 3.15 0.1076   not significant 
Pure Error 1.68 5 0.34 
Cor Total 28.24 19 
  
 Std. Dev. 0.91  R-Squared 0.5281 
 Mean 4.27  Adj R-Squared 0.4396 
 C.V. 21.39  Pred R-Squared 0.3598 
 PRESS 18.08 Adeq Precision 7.548 
 
  Coefficient  Standard 95% CI 95% CI 
Factor Estimate DF Error Low High  
 Intercept 3.72 1 0.29 3.11 4.33 
 A-SCF -0.11 1 0.29 -0.72 0.50  
 C-EPO 0.94 1 0.29 0.33 1.55  
 A2 1.09 1 0.41 0.22 1.95  
 
 
  Final Equation in Terms of Coded Factors: 
 
   2N  = 
  +3.72 
  -0.11   * A 
  +0.94   * C 
  +1.09   * A2 
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APPENDIX B 
Sensor calibration curves and performance data 
 
 
 
Appendix B provides all sensor calibration curves and operational stability performance 
of ammonia, pH and oxygen sensors. This work was done by Anna Radomska at the Institute of 
Biomedical Engineering, collaborators in this project. All graphs were produced and kindly 
provided by her. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure B.1 Dynamic response of PEG-modified electrode toward ammonium ions in step 
changes of 0.5 mM ammonia concentrations.  
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Figure B.2 Operational stability of ammonia sensors in culture media over eight day period. A 
comparison of the ISE sensitivity after every 24 hours is used. 
 
 
Figure B.3 Comparison of ammonia readings performed on our system (DAQ) versus a 
commercial system (Commercial). 
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Figure B.4 Calibration curves for three independent pH sensors. The average slope in response is 
58.8 mV/pH. 
 
 
Table B.1 Comparison of pH readings taken from our system (DAQ) versus a commercial 
system. 
Sensor No. DAQ Commercial board 
El 38 46 46 
El 6A 122 124 
El 13A 109 109 
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Figure B.5 Oxygen sensor calibration curves for three independent sensors. Average sensor slope 
is 1.71x10-10 A/µM 
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Table B.2 Recalibration data and lost of sensitivity in oxygen sensors after six days in culture. 
Sensor Slope (before) Slope (after) Lost in sensitivity 
12a -6.47 -6.21 4.02% 
7a -5.33 -5.21 2.25% 
4a -3.04 -3.06 -0.82% 
9a -6.30 -4.06 35.48% 
15a -4.43 -2.97 33.10% 
3a -5.77 -5.57 3.45% 
6a -5.66 -4.54 19.79% 
2a -5.662 -5.01 11.57% 
1a -4.99 -4.98 0.24% 
8a -4.84 -4.80 0.89% 
 
 
 
 
 
Table B.3 Comparison of oxygen sensor readings taken from our system versus a commercial 
system. 
Sensor DAQ Commercial 
El2A -5.655 -5.665 
El12A -6.021 -6.210 
 
 
 
